LV961A-1 |
Lentiviral Technology UltraRapid Lentiviral Global Titering Kit (Human and Mouse compatible) |
42 reactions |
616-Eur |
SBI |
|
LVP299 |
RFP (Neo) lentiviral particles: Pre-made lentiviral particles expressing RFP with Neomycin antibiotic marker, in DMEM medium with 10 percent FBS and 60ug_ml of polybrene. |
1x10e7 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP012 |
YFP (Bsd) lentiviral particles: Pre-made lentiviral particles expressing yellow fluorescent protein (YFP), rovided in DMEM medium with 10 percent FBS, 60ug_ml polybrene. |
1x10e7 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP307 |
YFP (Neo) lentiviral particles: Pre-made lentiviral particles expressing YFP with Neomycin antibiotic marker, provided in DMEM medium with 10 percent FBS and 60ug_ml of polybrene. |
1x10e7 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP399 |
RFP-LC3 fusion lentiviral particles: Pre-made lentiviral particles expressing a RFP and human LC3 ORF (NM_022818.4), provided in DMEM medium with 10 percent FBS and 60ug_ml of polybrene. |
1x10e7 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP306 |
CFP (Neo) lentiviral particles: Pre-made lentiviral particles expressing CFP with Neomycin antibiotic marker, provided in DMEM medium with 10 percent FBS and 60ug_ml of polybrene. |
1x10e7 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP300 |
GFP (Neo) lentiviral particles: Pre-made lentiviral particles expressing GFP with Neomycin antibiotic marker, provided in DMEM medium with 10 percent FBS and 60ug_ml of polybrene. |
1x10e7 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP340 |
GFP (puro) lentiviral particles: Pre-made lentiviral particles expressing GFP with Puromycin antibiotic marker, provided in DMEM medium with 10 percent FBS and 60ug_ml of polybrene. |
1x10e7 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP471 |
YFP (puro) lentiviral particles: Pre-made lentiviral particles expressing YFP with Puromycin antibiotic marker, provided in DMEM medium with 10 percent FBS and 60ug_ml of polybrene. |
1x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP342 |
CFP (puro) lentiviral particles: Pre-made lentiviral particles expressing CFP with Puromycin antibiotic marker, provided in DMEM medium with 10 percent FBS and 60ug_ml of polybrene. |
1x10e7 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP412-PBS |
Luciferase-2A-NLS-CRE, (GFP-Puro) lentiviral particles, in vivo ready; premade lentiviral particles |
5 x107 IFU/ml x 200ul |
980-Eur |
GenTarget |
|
LVP412-PBS |
Luciferase-2A-CRE, (GFP-Puro) lentiviral particles, in vivo ready, premade lentiviral particles |
5 x107 IFU/ml x 200ul |
933-Eur |
GenTarget |
|
LVP409-PBS |
Luciferase-2A-CRE (Puro), lentiviral particles, in vivo ready, premade lentiviral particles |
5 x107 IFU/ml x 200ul |
933-Eur |
GenTarget |
|
LVP426-PBS |
GFP (EF1a)-Puro lentiviral particles, in vivo ready; premade lentiviral particles |
1x108 IFU/ml x 200ul |
808-Eur |
GenTarget |
|
LVP432-PBS |
CFP (EF1a)-Puro lentiviral particles, in vivo ready, premade lentiviral particles |
1x108 IFU/ml x 200ul |
770-Eur |
GenTarget |
|
LVP359-RP |
Chained human iPS (MKOS) (RFP-Puro) lentiviral particles, premade lentiviral particles |
1x106 IFU/ml x 0.5 ml |
1130-Eur |
GenTarget |
|
LVP358 |
Chained human iPS (OKSM) inducible lentiviral particles; premade lentiviral particles |
1x106 IFU/ml x 1.0 ml |
1186-Eur |
GenTarget |
|
LVP359 |
Chained mouse iPS (OKSM) inducible lentiviral particles; premade lentiviral particles |
1x106 IFU/ml x 1.0 ml |
1186-Eur |
GenTarget |
|
LVP432-PBS |
CFP (EF1a)-Puro lentiviral particles, in vivo ready; premade lentiviral particles |
1x108 IFU/ml x 200ul |
808-Eur |
GenTarget |
|
LVP358-RP |
Chained human iPS (MKOS) (RFP-Puro) lentiviral particles, premade lentiviral particles |
1x106 IFU/ml x 0.5 ml |
1130-Eur |
GenTarget |
|
LVP429-PBS |
RFP (EF1a)-Puro lentiviral particles, in vivo ready, premade lentiviral particles |
1x10e8 IFU/ml x 200ul |
770-Eur |
GenTarget |
|
LVP429-PBS |
RFP (EF1a)-Puro lentiviral particles, in vivo ready; premade lentiviral particles |
1x108 IFU/ml x 200ul |
808-Eur |
GenTarget |
|
LVP414-PBS |
Luciferase-2A-NLS-CRE, (RFP-Puro) lentiviral particles, in vivo ready; premade lentiviral particles |
5 x107 IFU/ml x 200ul |
980-Eur |
GenTarget |
|
LVP467-PBS |
YFP (EF1a)-Puro lentiviral particles, in vivo ready, premade lentiviral particles |
1x10e8 IFU/ml x 200ul |
770-Eur |
GenTarget |
|
LVP426-PBS |
GFP (EF1a)-Puro lentiviral particles, in vivo ready, premade lentiviral particles |
1x10e8 IFU/ml x 200ul |
770-Eur |
GenTarget |
|
LVP409-PBS |
Luciferase-2A-NLS-CRE (Puro), lentiviral particles, in vivo ready; premade lentiviral particles |
5 x107 IFU/ml x 200ul |
980-Eur |
GenTarget |
|
LVP414-PBS |
Luciferase-2A-CRE, (RFP-Puro) lentiviral particles, in vivo ready, premade lentiviral particles |
5 x107 IFU/ml x 200ul |
933-Eur |
GenTarget |
|
LVP458-C |
Endosomes-GFP, LocLight lentiviral particles
: Pre-made lentiviral particles for sub-cellular fluorescent labeling, provided in DMEM medium with 10 percent FBS and 60ug_ml of polybrene. CFP fluoresce |
1x107 IFU/ml x 200ul |
552-Eur |
GenTarget |
|
LVP455-C |
Plasma-mem-CFP, LocLight lentiviral particles
: Pre-made lentiviral particles for sub-cellular fluorescent labeling, provided in DMEM medium with 10 percent FBS and 60ug_ml of polybrene. CFP fluoresc |
1x107 IFU/ml x 200ul |
552-Eur |
GenTarget |
|
LVP456-G |
Microtubule-GFP, LocLight lentiviral particles
: Pre-made lentiviral particles for sub-cellular fluorescent labeling, provided in DMEM medium with 10 percent FBS and 60ug_ml of polybrene. GFP fluores |
1x107 IFU/ml x 200ul |
552-Eur |
GenTarget |
|
LVP456-R |
Microtubule-RFP, LocLight lentiviral particles
: Pre-made lentiviral particles for sub-cellular fluorescent labeling, provided in DMEM medium with 10 percent FBS and 60ug_ml of polybrene. RFP fluores |
1x107 IFU/ml x 200ul |
552-Eur |
GenTarget |
|
LVP456-C |
Microtubule-CFP, LocLight lentiviral particles
: Pre-made lentiviral particles for sub-cellular fluorescent labeling, provided in DMEM medium with 10 percent FBS and 60ug_ml of polybrene. CFP fluores |
1x107 IFU/ml x 200ul |
552-Eur |
GenTarget |
|
LVP457-G |
Lysosomes-GFP, LocLight lentiviral particles
: Pre-made lentiviral particles for sub-cellular fluorescent labeling, provided in DMEM medium with 10 percent FBS and 60ug_ml of polybrene. GFP fluoresce |
1x107 IFU/ml x 200ul |
552-Eur |
GenTarget |
|
LVP457-R |
Lysosomes-GFP, LocLight lentiviral particles
: Pre-made lentiviral particles for sub-cellular fluorescent labeling, provided in DMEM medium with 10 percent FBS and 60ug_ml of polybrene. RFP fluoresce |
1x107 IFU/ml x 200ul |
552-Eur |
GenTarget |
|
LVP457-C |
Lysosomes-GFP, LocLight lentiviral particles
: Pre-made lentiviral particles for sub-cellular fluorescent labeling, provided in DMEM medium with 10 percent FBS and 60ug_ml of polybrene. CFP fluoresce |
1x107 IFU/ml x 200ul |
552-Eur |
GenTarget |
|
LVP458-G |
Endosomes-GFP, LocLight lentiviral particles
: Pre-made lentiviral particles for sub-cellular fluorescent labeling, provided in DMEM medium with 10 percent FBS and 60ug_ml of polybrene. GFP fluoresce |
1x107 IFU/ml x 200ul |
552-Eur |
GenTarget |
|
LVP458-R |
Endosomes-GFP, LocLight lentiviral particles
: Pre-made lentiviral particles for sub-cellular fluorescent labeling, provided in DMEM medium with 10 percent FBS and 60ug_ml of polybrene. RFP fluoresce |
1x107 IFU/ml x 200ul |
552-Eur |
GenTarget |
|
LVP455-R |
Plasma-mem-RFP, LocLight lentiviral particles
: Pre-made lentiviral particles for sub-cellular fluorescent labeling, provided in DMEM medium with 10 percent FBS and 60ug_ml of polybrene. RFP fluoresc |
1x107 IFU/ml x 200ul |
552-Eur |
GenTarget |
|
LVP454-G |
Peroxisome-GFP, LocLight lentiviral particles
: Pre-made lentiviral particles for sub-cellular fluorescent labeling, provided in DMEM medium with 10 percent FBS and 60ug_ml of polybrene. GFP fluoresc |
1x107 IFU/ml x 200ul |
552-Eur |
GenTarget |
|
LVP453-C |
Nuc-membrane-CFP, LocLight lentiviral particles
: Pre-made lentiviral particles for sub-cellular fluorescent labeling, provided in DMEM medium with 10 percent FBS and 60ug_ml of polybrene. CFP fluore |
1x107 IFU/ml x 200ul |
552-Eur |
GenTarget |
|
LVP453-R |
Nuc-membrane-RFP, LocLight lentiviral particles
: Pre-made lentiviral particles for sub-cellular fluorescent labeling, provided in DMEM medium with 10 percent FBS and 60ug_ml of polybrene. RFP fluore |
1x107 IFU/ml x 200ul |
552-Eur |
GenTarget |
|
LVP454-R |
Peroxisome-GFP, LocLight lentiviral particles
: Pre-made lentiviral particles for sub-cellular fluorescent labeling, provided in DMEM medium with 10 percent FBS and 60ug_ml of polybrene. RFP fluoresc |
1x107 IFU/ml x 200ul |
552-Eur |
GenTarget |
|
LVP453-G |
Nuc-membrane-GFP, LocLight lentiviral particles
: Pre-made lentiviral particles for sub-cellular fluorescent labeling, provided in DMEM medium with 10 percent FBS and 60ug_ml of polybrene. GFP fluore |
1x107 IFU/ml x 200ul |
552-Eur |
GenTarget |
|
LVP454-C |
Peroxisome-GFP, LocLight lentiviral particles
: Pre-made lentiviral particles for sub-cellular fluorescent labeling, provided in DMEM medium with 10 percent FBS and 60ug_ml of polybrene. CFP fluoresc |
1x107 IFU/ml x 200ul |
552-Eur |
GenTarget |
|
LVP455-G |
Plasma-mem-GFP, LocLight lentiviral particles
: Pre-made lentiviral particles for sub-cellular fluorescent labeling, provided in DMEM medium with 10 percent FBS and 60ug_ml of polybrene. GFP fluoresc |
1x107 IFU/ml x 200ul |
552-Eur |
GenTarget |
|
LVP427-PBS |
RFP (EF1a)-Bsd lentiviral particles, in vivo ready, premade lentiviral particles |
1x10e8 IFU/ml x 200ul |
770-Eur |
GenTarget |
|
LVP109 |
h NR3C1 variant 6 inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP475 |
HPyV6 small T-antigen lentiviral particles , premade lentiviral particles |
1x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP335-Bsd-PBS |
β-Lactamase (Bsd) lentiviral particles, in vivo ready; premade lentiviral particles |
5x108 IFU/ml x 200ul |
808-Eur |
GenTarget |
|
LVP335-Neo-PBS |
β-Lactamase (Neo) lentiviral particles, in vivo ready; premade lentiviral particles |
5x108 IFU/ml x 200ul |
808-Eur |
GenTarget |
|
LVP335-GB-PBS |
β-Lactamase (GFP-Bsd) lentiviral particles, in vivo ready; premade lentiviral particles |
5x108 IFU/ml x 200ul |
808-Eur |
GenTarget |
|
LVP473 |
MCPyV small T-antigen lentiviral particles , premade lentiviral particles |
1x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP335-RB-PBS |
β-Lactamase (RFP-Bsd) lentiviral particles, in vivo ready; premade lentiviral particles |
5x108 IFU/ml x 200ul |
808-Eur |
GenTarget |
|
LVP425-PBS |
GFP (EF1a)-Neo lentiviral particles, in vivo ready, premade lentiviral particles |
1x10e8 IFU/ml x 200ul |
770-Eur |
GenTarget |
|
LVP310-PBS |
GFP (EF1a)-Bsd lentiviral particles, in vivo ready, premade lentiviral particles |
1x108 IFU/ml x 200ul |
770-Eur |
GenTarget |
|
LVP108 |
h NR3C1 variant 1 inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP428-PBS |
RFP (EF1a)-Neo lentiviral particles, in vivo ready, premade lentiviral particles |
1x10e8 IFU/ml x 200ul |
770-Eur |
GenTarget |
|
LVP411-PBS |
Luciferase-2A-NLS-CRE, (GFP-Bsd) lentiviral particles, in vivo ready; premade lentiviral particles |
5 x107 IFU/ml x 200ul |
980-Eur |
GenTarget |
|
LVP410-PBS |
Luciferase-2A-NLS-CRE (Neo), lentiviral particles, in vivo ready; premade lentiviral particles |
5 x107 IFU/ml x 200ul |
980-Eur |
GenTarget |
|
LVP407-PBS |
NLS-CRE-2A-GFP (Puro), lentiviral particles , in vivo ready; premade lentiviral particles |
5 x107 IFU/ml x 200ul |
808-Eur |
GenTarget |
|
LVP411-PBS |
Luciferase-2A-CRE, (GFP-Bsd) lentiviral particles, in vivo ready, premade lentiviral particles |
5 x107 IFU/ml x 200ul |
933-Eur |
GenTarget |
|
LVP-Null-GP |
Negative Control lentiviral particles (GFP-Puro); premade lentiviral particles |
1 x107 IFU/ml x 200ul |
400-Eur |
GenTarget |
|
LVP410-PBS |
Luciferase-2A-CRE (Neo), lentiviral particles, in vivo ready, premade lentiviral particles |
5 x107 IFU/ml x 200ul |
933-Eur |
GenTarget |
|
LVP310-PBS |
GFP (EF1a)-Bsd lentiviral particles, in vivo ready; premade lentiviral particles |
1x108 IFU/ml x 200ul |
808-Eur |
GenTarget |
|
LVP425-PBS |
GFP (EF1a)-Neo lentiviral particles, in vivo ready; premade lentiviral particles |
1x108 IFU/ml x 200ul |
808-Eur |
GenTarget |
|
LVP427-PBS |
RFP (EF1a)-Bsd lentiviral particles, in vivo ready; premade lentiviral particles |
1x108 IFU/ml x 200ul |
808-Eur |
GenTarget |
|
LVP428-PBS |
RFP (EF1a)-Neo lentiviral particles, in vivo ready; premade lentiviral particles |
1x108 IFU/ml x 200ul |
808-Eur |
GenTarget |
|
LVP109 |
h NR3C1 variant 6 inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP108 |
h NR3C1 variant 1 inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP430-PBS |
CFP (EF1a)-Bsd lentiviral particles, in vivo ready, premade lentiviral particles |
1x108IFU/ml x 200ul |
770-Eur |
GenTarget |
|
LVP430-PBS |
CFP (EF1a)-Bsd lentiviral particles, in vivo ready; premade lentiviral particles |
1x108 IFU/ml x 200ul |
808-Eur |
GenTarget |
|
LVP431-PBS |
CFP (EF1a)-Neo lentiviral particles, in vivo ready; premade lentiviral particles |
1x108 IFU/ml x 200ul |
808-Eur |
GenTarget |
|
LVP413-PBS |
Luciferase-2A-NLS-CRE, (RFP-Bsd) lentiviral particles, in vivo ready; premade lentiviral particles |
5 x107 IFU/ml x 200ul |
980-Eur |
GenTarget |
|
LVP342-PBS |
CFP (Puro) lentiviral particles, in vivo ready; premade lentiviral particles |
1x109 IFU/ml x 200ul |
808-Eur |
GenTarget |
|
LVP304-PBS |
Luciferase-2A-NLS-CRE (Bsd), lentiviral particles, in vivo ready; premade lentiviral particles |
5 x107 IFU/ml x 200ul |
980-Eur |
GenTarget |
|
LVP342-PBS |
CFP (Puro) lentiviral particles, in vivo ready, premade lentiviral particles |
1x10e8 IFU/ml x 200ul |
770-Eur |
GenTarget |
|
LVP465-PBS |
YFP (EF1a)-Bsd lentiviral particles, in vivo ready, premade lentiviral particles |
1x10e8 IFU/ml x 200ul |
770-Eur |
GenTarget |
|
LVP340-PBS |
GFP (Puro) lentiviral particles, in vivo ready, premade lentiviral particles |
1x10e8 IFU/ml x 200ul |
770-Eur |
GenTarget |
|
LVP309-PBS |
RFP (Puro) lentiviral particles, in vivo ready, premade lentiviral particles |
1x10e8 IFU/ml x 200ul |
770-Eur |
GenTarget |
|
LVP474 |
TSPyV small T-antigen lentiviral particles , premade lentiviral particles |
1x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP466-PBS |
YFP (EF1a)-Neo lentiviral particles, in vivo ready, premade lentiviral particles |
1x10e8 IFU/ml x 200ul |
770-Eur |
GenTarget |
|
LVP338-PBS |
NLS-CRE-2A-RFP (Puro), lentiviral particles , in vivo ready; premade lentiviral particles |
5 x107 IFU/ml x 200ul |
808-Eur |
GenTarget |
|
LVP322 |
h KLF4 (EF1a) (Puro) Lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP413-PBS |
Luciferase-2A-CRE, (RFP-Bsd) lentiviral particles, in vivo ready, premade lentiviral particles |
5 x107 IFU/ml x 200ul |
933-Eur |
GenTarget |
|
LVP317 |
h OCT4 (EF1a) (Puro) Lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP318 |
h SOX2 (EF1a) (Puro) Lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP319 |
h NANOG (EF1a) (Puro) Lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP471-PBS |
YFP (Puro) lentiviral particles, in vivo ready, premade lentiviral particles |
1x10e8 IFU/ml x 200ul |
770-Eur |
GenTarget |
|
LVP335-Bsd-PBS |
β-Lactamase (Bsd) lentiviral particles, in vivo ready, premade lentiviral particles |
5x10e7 IFU/ml x 200ul |
770-Eur |
GenTarget |
|
LVP340-PBS |
GFP (Puro) lentiviral particles, in vivo ready; premade lentiviral particles |
1x109 IFU/ml x 200ul |
808-Eur |
GenTarget |
|
LVP431-PBS |
CFP (EF1a)-Neo lentiviral particles, in vivo ready, premade lentiviral particles |
1x108 IFU/ml x 200ul |
770-Eur |
GenTarget |
|
LVP309-PBS |
RFP (Puro) lentiviral particles, in vivo ready; premade lentiviral particles |
1x109 IFU/ml x 200ul |
808-Eur |
GenTarget |
|
LVP-Null-RP |
Negative Control lentiviral particles (RFP-Puro); premade lentiviral particles |
1 x107 IFU/ml x 200ul |
400-Eur |
GenTarget |
|
LVP335-GB-PBS |
β-Lactamase (GFP-Bsd) lentiviral particles, in vivo ready, premade lentiviral particles |
5x107 IFU/ml x 200ul |
770-Eur |
GenTarget |
|
LVP344-GP |
Lentiviral particles, shRNA (lacZ)-( GFP-Puro); premade lentiviral particles |
1 x107 IFU/ml x 200ul |
458-Eur |
GenTarget |
|
LVP344-RP |
Lentiviral particles, shRNA (lacZ)-( RFP-Puro), premade lentiviral particles |
1 x107 IFU/ml x 200ul |
436-Eur |
GenTarget |
|
LVP304-PBS |
Luciferase-2A-CRE (Bsd), lentiviral particles, in vivo ready, premade lentiviral particles |
5 x107 IFU/ml x 200ul |
933-Eur |
GenTarget |
|
LVP344-GP |
Lentiviral particles, shRNA (lacZ)-( GFP-Puro), premade lentiviral particles |
1 x107 IFU/ml x 200ul |
436-Eur |
GenTarget |
|
LVP335-RB-PBS |
β-Lactamase (RFP-Bsd) lentiviral particles, in vivo ready, premade lentiviral particles |
5x10e7 IFU/ml x 200ul |
770-Eur |
GenTarget |
|
LVP344-RP |
Lentiviral particles, shRNA (lacZ)-( RFP-Puro); premade lentiviral particles |
1 x107 IFU/ml x 200ul |
458-Eur |
GenTarget |
|
LVP335-Neo-PBS |
β-Lactamase (Neo) lentiviral particles, in vivo ready, premade lentiviral particles |
5x10e7 IFU/ml x 200ul |
770-Eur |
GenTarget |
|
LVP320 |
h LIN28 (EF1a) (Puro) Lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP300-PBS |
GFP (Neo) lentiviral particles, in vivo ready: Pre-made lentiviral particles expressing GFP with Neomycin antibiotic marker, concentrated particles provided in PBS solution. |
1x10e8 IFU/ml x 200ul |
770-Eur |
GenTarget |
|
LVP299-PBS |
RFP (Neo) lentiviral particles, in vivo ready: Pre-made lentiviral particles expressing RFP with Neomycin antibiotic marker, concentrated particles provided in PBS solution. |
1x10e8 IFU/ml x 200ul |
770-Eur |
GenTarget |
|
LVP471-PBS |
YFP (Puro) lentiviral particles, in vivo ready: Pre-made lentiviral particles expressing YFP with Puromycin antibiotic marker, concentrated particles provided in PBS solution. |
1x10e8 IFU/ml x 200ul |
770-Eur |
GenTarget |
|
LVP342-PBS |
CFP (Puro) lentiviral particles, in vivo ready: Pre-made lentiviral particles expressing CFP with Puromycin antibiotic marker, concentrated particles provided in PBS solution. |
1x10e8 IFU/ml x 200ul |
770-Eur |
GenTarget |
|
LVP340-PBS |
GFP (Puro) lentiviral particles, in vivo ready: Pre-made lentiviral particles expressing GFP with Puromycin antibiotic marker, concentrated particles provided in PBS solution. |
1x10e8 IFU/ml x 200ul |
770-Eur |
GenTarget |
|
LVP454-G |
Peroxisome-GFP, LocLight lentiviral particles
; premade lentiviral particles |
1x108 IFU/ml x 1.0 ml |
579-Eur |
GenTarget |
|
LVP450-R |
Cyto-RFP, LocLight lentiviral particles
; premade lentiviral particles |
1x108 IFU/ml x 1.0 ml |
579-Eur |
GenTarget |
|
LVP454-R |
Peroxisome-GFP, LocLight lentiviral particles
; premade lentiviral particles |
1x108 IFU/ml x 1.0 ml |
579-Eur |
GenTarget |
|
LVP455-G |
Plasma-mem-GFP, LocLight lentiviral particles
; premade lentiviral particles |
1x108 IFU/ml x 1.0 ml |
579-Eur |
GenTarget |
|
LVP455-R |
Plasma-mem-RFP, LocLight lentiviral particles
; premade lentiviral particles |
1x108 IFU/ml x 1.0 ml |
579-Eur |
GenTarget |
|
LVP455-C |
Plasma-mem-CFP, LocLight lentiviral particles
; premade lentiviral particles |
1x108 IFU/ml x 1.0 ml |
579-Eur |
GenTarget |
|
LVP451-R |
Golgoi-RFP, LocLight lentiviral particles
; premade lentiviral particles |
1x107 IFU/ml x 200ul |
579-Eur |
GenTarget |
|
LVP451-G |
Golgoi-GFP, LocLight lentiviral particles
; premade lentiviral particles |
1x107 IFU/ml x 200ul |
579-Eur |
GenTarget |
|
LVP445-C |
CFP-Annexin5 fusion Lentiviral particles; premade lentiviral particles |
1x108 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP456-G |
Microtubule-GFP, LocLight lentiviral particles
; premade lentiviral particles |
1x108 IFU/ml x 1.0 ml |
579-Eur |
GenTarget |
|
LVP445-R |
RFP-Annexin5 fusion Lentiviral particles; premade lentiviral particles |
1x108 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP456-R |
Microtubule-RFP, LocLight lentiviral particles
; premade lentiviral particles |
1x108 IFU/ml x 1.0 ml |
579-Eur |
GenTarget |
|
LVP450-G |
Cyto-GFP, LocLight lentiviral particles
; premade lentiviral particles |
1x108 IFU/ml x 1.0 ml |
579-Eur |
GenTarget |
|
LVP448-R |
RFP-hP53 fusion Lentiviral particles; premade lentiviral particles |
1x108 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP449-R |
RFP-Zyxin fusion Lentiviral particles; premade lentiviral particles |
1x108 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP448-G |
GFP-hP53 fusion Lentiviral particles; premade lentiviral particles |
1x108 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP448-C |
CFP-hP53 fusion Lentiviral particles; premade lentiviral particles |
1x108 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP449-G |
GFP-Zyxin fusion Lentiviral particles; premade lentiviral particles |
1x108 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP451-C |
Golgoi-CFP, LocLight lentiviral particles
; premade lentiviral particles |
1x107 IFU/ml x 200ul |
579-Eur |
GenTarget |
|
LVP450-C |
Cyto-CFP, LocLight lentiviral particles
; premade lentiviral particles |
1x108 IFU/ml x 1.0 ml |
579-Eur |
GenTarget |
|
LVP452-G |
Mito-GFP, LocLight lentiviral particles
; premade lentiviral particles |
1x107 IFU/ml x 200ul |
579-Eur |
GenTarget |
|
LVP446-C |
CFP-Actin fusion Lentiviral particles; premade lentiviral particles |
1x108 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP454-C |
Peroxisome-GFP, LocLight lentiviral particles
; premade lentiviral particles |
1x108 IFU/ml x 1.0 ml |
579-Eur |
GenTarget |
|
LVP452-R |
Mito-GFP, LocLight lentiviral particles
; premade lentiviral particles |
1x107 IFU/ml x 200ul |
579-Eur |
GenTarget |
|
LVP446-R |
RFP-Actin fusion Lentiviral particles; premade lentiviral particles |
1x108 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP452-C |
Mito-GFP, LocLight lentiviral particles
; premade lentiviral particles |
1x107 IFU/ml x 200ul |
579-Eur |
GenTarget |
|
LVP453-G |
Nuc-membrane-GFP, LocLight lentiviral particles
; premade lentiviral particles |
1x108 IFU/ml x 1.0 ml |
579-Eur |
GenTarget |
|
LVP453-R |
Nuc-membrane-RFP, LocLight lentiviral particles
; premade lentiviral particles |
1x108 IFU/ml x 1.0 ml |
579-Eur |
GenTarget |
|
LVP446-G |
GFP-Actin fusion Lentiviral particles; premade lentiviral particles |
1x108 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP449-C |
CFP-Zyxin fusion Lentiviral particles; premade lentiviral particles |
1x108 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP453-C |
Nuc-membrane-CFP, LocLight lentiviral particles
; premade lentiviral particles |
1x108 IFU/ml x 1.0 ml |
579-Eur |
GenTarget |
|
LVP330 |
h GRK5 inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP344-RB |
Lentiviral particles, shRNA (lacZ)-( RFP-Bsd), premade lentiviral particles |
1 x107 IFU/ml x 200ul |
436-Eur |
GenTarget |
|
LVP345-GP |
Lentiviral particles, shRNA (Luc)-( GFP-Puro), premade lentiviral particles |
1 x107 IFU/ml x 200ul |
436-Eur |
GenTarget |
|
LVP345-RP |
Lentiviral particles, shRNA (Luc)-( RFP-Puro), premade lentiviral particles |
1 x107 IFU/ml x 200ul |
436-Eur |
GenTarget |
|
LVP348 |
lacZ (RFP-puro) lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP349 |
h MAP1LC3B inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP351 |
m shank3 inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP352 |
h CYC1 inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP353 |
h Kiss1 inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP354 |
h RASA3 inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP355 |
h GDF9 inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP383 |
h Stat3 inducible lentiviral particles, premade lentiviral particles |
1 x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP344-GB |
Lentiviral particles, shRNA (lacZ)-( GFP-Bsd), premade lentiviral particles |
1 x107 IFU/ml x 200ul |
436-Eur |
GenTarget |
|
LVP343-RP |
Lentiviral particles, shRNA (h P53)-(RFP-Puro), premade lentiviral particles |
1 x107 IFU/ml x 200ul |
436-Eur |
GenTarget |
|
LVP343-GP |
Lentiviral particles, shRNA (h P53)-(GFP-Puro), premade lentiviral particles |
1 x107 IFU/ml x 200ul |
436-Eur |
GenTarget |
|
LVP331 |
h TNFAIP6 inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP335-GP |
β-Lactamase (GFP-Puro) lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP335-RP |
β-Lactamase (RFP-Puro) lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP335-luc |
β-Lactamase (Luciferase) lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP301 |
lacZ (Puro) lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP334 |
lacZ (luciferase) lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP299-PBS |
RFP (Neo) lentiviral particles, in vivo ready, premade lentiviral particles |
1x10e8 IFU/ml x 200ul |
770-Eur |
GenTarget |
|
LVP300-PBS |
GFP (Neo) lentiviral particles, in vivo ready, premade lentiviral particles |
1x10e8 IFU/ml x 200ul |
770-Eur |
GenTarget |
|
LVP306-PBS |
CFP (Neo) lentiviral particles,
in vivo ready, premade lentiviral particles |
1x10e8 IFU/ml x 200ul |
770-Eur |
GenTarget |
|
LVP307-PBS |
YFP (Neo) lentiviral particles,
in vivo ready, premade lentiviral particles |
1x10e8 IFU/ml x 200ul |
770-Eur |
GenTarget |
|
LVP147 |
m Myd88 inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP384 |
h LDHA inducible lentiviral particles, premade lentiviral particles |
1 x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP385 |
h RXRA inducible lentiviral particles, premade lentiviral particles |
1 x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP405 |
h Arf6 inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP406 |
h NPTN inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP409 |
Luciferase-2A-CRE (Puro), lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
552-Eur |
GenTarget |
|
LVP386 |
h GATA4 inducible lentiviral particles, premade lentiviral particles |
1 x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP412 |
Luciferase-2A-CRE, (GFP-Puro) lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
552-Eur |
GenTarget |
|
LVP458-C |
Endosomes-GFP, LocLight lentiviral particles
; premade lentiviral particles |
1x108 IFU/ml x 1.0 ml |
579-Eur |
GenTarget |
|
LVP458-R |
Endosomes-GFP, LocLight lentiviral particles
; premade lentiviral particles |
1x108 IFU/ml x 1.0 ml |
579-Eur |
GenTarget |
|
LVP458-G |
Endosomes-GFP, LocLight lentiviral particles
; premade lentiviral particles |
1x108 IFU/ml x 1.0 ml |
579-Eur |
GenTarget |
|
LVP457-C |
Lysosomes-GFP, LocLight lentiviral particles
; premade lentiviral particles |
1x107 IFU/ml x 200ul |
579-Eur |
GenTarget |
|
LVP457-R |
Lysosomes-GFP, LocLight lentiviral particles
; premade lentiviral particles |
1x107 IFU/ml x 200ul |
579-Eur |
GenTarget |
|
LVP457-G |
Lysosomes-GFP, LocLight lentiviral particles
; premade lentiviral particles |
1x107 IFU/ml x 200ul |
579-Eur |
GenTarget |
|
LVP404 |
h SOD2 inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
CMV-Null-RP |
CMV Control lentiviral particles (RFP-Puro), premade lentiviral particles |
1 x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
CMV-Null-GP |
CMV Control lentiviral particles (GFP-Puro), premade lentiviral particles |
1 x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP332 |
h ARID3B inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP387 |
h TBX5 inducible lentiviral particles, premade lentiviral particles |
1 x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP388 |
h VEGFA inducible lentiviral particles, premade lentiviral particles |
1 x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP389 |
h BARD1 inducible lentiviral particles, premade lentiviral particles |
1 x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP390 |
h BRAC1 inducible lentiviral particles, premade lentiviral particles |
1 x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP391 |
m IL10 inducible lentiviral particles, premade lentiviral particles |
1 x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP394 |
h Flt3 inducible lentiviral particles, premade lentiviral particles |
1 x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP395 |
h MMP9 inducible lentiviral particles, premade lentiviral particles |
1 x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP396 |
h CEBPB inducible lentiviral particles, premade lentiviral particles |
1 x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP397 |
h TP63 inducible lentiviral particles, premade lentiviral particles |
1 x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP398 |
m Git2 inducible lentiviral particles, premade lentiviral particles |
1 x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP456-C |
Microtubule-CFP, LocLight lentiviral particles
; premade lentiviral particles |
1x108 IFU/ml x 1.0 ml |
579-Eur |
GenTarget |
|
LVP388 |
h VEGFA inducible lentiviral particles; premade lentiviral particles |
1 x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP450-C |
Cyto-CFP, LocLight lentiviral particles
, premade lentiviral particles |
1x107 IFU/ml x 200ul |
552-Eur |
GenTarget |
|
LVP451-G |
Golgoi-GFP, LocLight lentiviral particles
, premade lentiviral particles |
1x107 IFU/ml x 200ul |
552-Eur |
GenTarget |
|
LVP451-R |
Golgoi-RFP, LocLight lentiviral particles
, premade lentiviral particles |
1x107 IFU/ml x 200ul |
552-Eur |
GenTarget |
|
LVP451-C |
Golgoi-CFP, LocLight lentiviral particles
, premade lentiviral particles |
1x107 IFU/ml x 200ul |
552-Eur |
GenTarget |
|
LVP452-G |
Mito-GFP, LocLight lentiviral particles
, premade lentiviral particles |
1x107 IFU/ml x 200ul |
552-Eur |
GenTarget |
|
LVP452-R |
Mito-GFP, LocLight lentiviral particles
, premade lentiviral particles |
1x107 IFU/ml x 200ul |
552-Eur |
GenTarget |
|
LVP452-C |
Mito-GFP, LocLight lentiviral particles
, premade lentiviral particles |
1x107 IFU/ml x 200ul |
552-Eur |
GenTarget |
|
LVP453-G |
Nuc-membrane-GFP, LocLight lentiviral particles
, premade lentiviral particles |
1x107 IFU/ml x 200ul |
552-Eur |
GenTarget |
|
LVP453-R |
Nuc-membrane-RFP, LocLight lentiviral particles
, premade lentiviral particles |
1x107 IFU/ml x 200ul |
552-Eur |
GenTarget |
|
LVP453-C |
Nuc-membrane-CFP, LocLight lentiviral particles
, premade lentiviral particles |
1x107 IFU/ml x 200ul |
552-Eur |
GenTarget |
|
LVP454-G |
Peroxisome-GFP, LocLight lentiviral particles
, premade lentiviral particles |
1x107 IFU/ml x 200ul |
552-Eur |
GenTarget |
|
LVP450-R |
Cyto-RFP, LocLight lentiviral particles
, premade lentiviral particles |
1x107 IFU/ml x 200ul |
552-Eur |
GenTarget |
|
LVP450-G |
Cyto-GFP, LocLight lentiviral particles
, premade lentiviral particles |
1x107 IFU/ml x 200ul |
552-Eur |
GenTarget |
|
LVP449-C |
CFP-Zyxin fusion Lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP387 |
h TBX5 inducible lentiviral particles; premade lentiviral particles |
1 x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP386 |
h GATA4 inducible lentiviral particles; premade lentiviral particles |
1 x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP385 |
h RXRA inducible lentiviral particles; premade lentiviral particles |
1 x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP384 |
h LDHA inducible lentiviral particles; premade lentiviral particles |
1 x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP383 |
h Stat3 inducible lentiviral particles; premade lentiviral particles |
1 x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP446-C |
CFP-Actin fusion Lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP448-G |
GFP-hP53 fusion Lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP448-R |
RFP-hP53 fusion Lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP448-C |
CFP-hP53 fusion Lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP449-G |
GFP-Zyxin fusion Lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP449-R |
RFP-Zyxin fusion Lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP454-R |
Peroxisome-GFP, LocLight lentiviral particles
, premade lentiviral particles |
1x107 IFU/ml x 200ul |
552-Eur |
GenTarget |
|
LVP454-C |
Peroxisome-GFP, LocLight lentiviral particles
, premade lentiviral particles |
1x107 IFU/ml x 200ul |
552-Eur |
GenTarget |
|
LVP353 |
h Kiss1 inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP352 |
h CYC1 inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP351 |
m shank3 inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP349 |
h MAP1LC3B inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP348 |
lacZ (RFP-puro) lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP345-RP |
Lentiviral particles, shRNA (Luc)-( RFP-Puro); premade lentiviral particles |
1 x107 IFU/ml x 200ul |
458-Eur |
GenTarget |
|
LVP345-GP |
Lentiviral particles, shRNA (Luc)-( GFP-Puro); premade lentiviral particles |
1 x107 IFU/ml x 200ul |
458-Eur |
GenTarget |
|
LVP344-RB |
Lentiviral particles, shRNA (lacZ)-( RFP-Bsd); premade lentiviral particles |
1 x107 IFU/ml x 200ul |
458-Eur |
GenTarget |
|
LVP344-GB |
Lentiviral particles, shRNA (lacZ)-( GFP-Bsd); premade lentiviral particles |
1 x107 IFU/ml x 200ul |
458-Eur |
GenTarget |
|
LVP343-RP |
Lentiviral particles, shRNA (h P53)-(RFP-Puro); premade lentiviral particles |
1 x107 IFU/ml x 200ul |
458-Eur |
GenTarget |
|
LVP343-GP |
Lentiviral particles, shRNA (h P53)-(GFP-Puro); premade lentiviral particles |
1 x107 IFU/ml x 200ul |
458-Eur |
GenTarget |
|
LVP354 |
h RASA3 inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP355 |
h GDF9 inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP458-C |
Endosomes-GFP, LocLight lentiviral particles
, premade lentiviral particles |
1x107 IFU/ml x 200ul |
552-Eur |
GenTarget |
|
LVP455-G |
Plasma-mem-GFP, LocLight lentiviral particles
, premade lentiviral particles |
1x107 IFU/ml x 200ul |
552-Eur |
GenTarget |
|
LVP455-R |
Plasma-mem-RFP, LocLight lentiviral particles
, premade lentiviral particles |
1x107 IFU/ml x 200ul |
552-Eur |
GenTarget |
|
LVP455-C |
Plasma-mem-CFP, LocLight lentiviral particles
, premade lentiviral particles |
1x107 IFU/ml x 200ul |
552-Eur |
GenTarget |
|
LVP456-G |
Microtubule-GFP, LocLight lentiviral particles
, premade lentiviral particles |
1x107 IFU/ml x 200ul |
552-Eur |
GenTarget |
|
LVP456-R |
Microtubule-RFP, LocLight lentiviral particles
, premade lentiviral particles |
1x107 IFU/ml x 200ul |
552-Eur |
GenTarget |
|
LVP456-C |
Microtubule-CFP, LocLight lentiviral particles
, premade lentiviral particles |
1x107 IFU/ml x 200ul |
552-Eur |
GenTarget |
|
LVP457-G |
Lysosomes-GFP, LocLight lentiviral particles
, premade lentiviral particles |
1x107 IFU/ml x 200ul |
552-Eur |
GenTarget |
|
LVP457-R |
Lysosomes-GFP, LocLight lentiviral particles
, premade lentiviral particles |
1x107 IFU/ml x 200ul |
552-Eur |
GenTarget |
|
LVP457-C |
Lysosomes-GFP, LocLight lentiviral particles
, premade lentiviral particles |
1x107 IFU/ml x 200ul |
552-Eur |
GenTarget |
|
LVP458-G |
Endosomes-GFP, LocLight lentiviral particles
, premade lentiviral particles |
1x107 IFU/ml x 200ul |
552-Eur |
GenTarget |
|
LVP458-R |
Endosomes-GFP, LocLight lentiviral particles
, premade lentiviral particles |
1x107 IFU/ml x 200ul |
552-Eur |
GenTarget |
|
LVP422 |
h LOXL2 inducible lentiviral particles, premade lentiviral particles |
1 x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP389 |
h BARD1 inducible lentiviral particles; premade lentiviral particles |
1 x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP445-G |
GFP-Annexin5 fusion Lentiviral particles; premade lentiviral particles |
1x108 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP424 |
m CSF2 inducible lentiviral particles, premade lentiviral particles |
1 x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP442 |
GFP-RFP fusion control lentiviral particles, premade lentiviral particles |
1x10e7 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP443 |
CFP-RFP fusion control lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP446-G |
GFP-Actin fusion Lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP444-G |
GFP-Histone 2B fusion lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP424 |
m CSF2 inducible lentiviral particles; premade lentiviral particles |
1 x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP423 |
h FASLG inducible lentiviral particles; premade lentiviral particles |
1 x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP422 |
h LOXL2 inducible lentiviral particles; premade lentiviral particles |
1 x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP421 |
h ANPEP inducible lentiviral particles; premade lentiviral particles |
1 x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP420 |
h CSF1 inducible lentiviral particles; premade lentiviral particles |
1 x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP419 |
h KDM5B inducible lentiviral particles; premade lentiviral particles |
1 x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP423 |
h FASLG inducible lentiviral particles, premade lentiviral particles |
1 x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP421 |
h ANPEP inducible lentiviral particles, premade lentiviral particles |
1 x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP420 |
h CSF1 inducible lentiviral particles, premade lentiviral particles |
1 x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP444-C |
CFP-Histone 2B fusion lentiviral particles; premade lentiviral particles |
1x108 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP444-R |
RFP-Histone 2B fusion lentiviral particles; premade lentiviral particles |
1x108 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP444-G |
GFP-Histone 2B fusion lentiviral particles; premade lentiviral particles |
1x108 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP443 |
CFP-RFP fusion control lentiviral particles; premade lentiviral particles |
1x108 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP442 |
GFP-RFP fusion control lentiviral particles; premade lentiviral particles |
1x108 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP414 |
Luciferase-2A-CRE, (RFP-Puro) lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
552-Eur |
GenTarget |
|
LVP415 |
h GYG1 inducible lentiviral particles, premade lentiviral particles |
1 x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP416 |
h FII (thrombin) inducible lentiviral particles, premade lentiviral particles |
1 x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP417 |
h MSH3 inducible lentiviral particles, premade lentiviral particles |
1 x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP418 |
h KDM5A inducible lentiviral particles, premade lentiviral particles |
1 x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP419 |
h KDM5B inducible lentiviral particles, premade lentiviral particles |
1 x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP418 |
h KDM5A inducible lentiviral particles; premade lentiviral particles |
1 x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP417 |
h MSH3 inducible lentiviral particles; premade lentiviral particles |
1 x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP-Null-Neo |
Negative Control lentiviral particles (Neo); premade lentiviral particles |
1 x107 IFU/ml x 200ul |
400-Eur |
GenTarget |
|
LVP-Null-Bsd |
Negative Control lentiviral particles (Bsd); premade lentiviral particles |
1 x107 IFU/ml x 200ul |
400-Eur |
GenTarget |
|
LVP445-R |
RFP-Annexin5 fusion Lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP445-C |
CFP-Annexin5 fusion Lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP446-R |
RFP-Actin fusion Lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP398 |
m Git2 inducible lentiviral particles; premade lentiviral particles |
1 x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP397 |
h TP63 inducible lentiviral particles; premade lentiviral particles |
1 x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP396 |
h CEBPB inducible lentiviral particles; premade lentiviral particles |
1 x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP395 |
h MMP9 inducible lentiviral particles; premade lentiviral particles |
1 x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP394 |
h Flt3 inducible lentiviral particles; premade lentiviral particles |
1 x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP391 |
m IL10 inducible lentiviral particles; premade lentiviral particles |
1 x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP-Null-GB |
Negative Control lentiviral particles (GFP-Bsd); premade lentiviral particles |
1 x107 IFU/ml x 200ul |
400-Eur |
GenTarget |
|
LVP-Null-RB |
Negative Control lentiviral particles (RFP-Bsd); premade lentiviral particles |
1 x107 IFU/ml x 200ul |
400-Eur |
GenTarget |
|
LVP445-G |
GFP-Annexin5 fusion Lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP416 |
h FII (thrombin) inducible lentiviral particles; premade lentiviral particles |
1 x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP415 |
h GYG1 inducible lentiviral particles; premade lentiviral particles |
1 x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP444-R |
RFP-Histone 2B fusion lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP414 |
Luciferase-2A-NLS-CRE, (RFP-Puro) lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
579-Eur |
GenTarget |
|
LVP412 |
Luciferase-2A-NLS-CRE, (GFP-Puro) lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
579-Eur |
GenTarget |
|
LVP409 |
Luciferase-2A-NLS-CRE (Puro), lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
579-Eur |
GenTarget |
|
LVP408-PBS |
NLS-CRE-2A-GFP (Neo), lentiviral particles , in vivo ready; premade lentiviral particles |
5 x107 IFU/ml x 200ul |
808-Eur |
GenTarget |
|
LVP406 |
h NPTN inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP405 |
h Arf6 inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP404 |
h SOD2 inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP444-C |
CFP-Histone 2B fusion lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP390 |
h BRAC1 inducible lentiviral particles; premade lentiviral particles |
1 x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP328 |
h PRELP inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP102 |
h PDHA1 inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP121 |
h ARRB2 inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP122 |
h ATF2 inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP123 |
h AURKB inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP125 |
h PARS2 inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP126 |
h BCKDK inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP128 |
h TRIB3 inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP129 |
h CAMK1 inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP130 |
h CAMK1D inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP131 |
m Acp2 inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP132 |
h SPZ1 inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP133 |
h CAMK4 inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP134 |
h CCND3 inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP135 |
h CCNH inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP136 |
h CDC2L5 inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP120 |
h SPEG inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP119 |
h CDK15 inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP103 |
h CXCR4 inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP104 |
h CXCR7 inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP105 |
h TERT inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP106 |
h AAK1 inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP107 |
h STRADB inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP110 |
h NPM1 inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP112 |
h GPSM3 inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP113 |
h CHUK inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP114 |
h RNASEH2A inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP115 |
h TNK2 inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP116 |
h ADCK1 inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP117 |
h AKT1 inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP118 |
h ACVR1C inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP213 |
h PHKG2 inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP137 |
h CDC42 inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP138 |
h DNAJC28 inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP156 |
h EPHA2 inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP157 |
h EPHB3 inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP158 |
h ERBB3 inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP159 |
h ETS1 inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP160 |
h ETS2 inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP161 |
h FASTK inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP162 |
h FGFR2 inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP164 |
h ULK4 inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP165 |
h NEK10 inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP167 |
h GSK3B inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP168 |
h NFKBIA inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP169 |
h IKBKB inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP170 |
h IKBKG inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP171 |
h TAOK3 inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP155 |
h ELK4 inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP154 |
h ELK1 inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP139 |
h CDK9 inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP140 |
h CDKN1A inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP141 |
m Gadd45a inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP142 |
h CHEK2 inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP143 |
h CLK1 inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP144 |
h COL4A3BP inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP145 |
h CREB1 inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP146 |
h CSNK1D inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP148 |
h CSNK2A1 inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP149 |
h DDIT3 inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP150 |
h DDR1 inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP151 |
h STYK1 inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP152 |
h DYRK2 inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP153 |
h EEF2K inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP173 |
h TNIK inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP015 |
h GLUL inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP047 |
h NUAK2 inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP048 |
h DAPK2 inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP049 |
h CAMK2A inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP050 |
h NME1 inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP051 |
h TYK2 inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP052 |
h PDIK1L inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP053 |
h CDK5R1 inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP054 |
h TGFBR2 inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP056 |
h STK17B inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP057 |
h WIF1 inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP058 |
h PIP5K1A inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP059 |
h YES1 inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP060 |
h PDK3 inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP061 |
h DCLK1 inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP046 |
h GRK6 inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP044 |
h CDK18 inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP025 |
h PFKM inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP026 |
h DGKE inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP028 |
h NME5 inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP029 |
h MARK3 inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP030 |
h MATK inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP032 |
h MARK2 inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP033 |
h LIMK2 inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP034 |
h PIM2 inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP037 |
h PAK6 inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP038 |
h CSNK1G1 inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP040 |
h GALK2 inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP041 |
h CMPK1 inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP042 |
h TRIB2 inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP043 |
h BUB1 inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP062 |
h PIM1 inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP063 |
h STK32C inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP084 |
h TSSK1B inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP085 |
h CDK3 inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP086 |
h RPS6KL1 inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP087 |
h TWF1 inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP088 |
h RAGE inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP089 |
h NEK11 inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP090 |
h STK11 inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP091 |
h CLK3 inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP093 |
h TWF2 inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP094 |
h PRKAA2 inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP096 |
h TUBA1B inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP097 |
h TMEM50B inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP098 |
h B3GALNT2 inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP099 |
h PROM1 inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP083 |
h EPHA4 inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP082 |
h CDKL5 inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP065 |
h CLCN2 inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP066 |
h FGFR1 inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP068 |
h POMP inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP069 |
h TPT1 inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP070 |
h XPO5 inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP071 |
h ELAVL1 inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP072 |
h PPP1R7 inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP073 |
h IL17BR inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP075 |
h MAPKAPK3 inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP076 |
h GORASP2 inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP078 |
h BRD3 inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP079 |
h CDKL3 inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP080 |
h STK4 inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP081 |
h STK10 inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP100 |
h NFIC inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP174 |
h LMNA inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP243 |
h SRPK1 inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP260 |
h RhoA inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP261 |
h CCND1 inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP262 |
h CDKN2B inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP263 |
h CDK2 inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP264 |
h CDK4 inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP265 |
h CDK7 inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP266 |
h Rac1 inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP267 |
h Rac2 inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP268 |
m Mitf inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP269 |
m PAX6 inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP270 |
m MEF2C inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP271 |
m Mesp1 inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP272 |
h NRAS inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP273 |
h GGA3 inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP259 |
h OXSR1 inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP258 |
h Foxo3 inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP244 |
h TPTE inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP245 |
h TSSK3 inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP246 |
h STK25 inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP247 |
h BRSK2 inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP248 |
h STK3 inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP249 |
h STK38 inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP250 |
h AURKA inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP251 |
h RIOK3 inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP252 |
h WEE1 inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP253 |
h TP53 inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP254 |
h TTBK2 inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP255 |
h VRK3 inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP256 |
h ZAP70 inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP257 |
h ACVR1 inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP274 |
h RalBP1 inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP275 |
h RanBP1 inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP302 |
h IDO1 inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP017-Hygro |
CMV-TetR (Bsd) Lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
441-Eur |
GenTarget |
|
LVP321 |
h Myc (EF1a) (Puro) Lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP588 |
h OCT4 (EF1a) (RP) Lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP589 |
h SOX2 (EF1a) (RP) Lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP590 |
h NANOG (EF1a) (RP) Lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP591 |
h LIN28 (EF1a) (RP) Lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP593 |
h KLF4 (EF1a) (RP) Lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP016-GP |
T-antigen (GFP-Puro), CMV lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP016-RP |
T-antigen (RFP-Puro), CMV lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP557-RB |
T-antigen (RFP-Bsd), EF1a lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP557-Neo |
T-antigen (Neo), EF1a lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP557-Bsd |
T-antigen (Bsd), EF1a lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP557-GP |
T-antigen (GFP-Puro), CMV lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP296 |
h FGF18 inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP295 |
h IL20 inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP276 |
h TAPBP inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP277 |
h IFNG inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP278 |
h PCBP2 inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP279 |
h ZFP36 inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP280 |
h RGS16 inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP281 |
h RUVBL2 inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP282 |
h CTSD inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP284 |
h RASSF5 inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP285 |
h ACTG1 inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP286 |
h NCOA4 inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP289 |
h TGFB1 inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP290 |
h KCNJ5 inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP291 |
h BDKRB1 inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP294 |
h KITLG inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP557-RP |
T-antigen (RFP-Puro), CMV lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP175 |
h SMAD2 inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP192 |
h MAPK9 inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP193 |
h RPS6KA1 inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP194 |
h RPS6KA3 inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP195 |
h MAPKAPK5 inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP196 |
h MAST2 inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP198 |
h MEF2BNB inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP199 |
h MEF2C inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP200 |
h CSNK1A1L inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP201 |
h NIM1 inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP202 |
h STK40 inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP203 |
h CAMKV inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP204 |
h MKNK1 inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP205 |
h DUSP4 inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP206 |
h DUSP6 inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP191 |
h MAPK8 inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP190 |
h MAPK7 inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP176 |
h MAP2K2 inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP177 |
h MAP2K3 inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP178 |
h MAP2K4 inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP179 |
m CSN3 inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP180 |
h MAP3K12 inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP181 |
h MAP3K14 inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP182 |
h MAP3K5 inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP183 |
h MAP3K7 inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP184 |
h MAP3K8 inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP185 |
h MAPK1 inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP186 |
h MAPK12 inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP187 |
h MAPK13 inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP188 |
h MAPK3 inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP189 |
h MAPK6 inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP207 |
h MYD88 inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP208 |
h NFATC3 inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP227 |
h TSSK2 inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP228 |
h MAP2K5 inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP229 |
h MRE11A inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP230 |
h NEK6 inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP231 |
h PAK4 inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP232 |
h CDK16 inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP233 |
h PKMYT1 inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP234 |
h PLK1 inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP235 |
h PRKACB inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP236 |
h PRKCG inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP237 |
h RELA inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP238 |
h RPS6KA2 inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP239 |
h RPS6KB1 inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP240 |
h SGK3 inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP226 |
h PLK4 inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP225 |
h STK16 inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP209 |
h IRAK3 inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP210 |
h NFkB1 inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP211 |
h PAK2 inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP212 |
h PDK4 inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP214 |
h PIK3CB inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP215 |
h PIK3R3 inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP216 |
h PPARg inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP217 |
h PRKAA1 inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP218 |
h PRKACA inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP219 |
h PRKCA inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP220 |
h PTK2B inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP222 |
h RIPK2 inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP223 |
h SGK2 inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP224 |
h STAT3 inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP242 |
h SPAG9 inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP153 |
h EEF2K inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP139 |
h CDK9 inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP138 |
h DNAJC28 inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP137 |
h CDC42 inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP136 |
h CDC2L5 inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP135 |
h CCNH inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP134 |
h CCND3 inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP133 |
h CAMK4 inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP132 |
h SPZ1 inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP131 |
m Acp2 inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP130 |
h CAMK1D inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP129 |
h CAMK1 inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP140 |
h CDKN1A inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP141 |
m Gadd45a inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP152 |
h DYRK2 inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP151 |
h STYK1 inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP150 |
h DDR1 inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP149 |
h DDIT3 inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP148 |
h CSNK2A1 inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP147 |
m Myd88 inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP146 |
h CSNK1D inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP145 |
h CREB1 inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP144 |
h COL4A3BP inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP143 |
h CLK1 inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP142 |
h CHEK2 inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP128 |
h TRIB3 inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP126 |
h BCKDK inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP125 |
h PARS2 inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP107 |
h STRADB inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP106 |
h AAK1 inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP105 |
h TERT inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP104 |
h CXCR7 inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP103 |
h CXCR4 inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP102 |
h PDHA1 inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP100 |
h NFIC inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP099 |
h PROM1 inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP098 |
h B3GALNT2 inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP097 |
h TMEM50B inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP096 |
h TUBA1B inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP110 |
h NPM1 inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP112 |
h GPSM3 inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP123 |
h AURKB inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP122 |
h ATF2 inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP121 |
h ARRB2 inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP120 |
h SPEG inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP119 |
h CDK15 inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP118 |
h ACVR1C inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP117 |
h AKT1 inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP116 |
h ADCK1 inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP115 |
h TNK2 inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP114 |
h RNASEH2A inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP113 |
h CHUK inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP094 |
h PRKAA2 inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP210 |
h NFkB1 inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP195 |
h MAPKAPK5 inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP194 |
h RPS6KA3 inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP193 |
h RPS6KA1 inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP192 |
h MAPK9 inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP191 |
h MAPK8 inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP190 |
h MAPK7 inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP189 |
h MAPK6 inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP188 |
h MAPK3 inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP187 |
h MAPK13 inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP186 |
h MAPK12 inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP185 |
h MAPK1 inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP196 |
h MAST2 inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP198 |
h MEF2BNB inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP209 |
h IRAK3 inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP208 |
h NFATC3 inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP207 |
h MYD88 inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP206 |
h DUSP6 inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP205 |
h DUSP4 inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP204 |
h MKNK1 inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP203 |
h CAMKV inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP202 |
h STK40 inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP201 |
h NIM1 inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP200 |
h CSNK1A1L inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP199 |
h MEF2C inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP184 |
h MAP3K8 inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP183 |
h MAP3K7 inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP182 |
h MAP3K5 inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP167 |
h GSK3B inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP165 |
h NEK10 inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP164 |
h ULK4 inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP162 |
h FGFR2 inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP161 |
h FASTK inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP160 |
h ETS2 inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP159 |
h ETS1 inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP158 |
h ERBB3 inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP157 |
h EPHB3 inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP156 |
h EPHA2 inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP155 |
h ELK4 inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP168 |
h NFKBIA inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP169 |
h IKBKB inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP181 |
h MAP3K14 inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP180 |
h MAP3K12 inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP179 |
m CSN3 inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP178 |
h MAP2K4 inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP177 |
h MAP2K3 inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP176 |
h MAP2K2 inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP175 |
h SMAD2 inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP174 |
h LMNA inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP173 |
h TNIK inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP171 |
h TAOK3 inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP170 |
h IKBKG inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP154 |
h ELK1 inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP029 |
h MARK3 inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP581-PBS |
GFP (CAG)-Neo lentiviral particles, in vivo ready, premade lentiviral particles |
5 x 107 IFU/ml x 200ul |
770-Eur |
GenTarget |
|
LVP584-PBS |
RFP (CAG)-Neo lentiviral particles, in vivo ready, premade lentiviral particles |
5 x 107 IFU/ml x 200ul |
770-Eur |
GenTarget |
|
LVP587-PBS |
CFP (CAG)-Neo lentiviral particles, in vivo ready, premade lentiviral particles |
5 x 107 IFU/ml x 200ul |
770-Eur |
GenTarget |
|
LVP550-R |
RFP-CLCN2 fusion lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP551-R |
RFP-KCNN4 fusion lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP552-R |
RFP-TRPV1 fusion lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP554-R |
RFP-TRPC3 fusion lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP556-R |
RFP-CSF1 fusion lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP550-C |
CFP-CLCN2 fusion lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP551-C |
CFP-KCNN4 fusion lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP552-C |
CFP-TRPV1 fusion lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP580-PBS |
GFP (CAG)-Bsd lentiviral particles, in vivo ready, premade lentiviral particles |
5 x 107 IFU/ml x 200ul |
770-Eur |
GenTarget |
|
LVP528 |
h FGF2 inducible lentiviral particles , premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP028 |
h NME5 inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP026 |
h DGKE inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP025 |
h PFKM inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP511 |
h PLK2 inducible lentiviral particles , premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP512 |
h WSF1 inducible lentiviral particles , premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP514 |
h TWIST1 inducible lentiviral particles , premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP015 |
h GLUL inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP515 |
h RTN3 inducible lentiviral particles , premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP516 |
h KCNN4 inducible lentiviral particles , premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP517 |
h TRPC3 inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP518 |
h CFTR inducible lentiviral particles , premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP554-C |
CFP-TRPC3 fusion lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP556-C |
CFP-CSF1 fusion lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP529 |
h SLC2A10 inducible lentiviral particles , premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP546 |
m CD74 inducible lentiviral particles , premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP547 |
m SAA1 inducible lentiviral particles , premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP548 |
h PPARG2 inducible lentiviral particles , premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP605 |
h ASAH1 inducible lentiviral particles , premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP549 |
h Snai1 inducible lentiviral particles , premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP553 |
h BCL2 inducible lentiviral particles , premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP555 |
h SMAD4 inducible lentiviral particles , premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP594 |
h TACC3 inducible lentiviral particles , premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP595 |
h ICAM1 inducible lentiviral particles , premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP596 |
h GNRHR inducible lentiviral particles , premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP597 |
h SLC2A4 inducible lentiviral particles , premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP545 |
m mmp7 inducible lentiviral particles , premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP544 |
h CCL20 inducible lentiviral particles , premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP530 |
m Gulo inducible lentiviral particles , premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP491 |
h PAX3 inducible lentiviral particles , premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP513 |
h CCR6 inducible lentiviral particles , premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP479 |
h MITF inducible lentiviral particles , premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP533 |
h Foxo1 inducible lentiviral particles , premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP534 |
h PTEN inducible lentiviral particles , premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP535 |
h Raptor inducible lentiviral particles , premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP537 |
h MCR4 inducible lentiviral particles , premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP539 |
h CDCD1 inducible lentiviral particles , premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP541 |
h LMNB1 inducible lentiviral particles , premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP543 |
h SLC16A1 inducible lentiviral particles , premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP599 |
h IL13RA2 inducible lentiviral particles , premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP093 |
h TWF2 inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP078 |
h BRD3 inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP076 |
h GORASP2 inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP075 |
h MAPKAPK3 inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP073 |
h IL17BR inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP072 |
h PPP1R7 inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP071 |
h ELAVL1 inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP070 |
h XPO5 inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP069 |
h TPT1 inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP068 |
h POMP inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP066 |
h FGFR1 inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP065 |
h CLCN2 inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP079 |
h CDKL3 inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP080 |
h STK4 inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP091 |
h CLK3 inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP090 |
h STK11 inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP089 |
h NEK11 inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP088 |
h RAGE inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP087 |
h TWF1 inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP086 |
h RPS6KL1 inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP085 |
h CDK3 inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP084 |
h TSSK1B inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP083 |
h EPHA4 inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP082 |
h CDKL5 inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP081 |
h STK10 inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP063 |
h STK32C inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP062 |
h PIM1 inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP061 |
h DCLK1 inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP046 |
h GRK6 inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP044 |
h CDK18 inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP043 |
h BUB1 inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP042 |
h TRIB2 inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP041 |
h CMPK1 inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP040 |
h GALK2 inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP038 |
h CSNK1G1 inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP037 |
h PAK6 inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP034 |
h PIM2 inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP033 |
h LIMK2 inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP032 |
h MARK2 inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP047 |
h NUAK2 inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP048 |
h DAPK2 inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP060 |
h PDK3 inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP059 |
h YES1 inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP058 |
h PIP5K1A inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP057 |
h WIF1 inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP056 |
h STK17B inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP054 |
h TGFBR2 inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP053 |
h CDK5R1 inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP052 |
h PDIK1L inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP051 |
h TYK2 inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP050 |
h NME1 inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP049 |
h CAMK2A inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP030 |
h MATK inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP211 |
h PAK2 inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP501 |
h NELL1 inducible lentiviral particles , premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP291 |
h BDKRB1 inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP290 |
h KCNJ5 inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP289 |
h TGFB1 inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP286 |
h NCOA4 inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP285 |
h ACTG1 inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP284 |
h RASSF5 inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP509 |
h SPP1 inducible lentiviral particles , premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP510 |
h TSHR inducible lentiviral particles , premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP282 |
h CTSD inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP294 |
h KITLG inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP295 |
h IL20 inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP307-PBS |
YFP (Neo) lentiviral particles,
in vivo ready; premade lentiviral particles |
1x109 IFU/ml x 200ul |
808-Eur |
GenTarget |
|
LVP502 |
h ATP2B2 inducible lentiviral particles , premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP503 |
h TRPV1 inducible lentiviral particles , premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP504 |
h ERBB2 inducible lentiviral particles , premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP505 |
h RFC1 inducible lentiviral particles , premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP506 |
h FZD7 inducible lentiviral particles , premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP507 |
h SNCA inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP508 |
m SNCA inducible lentiviral particles , premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP302 |
h IDO1 inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP281 |
h RUVBL2 inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP280 |
h RGS16 inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP279 |
h ZFP36 inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP265 |
h CDK7 inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP264 |
h CDK4 inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP263 |
h CDK2 inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP262 |
h CDKN2B inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP261 |
h CCND1 inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP260 |
h RhoA inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP259 |
h OXSR1 inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP296 |
h FGF18 inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP258 |
h Foxo3 inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP266 |
h Rac1 inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP267 |
h Rac2 inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP278 |
h PCBP2 inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP277 |
h IFNG inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP276 |
h TAPBP inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP275 |
h RanBP1 inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP273 |
h GGA3 inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP272 |
h NRAS inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP271 |
m Mesp1 inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP270 |
m MEF2C inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP269 |
m PAX6 inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP257 |
h ACVR1 inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP478 |
h YAP1 inducible lentiviral particles , premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP332 |
h ARID3B inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP331 |
h TNFAIP6 inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP330 |
h GRK5 inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP470 |
h ZDHHC17 inducible lentiviral particles , premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP469 |
h ZDHHC13 inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP328 |
h PRELP inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP480 |
h FZD6 inducible lentiviral particles , premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP299-PBS |
RFP (Neo) lentiviral particles, in vivo ready; premade lentiviral particles |
1x109 IFU/ml x 200ul |
808-Eur |
GenTarget |
|
LVP481 |
h BMP2 inducible lentiviral particles , premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP334 |
lacZ (luciferase) lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP301 |
lacZ (Puro) lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP027-PBS |
NLS-CRE-2A-RFP (Neo), lentiviral particles , in vivo ready; premade lentiviral particles |
5 x107 IFU/ml x 200ul |
808-Eur |
GenTarget |
|
LVP013-PBS |
NLS-CRE-2A-RFP (Bsd), lentiviral particles , in vivo ready; premade lentiviral particles |
5 x107 IFU/ml x 200ul |
808-Eur |
GenTarget |
|
LVP477 |
h CCR9 inducible lentiviral particles , premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP335-luc |
β-Lactamase (Luciferase) lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
400-Eur |
GenTarget |
|
LVP335-RP |
β-Lactamase (RFP-Puro) lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
400-Eur |
GenTarget |
|
LVP335-GP |
β-Lactamase (GFP-Puro) lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
400-Eur |
GenTarget |
|
LVP337-PBS |
NLS-CRE-2A-GFP (Bsd), lentiviral particles , in vivo ready; premade lentiviral particles |
5 x107 IFU/ml x 200ul |
808-Eur |
GenTarget |
|
LVP476 |
h CSF1R inducible lentiviral particles , premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP472 |
h SNAI2 inducible lentiviral particles , premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP482 |
h HIF1A inducible lentiviral particles , premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP483 |
h RUNX1 inducible lentiviral particles , premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP484 |
h PAX4 inducible lentiviral particles , premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP489 |
h LHX9 inducible lentiviral particles , premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP490 |
h MMP8 inducible lentiviral particles , premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP492 |
h TPI1 inducible lentiviral particles , premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP493 |
h MDH2 inducible lentiviral particles , premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP494 |
h ENO1 inducible lentiviral particles , premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP495 |
h HSP90AB1 inducible lentiviral particles , premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP497 |
h MSX2 inducible lentiviral particles , premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP306-PBS |
CFP (Neo) lentiviral particles,
in vivo ready; premade lentiviral particles |
1x109 IFU/ml x 200ul |
808-Eur |
GenTarget |
|
LVP243 |
h SRPK1 inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP488 |
r LRP11 inducible lentiviral particles , premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP317 |
h OCT4 (EF1a) Lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
400-Eur |
GenTarget |
|
LVP485 |
m PAX4 inducible lentiviral particles , premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP486 |
h PTGES inducible lentiviral particles , premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP016-RP |
T-antigen (RFP-Puro) lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
400-Eur |
GenTarget |
|
LVP487 |
h KLF1 inducible lentiviral particles , premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP322 |
h KLF4 (EF1a) Lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
400-Eur |
GenTarget |
|
LVP320 |
h LIN28 (EF1a) Lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
400-Eur |
GenTarget |
|
LVP319 |
h NANOG (EF1a) Lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
400-Eur |
GenTarget |
|
LVP300-PBS |
GFP (Neo) lentiviral particles, in vivo ready; premade lentiviral particles |
1x109 IFU/ml x 200ul |
808-Eur |
GenTarget |
|
LVP318 |
h SOX2 (EF1a) Lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
400-Eur |
GenTarget |
|
LVP500 |
m SNAI1 inducible lentiviral particles , premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP256 |
h ZAP70 inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP242 |
h SPAG9 inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP234 |
h PLK1 inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP233 |
h PKMYT1 inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP248 |
h STK3 inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP232 |
h CDK16 inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP231 |
h PAK4 inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP230 |
h NEK6 inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP229 |
h MRE11A inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP227 |
h TSSK2 inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP226 |
h PLK4 inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP225 |
h STK16 inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP235 |
h PRKACB inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP247 |
h BRSK2 inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP228 |
h MAP2K5 inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP268 |
m Mitf inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP240 |
h SGK3 inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP239 |
h RPS6KB1 inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP238 |
h RPS6KA2 inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP237 |
h RELA inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP236 |
h PRKCG inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP244 |
h TPTE inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP245 |
h TSSK3 inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP246 |
h STK25 inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP249 |
h STK38 inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP250 |
h AURKA inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP212 |
h PDK4 inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP252 |
h WEE1 inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP219 |
h PRKCA inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP254 |
h TTBK2 inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP214 |
h PIK3CB inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP217 |
h PRKAA1 inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP274 |
h RalBP1 inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP216 |
h PPARg inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP215 |
h PIK3R3 inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP220 |
h PTK2B inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP222 |
h RIPK2 inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP251 |
h RIOK3 inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP224 |
h STAT3 inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP223 |
h SGK2 inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP218 |
h PRKACA inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP253 |
h TP53 inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP255 |
h VRK3 inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP213 |
h PHKG2 inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP016-RP |
T-antigen (RFP-Puro) lentiviral particles: Pre-made lentiviral particles expressing SV40 large T-antigen with RFP-puromycin fusion dual marker. |
1x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP496 |
m EPO inducible lentiviral particles : Pre-made optional inducible lentiviral particles for expressing human target: m EPO (alternative name: none). The sub-cloned codon sequence is identical (100% |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP431-PBS |
CFP (EF1a)-Neo lentiviral particles, in vivo ready: Pre-made lentiviral particles expressing CFP under EF1a promoter with Neomycin selection marker, provided in PBS solution. |
1x10e8 IFU/ml x 200ul |
770-Eur |
GenTarget |
|
LVP304-PBS |
Luciferase-2A-CRE (Bsd), lentiviral particles, in vivo ready: Pre-made lentiviral particles bicistronically express individual firefly luciferase and nuclear permeable CRE recombinase under the same s |
5 x107 IFU/ml x 200ul |
933-Eur |
GenTarget |
|
LVP343-GB |
Lentiviral particles, shRNA (h P53)-(GFP-Bsd): Pre-made optional inducible lentiviral shRNA expression particles containing a hairpin insert to knockdown human P53 gene. It also contains a GFP-Blastic |
1 x107 IFU/ml x 200ul |
436-Eur |
GenTarget |
|
LVP304 |
Luciferase-2A-CRE (Bsd), lentiviral particles: Pre-made lentiviral particles bicistronically express individual firefly luciferase and nuclear permeable CRE recombinase under the same suCMV promoter. |
1x107 IFU/ml x 200ul |
552-Eur |
GenTarget |
|
LVP317 |
h OCT4 (EF1a) Lentiviral particles: Pre-made serum-free lentiviral particles constitutively expressing human Oct3_4 gene under EF1a promoter. |
1x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP430-PBS |
CFP (EF1a)-Bsd lentiviral particles, in vivo ready: Pre-made lentiviral particles expressing CFP under EF1a promoter with Blasticidin selection marker, provided in PBS solution. |
1x10e8 IFU/ml x 200ul |
770-Eur |
GenTarget |
|
LVP360-G |
Nuc-GFP, LocLight lentiviral particles
: Pre-made lentiviral particles for sub-cellular fluorescent labeling, provided in DMEM medium with 10 percent FBS and 60ug_ml of polybrene. GFP fluorescent si |
1x10e7 IFU/ml x 1.0 ml |
552-Eur |
GenTarget |
|
LVP360-R |
Nuc-RFP, LocLight lentiviral particles
: Pre-made lentiviral particles for sub-cellular fluorescent labeling, provided in DMEM medium with 10 percent FBS and 60ug_ml of polybrene. RFP fluorescent sig |
1x10e7 IFU/ml x 1.0 ml |
552-Eur |
GenTarget |
|
LVP360-C |
Nuc-CFP, LocLight lentiviral particles
: Pre-made lentiviral particles for sub-cellular fluorescent labeling, provided in DMEM medium with 10 percent FBS and 60ug_ml of polybrene. CFP fluorescent sig |
1x10e7 IFU/ml x 1.0 ml |
552-Eur |
GenTarget |
|
LVP410 |
Luciferase-2A-CRE (Neo), lentiviral particles: Pre-made lentiviral particles bicistronically express individual firefly luciferase and nuclear permeable CRE recombinase under the same suCMV promoter. |
1x107 IFU/ml x 200ul |
552-Eur |
GenTarget |
|
LVP465-PBS |
YFP (EF1a)-Bsd lentiviral particles, in vivo ready: Pre-made lentiviral particles expressing YFP under EF1a promoter with Blasticidin selection marker, provided in PBS solution. |
1x10e8 IFU/ml x 200ul |
770-Eur |
GenTarget |
|
LVP017-Hygro |
CMV-TetR (Bsd) Lentiviral particles: Pre-made lentiviral particles expressing tetracycline regulator protein (TetR) under CMV promoter, with Hygromycin antibiotic marker. |
1x107 IFU/ml x 200ul |
441-Eur |
GenTarget |
|
LVP466-PBS |
YFP (EF1a)-Neo lentiviral particles, in vivo ready: Pre-made lentiviral particles expressing YFP under EF1a promoter with Neomycin selection marker, provided in PBS solution. |
1x10e8 IFU/ml x 200ul |
770-Eur |
GenTarget |
|
LVP413-PBS |
Luciferase-2A-CRE, (RFP-Bsd) lentiviral particles, in vivo ready: Pre-made lentiviral particles bicistronically express individual firefly luciferase and nuclear permeable CRE recombinase under the sa |
5 x107 IFU/ml x 200ul |
933-Eur |
GenTarget |
|
LVP345-RB |
Lentiviral particles, shRNA (Luc)-( RFP-Bsd): Pre-made optional inducible lentiviral shRNA expression particles containing a hairpin insert to knockdown luciferase gene. It also contains a RFP-Blastic |
1 x107 IFU/ml x 200ul |
436-Eur |
GenTarget |
|
LVP416 |
h FII (thrombin) inducible lentiviral particles: Pre-made optional inducible lentiviral particles for expressing human target: h FII (alternative name: PT), with ORF sequence 100 percent matching to |
1 x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP413 |
Luciferase-2A-CRE, (RFP-Bsd) lentiviral particles: Pre-made lentiviral particles bicistronically express individual firefly luciferase and nuclear permeable CRE recombinase under the same suCMV promot |
1x107 IFU/ml x 200ul |
552-Eur |
GenTarget |
|
LVP411-PBS |
Luciferase-2A-CRE, (GFP-Bsd) lentiviral particles, in vivo ready: Pre-made lentiviral particles bicistronically express individual firefly luciferase and nuclear permeable CRE recombinase under the sa |
5 x107 IFU/ml x 200ul |
933-Eur |
GenTarget |
|
LVP411 |
Luciferase-2A-CRE, (GFP-Bsd) lentiviral particles: Pre-made lentiviral particles bicistronically express individual firefly luciferase and nuclear permeable CRE recombinase under the same suCMV promot |
1x107 IFU/ml x 200ul |
552-Eur |
GenTarget |
|
LVP343-RB |
Lentiviral particles, shRNA (h P53)-(RFP-Bsd): Pre-made optional inducible lentiviral shRNA expression particles containing a hairpin insert to knockdown human P53 gene. It also contains a RFP-Blastic |
1 x107 IFU/ml x 200ul |
436-Eur |
GenTarget |
|
LVP410-PBS |
Luciferase-2A-CRE (Neo), lentiviral particles, in vivo ready: Pre-made lentiviral particles bicistronically express individual firefly luciferase and nuclear permeable CRE recombinase under the same s |
5 x107 IFU/ml x 200ul |
933-Eur |
GenTarget |
|
LVP345-GB |
Lentiviral particles, shRNA (Luc)-( GFP-Bsd): Pre-made optional inducible lentiviral shRNA expression particles containing a hairpin insert to knockdown firefly luciferase gene. It also contains a GFP |
1 x107 IFU/ml x 200ul |
436-Eur |
GenTarget |
|
LVP428-PBS |
RFP (EF1a)-Neo lentiviral particles, in vivo ready: Pre-made lentiviral particles expressing RFP under EF1a promoter with Neomycin selection marker, provided in PBS solution. |
1x10e8 IFU/ml x 200ul |
770-Eur |
GenTarget |
|
LVP427-PBS |
RFP (EF1a)-Bsd lentiviral particles, in vivo ready: Pre-made lentiviral particles expressing RFP under EF1a promoter with Blasticidin selection marker, provided in PBS solution. |
1x10e8 IFU/ml x 200ul |
770-Eur |
GenTarget |
|
LVP409 |
Luciferase-2A-CRE (Puro), lentiviral particles: Pre-made lentiviral particles bicistronically express individual firefly luciferase and nuclear permeable CRE recombinase under the same suCMV promoter. |
1x107 IFU/ml x 200ul |
552-Eur |
GenTarget |
|
LVP345-GP |
Lentiviral particles, shRNA (Luc)-( GFP-Puro): Pre-made optional inducible lentiviral shRNA expression particles containing a hairpin insert to knockdown luciferase gene. It also contains a GFP-Puromy |
1 x107 IFU/ml x 200ul |
436-Eur |
GenTarget |
|
LVP345-RP |
Lentiviral particles, shRNA (Luc)-( RFP-Puro): Pre-made optional inducible lentiviral shRNA expression particles containing a hairpin insert to knockdown luciferase gene. It also contains a RFP-puromy |
1 x107 IFU/ml x 200ul |
436-Eur |
GenTarget |
|
LVP452-R |
Mito-GFP, LocLight lentiviral particles
: Pre-made lentiviral particles for sub-cellular fluorescent labeling, provided in DMEM medium with 10 percent FBS and 60ug_ml of polybrene. RFP fluorescent si |
1x107 IFU/ml x 200ul |
552-Eur |
GenTarget |
|
LVP412-PBS |
Luciferase-2A-CRE, (GFP-Puro) lentiviral particles, in vivo ready: Pre-made lentiviral particles bicistronically express individual firefly luciferase and nuclear permeable CRE recombinase under the s |
5 x107 IFU/ml x 200ul |
933-Eur |
GenTarget |
|
LVP412 |
Luciferase-2A-CRE, (GFP-Puro) lentiviral particles: Pre-made lentiviral particles bicistronically express individual firefly luciferase and nuclear permeable CRE recombinase under the same suCMV promo |
1x107 IFU/ml x 200ul |
552-Eur |
GenTarget |
|
LVP451-G |
Golgoi-GFP, LocLight lentiviral particles
: Pre-made lentiviral particles for sub-cellular fluorescent labeling, provided in DMEM medium with 10 percent FBS and 60ug_ml of polybrene. GFP fluorescent |
1x107 IFU/ml x 200ul |
552-Eur |
GenTarget |
|
LVP450-C |
Cyto-CFP, LocLight lentiviral particles
: Pre-made lentiviral particles for sub-cellular fluorescent labeling, provided in DMEM medium with 10 percent FBS and 60ug_ml of polybrene. CFP fluorescent si |
1x107 IFU/ml x 200ul |
552-Eur |
GenTarget |
|
LVP447-G |
GFP-TAT fusion Lentiviral particles: Pre-made lentiviral particles expressing (GFP-HIV-1 Tat) fusion contruct under suCMV promoter, provided in DMEM medium with 10 percent FBS and 60ug_ml of polybren |
1x10e7 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP450-R |
Cyto-RFP, LocLight lentiviral particles
: Pre-made lentiviral particles for sub-cellular fluorescent labeling, provided in DMEM medium with 10 percent FBS and 60ug_ml of polybrene. RFP fluorescent si |
1x107 IFU/ml x 200ul |
552-Eur |
GenTarget |
|
LVP450-G |
Cyto-GFP, LocLight lentiviral particles
: Pre-made lentiviral particles for sub-cellular fluorescent labeling, provided in DMEM medium with 10 percent FBS and 60ug_ml of polybrene. GFP fluorescent si |
1x10e7 IFU/ml x 1.0 ml |
552-Eur |
GenTarget |
|
LVP467-PBS |
YFP (EF1a)-Puro lentiviral particles, in vivo ready: Pre-made lentiviral particles expressing YFP under EF1a promoter with Puromycin selection marker, provided in PBS solution. |
1x10e8 IFU/ml x 200ul |
770-Eur |
GenTarget |
|
LVP452-C |
Mito-GFP, LocLight lentiviral particles
: Pre-made lentiviral particles for sub-cellular fluorescent labeling, provided in DMEM medium with 10 percent FBS and 60ug_ml of polybrene. CFP fluorescent si |
1x107 IFU/ml x 200ul |
552-Eur |
GenTarget |
|
LVP447-R |
RFP-TAT fusion Lentiviral particles: Pre-made lentiviral particles expressing (RFP-HIV-1 Tat) fusion contruct under suCMV promoter, provided in DMEM medium with 10 percent FBS and 60ug_ml of polybren |
1x10e7 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP409-PBS |
Luciferase-2A-CRE (Puro), lentiviral particles, in vivo ready: Pre-made lentiviral particles bicistronically express individual firefly luciferase and nuclear permeable CRE recombinase under the same |
5 x107 IFU/ml x 200ul |
933-Eur |
GenTarget |
|
LVP451-R |
Golgoi-RFP, LocLight lentiviral particles
: Pre-made lentiviral particles for sub-cellular fluorescent labeling, provided in DMEM medium with 10 percent FBS and 60ug_ml of polybrene. RFP fluorescent |
1x107 IFU/ml x 200ul |
552-Eur |
GenTarget |
|
LVP414-PBS |
Luciferase-2A-CRE, (RFP-Puro) lentiviral particles, in vivo ready: Pre-made lentiviral particles bicistronically express individual firefly luciferase and nuclear permeable CRE recombinase under the s |
5 x107 IFU/ml x 200ul |
933-Eur |
GenTarget |
|
LVP425-PBS |
GFP (EF1a)-Neo lentiviral particles, in vivo ready: Pre-made lentiviral particles expressing eGFP under EF1a promoter with Neomycin selection marker, provided in PBS solution. |
1x10e8 IFU/ml x 200ul |
770-Eur |
GenTarget |
|
LVP452-G |
Mito-GFP, LocLight lentiviral particles
: Pre-made lentiviral particles for sub-cellular fluorescent labeling, provided in DMEM medium with 10 percent FBS and 60ug_ml of polybrene. GFP fluorescent si |
1x107 IFU/ml x 200ul |
552-Eur |
GenTarget |
|
LVP451-C |
Golgoi-CFP, LocLight lentiviral particles
: Pre-made lentiviral particles for sub-cellular fluorescent labeling, provided in DMEM medium with 10 percent FBS and 60ug_ml of polybrene. CFP fluorescent |
1x107 IFU/ml x 200ul |
552-Eur |
GenTarget |
|
LVP498 |
h OPN-a inducible lentiviral particles : Pre-made optional inducible lentiviral particles for expressing human target: OPN-a (alternative name: SPP1, PSEC0156, BNSP, BSPI, ETA-1, OPN). The sub-cloned |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP343-GP |
Lentiviral particles, shRNA (h P53)-(GFP-Puro): Pre-made optional inducible lentiviral shRNA expression particles containing a hairpin insert to knockdown human P53 gene. It also contains a GFP-Puromy |
1 x107 IFU/ml x 200ul |
436-Eur |
GenTarget |
|
LVP414 |
Luciferase-2A-CRE, (RFP-Puro) lentiviral particles: Pre-made lentiviral particles bicistronically express individual firefly luciferase and nuclear permeable CRE recombinase under the same suCMV promo |
1x107 IFU/ml x 200ul |
552-Eur |
GenTarget |
|
LVP343-RP |
Lentiviral particles, shRNA (h P53)-(RFP-Puro): Pre-made optional inducible lentiviral shRNA expression particles containing a hairpin insert to knockdown human P53 gene. It also contains a RFP-puromy |
1 x107 IFU/ml x 200ul |
436-Eur |
GenTarget |
|
LVP499 |
h OPN-c inducible lentiviral particles : Pre-made optional inducible lentiviral particles for expressing human target: OPN-c (alternative name: SPP1, PSEC0156, BNSP, BSPI, ETA-1, OPN). The sub-cloned |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP429-PBS |
RFP (EF1a)-Puro lentiviral particles, in vivo ready: Pre-made lentiviral particles expressing RFP under EF1a promoter with Puromycin selection marker, provided in PBS solution. |
1x10e8 IFU/ml x 200ul |
770-Eur |
GenTarget |
|
LVP447-C |
CFP-TAT fusion Lentiviral particles: Pre-made lentiviral particles expressing (CFP-HIV-1 Tat) fusion contruct under suCMV promoter, provided in DMEM medium with 10 percent FBS and 60ug_ml of polybren |
1x10e7 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP432-PBS |
CFP (EF1a)-Puro lentiviral particles, in vivo ready: Pre-made lentiviral particles expressing CFP under EF1a promoter with Puromycin selection marker, provided in PBS solution. |
1x10e8 IFU/ml x 200ul |
770-Eur |
GenTarget |
|
LVP310-PBS |
GFP (EF1a)-Bsd lentiviral particles, in vivo ready: Pre-made lentiviral particles expressing eGFP under EF1a promoter with Blasticidin selection marker, provided in PBS solution. |
1x10e8 IFU/ml x 200ul |
770-Eur |
GenTarget |
|
LVP016-RB |
T-antigen (RFP-Bsd) lentiviral particles: Pre-made lentiviral particles expressing SV40 large T-antigen with RFP-Blasticidin fusion dual marker. |
1x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP321 |
h Myc (EF1a) Lentiviral particles: Pre-made serum-free lentiviral particles constitutively expressing human Myc gene under EF1a promoter. |
1x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP016-GB |
T-antigen (GFP-Bsd) lentiviral particles: Pre-made lentiviral particles expressing SV40 large T-antigen with GFP-Blasticidin fusion dual marker. |
1x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP426-PBS |
GFP (EF1a)-Puro lentiviral particles, in vivo ready: Pre-made lentiviral particles expressing eGFP under EF1a promoter with Puromycin selection marker, provided in PBS solution. |
1x10e8 IFU/ml x 200ul |
770-Eur |
GenTarget |
|
LVP442 |
GFP-RFP fusion control lentiviral particles: Pre-made lentiviral particles expressing GFP-RFP fusion contruct under suCMV promoter, provided in DMEM medium with 10 percent FBS and 60ug_ml of polybren |
1x10e7 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP333 |
lacZ (Neo) lentiviral particles: Pre-made lentiviral particles expressing full length lacZ enzyme (β-Galactosidase) with Neomycin marker, provided in DMDM medium with 10 percent FBS. |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP346 |
lacZ (Bsd) lentiviral particles: Pre-made lentiviral particles expressing full length lacZ enzyme (β-Galactosidase) with blasticidin marker, provided in DMDM medium with 10 percent FBS. |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP443 |
CFP-RFP fusion control lentiviral particles: Pre-made lentiviral particles expressing CFP-RFP fusion contruct under suCMV promoter, provided in DMEM medium with 10 percent FBS and 60ug_ml of polybren |
1x10e7 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP301 |
lacZ (Puro) lentiviral particles: Pre-made lentiviral particles expressing full length lacZ enzyme (β-Galactosidase) with puromycin marker, provided in DMDM medium with 10 percent FBS. |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP448-G |
GFP-hP53 fusion Lentiviral particles: Pre-made lentiviral particles expressing (GFP-human P53) fusion contruct under suCMV promoter, provided in DMEM medium with 10 percent FBS and 60ug_ml of polybre |
1x10e7 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP445-G |
GFP-Annexin5 fusion Lentiviral particles: Pre-made lentiviral particles expressing (GFP-human Annexin 5) fusion contruct under suCMV promoter, provided in DMEM medium with 10 percent FBS and 60ug_ml |
1x10e7 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP445-R |
RFP-Annexin5 fusion Lentiviral particles: Pre-made lentiviral particles expressing (RFP-human Annexin 5) fusion contruct under suCMV promoter, provided in DMEM medium with 10 percent FBS and 60ug_ml |
1x10e7 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP347 |
lacZ (GFP-Bsd) lentiviral particles: Pre-made lentiviral particles expressing full length lacZ enzyme (β-Galactosidase) with GFP-Blasticidin fusion marker, provided in DMDM medium with 10 percent FBS |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP448-R |
RFP-hP53 fusion Lentiviral particles: Pre-made lentiviral particles expressing (RFP-human P53) fusion contruct under suCMV promoter, provided in DMEM medium with 10 percent FBS and 60ug_ml of polybre |
1x10e7 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP448-C |
CFP-hP53 fusion Lentiviral particles: Pre-made lentiviral particles expressing (CFP-human P53) fusion contruct under suCMV promoter, provided in DMEM medium with 10 percent FBS and 60ug_ml of polybre |
1x10e7 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP445-C |
CFP-Annexin5 fusion Lentiviral particles: Pre-made lentiviral particles expressing (CFP-human Annexin 5) fusion contruct under suCMV promoter, provided in DMEM medium with 10 percent FBS and 60ug_ml |
1x10e7 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP348 |
lacZ (RFP-puro) lentiviral particles: Pre-made lentiviral particles expressing full length lacZ enzyme (β-Galactosidase) with RFP-Puromycin fusion marker, provided in DMDM medium with 10 percent FBS. |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP010 |
lacZ (RFP-Bsd) lentiviral particles : Pre-made lentiviral particles expressing full length lacZ enzyme (β-Galactosidase) with RFP-Blasticidin fusion dual marker, provided in DMEM medium with 10 percen |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP016-Neo |
T-antigen (Neo) lentiviral particles: Pre-made lentiviral particles expressing SV40 large T-antigen with Neomycin marker. |
1x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP016-Bsd |
T-antigen (Bsd) lentiviral particles: Pre-made lentiviral particles expressing SV40 large T-antigen with Blasticidin marker. |
1x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP304 |
Luciferase-2A-NLS-CRE (Bsd), lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
579-Eur |
GenTarget |
|
LVP471 |
YFP (puro) lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP333 |
lacZ (Neo) lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP022 |
h UBD inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP163 |
h FGR inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP339 |
NLS-CRE (Puro) lentiviral particles
; premade lentiviral particles |
1x107 IFU/ml x 200ul |
400-Eur |
GenTarget |
|
LVP036 |
h BMX inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP064 |
h RP2 inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP031 |
h AK3 inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP585 |
CFP (CAG)-Puro lentiviral particles, premade lentiviral particles |
1 x 107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP055 |
h CKM inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP035 |
h CKB inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP172 |
h JUN inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP166 |
h FOS inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP039 |
h GAK inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP338 |
NLS-CRE-2A-RFP (Puro), lentiviral particles
; premade lentiviral particles |
1x107 IFU/ml x 200ul |
400-Eur |
GenTarget |
|
LVP356 |
h EPO inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP111 |
h NBN inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP340 |
GFP (puro) lentiviral particles; premade lentiviral particles |
1x108 IFU/ml x 200ul |
400-Eur |
GenTarget |
|
LVP343-RB |
Lentiviral particles, shRNA (h P53)-(RFP-Bsd); premade lentiviral particles |
1 x107 IFU/ml x 200ul |
458-Eur |
GenTarget |
|
LVP309 |
RFP (Puro) lentiviral particles; premade lentiviral particles |
1x108 IFU/ml x 200ul |
400-Eur |
GenTarget |
|
LVP345-GB |
Lentiviral particles, shRNA (Luc)-( GFP-Bsd); premade lentiviral particles |
1 x107 IFU/ml x 200ul |
458-Eur |
GenTarget |
|
LVP127 |
h BTK inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP124 |
h AXL inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP074 |
h GBA inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP092 |
h MAK inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP045 |
h GCK inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP343-GB |
Lentiviral particles, shRNA (h P53)-(GFP-Bsd); premade lentiviral particles |
1 x107 IFU/ml x 200ul |
458-Eur |
GenTarget |
|
LVP345-RB |
Lentiviral particles, shRNA (Luc)-( RFP-Bsd); premade lentiviral particles |
1 x107 IFU/ml x 200ul |
458-Eur |
GenTarget |
|
LVP-Ctr-GP |
Lentiviral particles, shRNA (Neg)-( GFP-Puro); premade lentiviral particles |
1 x107 IFU/ml x 200ul |
400-Eur |
GenTarget |
|
LVP542 |
h BSG inducible lentiviral particles , premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP598 |
h AR inducible lentiviral particles , premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP077 |
h FYN inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP350 |
m SRC inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP309 |
RFP (Puro) lentiviral particles, premade lentiviral particles |
1x10e7 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP067 |
h TXN inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP347 |
lacZ (GFP-Bsd) lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP540 |
h ID2 inducible lentiviral particles , premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP346 |
lacZ (Bsd) lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP101 |
h LBR inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP-Ctr-RP |
Lentiviral particles, shRNA (Neg)-( RFP-Puro); premade lentiviral particles |
1 x107 IFU/ml x 200ul |
400-Eur |
GenTarget |
|
LVP095 |
h PBK inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP498 |
h OPN-a inducible lentiviral particles , premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP335-RB |
β-Lactamase (RFP-Bsd) lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP346 |
lacZ (Bsd) lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP111 |
h NBN inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP293 |
h IL2 inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP292 |
h IL3 inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP287 |
h TNF inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP288 |
h BAX inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP288 |
h BAX inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP287 |
h TNF inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP292 |
h IL3 inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP293 |
h IL2 inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP447-R |
RFP-TAT fusion Lentiviral particles; premade lentiviral particles |
1x108 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP447-C |
CFP-TAT fusion Lentiviral particles; premade lentiviral particles |
1x108 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP350 |
m SRC inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP499 |
h OPN-c inducible lentiviral particles , premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP407 |
NLS-CRE-2A-GFP (Puro), lentiviral particles
; premade lentiviral particles |
1x107 IFU/ml x 200ul |
400-Eur |
GenTarget |
|
LVP092 |
h MAK inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP095 |
h PBK inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP410 |
Luciferase-2A-NLS-CRE (Neo), lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
579-Eur |
GenTarget |
|
LVP411 |
Luciferase-2A-NLS-CRE, (GFP-Bsd) lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
579-Eur |
GenTarget |
|
LVP101 |
h LBR inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP413 |
Luciferase-2A-NLS-CRE, (RFP-Bsd) lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
579-Eur |
GenTarget |
|
LVP303 |
h HLA-G inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP356 |
h EPO inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP241 |
h SP1 inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP345-RB |
Lentiviral particles, shRNA (Luc)-( RFP-Bsd), premade lentiviral particles |
1 x107 IFU/ml x 200ul |
436-Eur |
GenTarget |
|
LVP345-GB |
Lentiviral particles, shRNA (Luc)-( GFP-Bsd), premade lentiviral particles |
1 x107 IFU/ml x 200ul |
436-Eur |
GenTarget |
|
LVP172 |
h JUN inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP016-Bsd |
T-antigen (Bsd), CMV lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP016-GB |
T-antigen (GFP-Bsd), CMV lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP557-GB |
T-antigen (GFP-Bsd), CMV lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP347 |
lacZ (GFP-Bsd) lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP327 |
h PGR inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP413 |
Luciferase-2A-CRE, (RFP-Bsd) lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
552-Eur |
GenTarget |
|
LVP329 |
h OMD inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP333 |
lacZ (Neo) lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP304 |
Luciferase-2A-CRE (Bsd), lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
552-Eur |
GenTarget |
|
LVP335-Bsd |
β-Lactamase (Bsd) lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP335-Neo |
β-Lactamase (Neo) lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP016-Neo |
T-antigen (Neo), CMV lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP016-RB |
T-antigen (RFP-Bsd), CMV lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP342 |
CFP (puro) lentiviral particles; premade lentiviral particles |
1x108 IFU/ml x 200ul |
400-Eur |
GenTarget |
|
LVP343-RB |
Lentiviral particles, shRNA (h P53)-(RFP-Bsd), premade lentiviral particles |
1 x107 IFU/ml x 200ul |
436-Eur |
GenTarget |
|
LVP343-GB |
Lentiviral particles, shRNA (h P53)-(GFP-Bsd), premade lentiviral particles |
1 x107 IFU/ml x 200ul |
436-Eur |
GenTarget |
|
LVP166 |
h FOS inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP342 |
CFP (puro) lentiviral particles, premade lentiviral particles |
1x10e7 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP340 |
GFP (puro) lentiviral particles, premade lentiviral particles |
1x10e7 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP399 |
RFP-LC3 fusion lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP163 |
h FGR inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP399 |
RFP-LC3 fusion lentiviral particles; premade lentiviral particles |
1x108 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP303 |
h HLA-G inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP127 |
h BTK inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP592 |
h Myc (EF1a) (RP) Lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP335-GB |
β-Lactamase (GFP-Bsd) lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP496 |
m EPO inducible lentiviral particles , premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP411 |
Luciferase-2A-CRE, (GFP-Bsd) lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
552-Eur |
GenTarget |
|
LVP335-Neo |
β-Lactamase (Neo) lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
400-Eur |
GenTarget |
|
LVP360-C |
Nuc-CFP, LocLight lentiviral particles
, premade lentiviral particles |
1x107 IFU/ml x 200ul |
552-Eur |
GenTarget |
|
LVP035 |
h CKB inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP036 |
h BMX inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP360-R |
Nuc-RFP, LocLight lentiviral particles
, premade lentiviral particles |
1x107 IFU/ml x 200ul |
552-Eur |
GenTarget |
|
LVP360-G |
Nuc-GFP, LocLight lentiviral particles
, premade lentiviral particles |
1x107 IFU/ml x 200ul |
552-Eur |
GenTarget |
|
LVP124 |
h AXL inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP039 |
h GAK inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP335-GB |
β-Lactamase (GFP-Bsd) lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
400-Eur |
GenTarget |
|
LVP329 |
h OMD inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP045 |
h GCK inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP031 |
h AK3 inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP197 |
h MAX inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP410 |
Luciferase-2A-CRE (Neo), lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
552-Eur |
GenTarget |
|
LVP221 |
h RET inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
CMV-Null-RB |
CMV Control lentiviral particles (RFP-Bsd), premade lentiviral particles |
1 x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
CMV-Null-GB |
CMV Control lentiviral particles (GFP-Bsd), premade lentiviral particles |
1 x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
CMV-Null-Neo |
CMV Control lentiviral particles (Neo), premade lentiviral particles |
1 x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
CMV-Null-Bsd |
CMV Control lentiviral particles (Bsd), premade lentiviral particles |
1 x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP197 |
h MAX inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP022 |
h UBD inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP360-C |
Nuc-CFP, LocLight lentiviral particles
; premade lentiviral particles |
1x108 IFU/ml x 1.0 ml |
579-Eur |
GenTarget |
|
LVP360-R |
Nuc-RFP, LocLight lentiviral particles
; premade lentiviral particles |
1x108 IFU/ml x 1.0 ml |
579-Eur |
GenTarget |
|
LVP335-Bsd |
β-Lactamase (Bsd) lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
400-Eur |
GenTarget |
|
LVP360-G |
Nuc-GFP, LocLight lentiviral particles
; premade lentiviral particles |
1x108 IFU/ml x 1.0 ml |
579-Eur |
GenTarget |
|
LVP241 |
h SP1 inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP016-Neo |
T-antigen (Neo) lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
400-Eur |
GenTarget |
|
LVP064 |
h RP2 inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP016-RB |
T-antigen (RFP-Bsd) lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
400-Eur |
GenTarget |
|
LVP074 |
h GBA inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP447-G |
GFP-TAT fusion Lentiviral particles; premade lentiviral particles |
1x108 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP016-GB |
T-antigen (GFP-Bsd) lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
400-Eur |
GenTarget |
|
LVP067 |
h TXN inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP321 |
h Myc (EF1a) Lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
400-Eur |
GenTarget |
|
LVP016-Bsd |
T-antigen (Bsd) lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
400-Eur |
GenTarget |
|
LVP447-C |
CFP-TAT fusion Lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP077 |
h FYN inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP327 |
h PGR inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP335-RB |
β-Lactamase (RFP-Bsd) lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
400-Eur |
GenTarget |
|
LVP055 |
h CKM inducible lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP447-R |
RFP-TAT fusion Lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP221 |
h RET inducible lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP447-G |
GFP-TAT fusion Lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
TLV-C |
293T lentivirus packing cells: Lentiviral Packaging Cell Line. 293HEK cells stably expressing SV40 larget T-antigen, for producing high-titer lentivirus when transfected with lentiviral vectors. |
2 x 106 cell/ml x 1ml |
381-Eur |
GenTarget |
|
LVP335-RP |
β-Lactamase (RFP-Puro) lentiviral particles: pre-made lentiviral particles expressing β-Lactamase gene. A RFP-puromycin marker was expressed under RSV promoter. Particles is provided in DMEM medium w |
1x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP335-GP |
β-Lactamase (GFP-Puro) lentiviral particles: pre-made lentiviral particles expressing β-Lactamase gene. A GFP-puromycin fusion marker was expressed under RSV promoter. Particles is provided in DMEM m |
1x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP335-GB |
β-Lactamase (GFP-Bsd) lentiviral particles: pre-made lentiviral particles expressing β-Lactamase gene. A GFP-Blasticidin fusion marker was expressed under RSV promoter. Particles is provided in DMEM |
1x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP335-Neo-PBS |
β-Lactamase (Neo) lentiviral particles, in vivo ready: pre-made lentiviral particles expressing β-Lactamase gene. A Neomycin marker was expressed under RSV promoter. Particles are purified into PBS s |
5x10e7 IFU/ml x 200ul |
770-Eur |
GenTarget |
|
LVP335-Bsd-PBS |
β-Lactamase (Bsd) lentiviral particles, in vivo ready: pre-made lentiviral particles expressing β-Lactamase gene. A blasticidin marker was expressed under RSV promoter. Particles are purified into PB |
5x10e7 IFU/ml x 200ul |
770-Eur |
GenTarget |
|
LVP335-Bsd |
β-Lactamase (Bsd) lentiviral particles: pre-made lentiviral particles expressing β-Lactamase gene. A blasticidin marker was expressed under RSV promoter. Particles is provided in DMEM medium with 10& |
1x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP335-Neo |
β-Lactamase (Neo) lentiviral particles: pre-made lentiviral particles expressing β-Lactamase gene. A Neomycin marker was expressed under RSV promoter. Particles is provided in DMEM medium with 10% |
1x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP335-GB-PBS |
β-Lactamase (GFP-Bsd) lentiviral particles, in vivo ready: pre-made lentiviral particles expressing β-Lactamase gene. A GFP-Blasticidin fusion marker was expressed under RSV promoter. Particles are p |
5x107 IFU/ml x 200ul |
770-Eur |
GenTarget |
|
LVP335-RB |
β-Lactamase (RFP-Bsd) lentiviral particles: pre-made lentiviral particles expressing β-Lactamase gene. A RFP-Blasticidin fusionmarker was expressed under RSV promoter. Particles is provided in DMEM m |
1x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP335-RB-PBS |
β-Lactamase (RFP-Bsd) lentiviral particles, in vivo ready: pre-made lentiviral particles expressing β-Lactamase gene. A RFP-Blasticidin fusionmarker was expressed under RSV promoter. Particles are pu |
5x10e7 IFU/ml x 200ul |
770-Eur |
GenTarget |
|
LVP335-Puro-PBS |
β-Lactamase (Puro) lentiviral particles, in vivo ready, premade lentiviral particles |
5x10e7 IFU/ml x 200ul |
770-Eur |
GenTarget |
|
LVP335-Puro-PBS |
β-Lactamase (Puro) lentiviral particles, in vivo ready; premade lentiviral particles |
5x108 IFU/ml x 200ul |
808-Eur |
GenTarget |
|
LVP359-Puro |
Chained human iPS (MKOS) (RFP-Puro) lentiviral particles, premade lentiviral particles |
1x106 IFU/ml x 0.5 ml |
1130-Eur |
GenTarget |
|
LVP358-Puro |
Chained human iPS (MKOS) (RFP-Puro) lentiviral particles, premade lentiviral particles |
1x106 IFU/ml x 0.5 ml |
1130-Eur |
GenTarget |
|
LVP334 |
lacZ (luciferase) lentiviral particles: Pre-made lentiviral particles expressing full length lacZ enzyme (β-Galactosidase) with luciferase marker, provided in DMDM medium with 10 percent FBS. |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP383 |
h Stat3 inducible lentiviral particles: Pre-made inducible lentiviral particles for expressing human target: h Stat3 (alternative name: APRF; HIES), with ORF sequence 100 percent matching to CDS regi |
1 x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP388 |
h VEGFA inducible lentiviral particles: Pre-made inducible lentiviral particles for expressing human target: h VEGFA (alternative name: VPF; VEGF; MVCD1; MGC70609), with ORF sequence 100 percent matc |
1 x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP394 |
h Flt3 inducible lentiviral particles: Pre-made inducible lentiviral particles for expressing human target: h Flt3 (alternative name: CD135; FLK2; STK1), with ORF sequence 100 percent matching to CDS |
1 x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP395 |
h MMP9 inducible lentiviral particles: Pre-made inducible lentiviral particles for expressing human target: h MMP9 (alternative name: CLG4B; GELB; MANDP2; MMP-9), with ORF sequence 100 percent matchi |
1 x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP396 |
h CEBPB inducible lentiviral particles: Pre-made inducible lentiviral particles for expressing human target: h CEBPB (alternative name: C_EBP-beta; CRP2; IL6DBP; LAP; MGC32080), with ORF sequence 100& |
1 x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP517 |
h TPRC3 inducible lentiviral particles: Pre-made optional inducible lentiviral particles for expressing human target: TPRC3 (alternative name: TRP3, ). The sub-cloned codon sequence is identical (100& |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP419 |
h KDM5B inducible lentiviral particles: Pre-made optional inducible lentiviral particles for expressing human target: h KDM5B (alternative name: CT31, JARID1B, PLU-1, PLU1, PUT1, RBBP2H1A), with ORF s |
1 x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP497 |
h MSX2 inducible lentiviral particles : Pre-made optional inducible lentiviral particles for expressing human target: MSX2 (alternative name: CRS2, FPP, HOX8, MSH, PFM, PFM1). The sub-cloned codon se |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP503 |
h TRPV1 inducible lentiviral particles : Pre-made optional inducible lentiviral particles for expressing human target: TRPV1 (alternative name: VR1, OTRPC1). The sub-cloned codon sequence is identica |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP507 |
h SNCA inducible lentiviral particles: Pre-made optional inducible lentiviral particles for expressing human target: SNCA (alternative name: ACP, PARK1, PARK4, PD1). The sub-cloned codon sequence is i |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP481 |
h BMP2 inducible lentiviral particles : Pre-made optional inducible lentiviral particles for expressing human target: BMP2 (alternative name: BDA2, BMP2A, BMP-2A;). The sub-cloned codon sequence is id |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP509 |
h SPP1 inducible lentiviral particles : Pre-made optional inducible lentiviral particles for expressing human target: SPP1 (alternative name: PSEC0156, BNSP, BSPI, ETA-1, OPN). The sub-cloned codon se |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP420 |
h CSF1 inducible lentiviral particles: Pre-made optional inducible lentiviral particles for expressing human target: h CSF1 (alternative name: RP11-195M16.2, CSF-1, MCSF), with ORF sequence 100 percen |
1 x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP418 |
h KDM5A inducible lentiviral particles: Pre-made optional inducible lentiviral particles for expressing human target: h KDM5A (alternative name: JARID1A, RBBP-2, RBBP2, RBP2), with ORF sequence 100 |
1 x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP493 |
h MDH2 inducible lentiviral particles : Pre-made optional inducible lentiviral particles for expressing human target: MDH2 (alternative name: M-MDH, MDH, MGC:3559, MOR1). The sub-cloned codon sequence |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP490 |
h MMP8 inducible lentiviral particles : Pre-made optional inducible lentiviral particles for expressing human target: MMP8 (alternative name: CLG1, HNC, MMP-8, PMNL-CL). The sub-cloned codon sequence |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP469 |
h ZDHHC13 inducible lentiviral particles: Pre-made optional inducible lentiviral particles for expressing human target: ZDHHC13 (alternative name: HIP14L, HIP3RP). The sub-cloned codon sequence is id |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP494 |
h ENO1 inducible lentiviral particles : Pre-made optional inducible lentiviral particles for expressing human target: ENO1 (alternative name: ENO1L1, MPB1, NNE, PPH). The sub-cloned codon sequence is |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP484 |
h PAX4 inducible lentiviral particles : Pre-made optional inducible lentiviral particles for expressing human target: PAX4 (alternative name: KPD, MODY9). The sub-cloned codon sequence is identical (1 |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP478 |
h YAP1 inducible lentiviral particles : Pre-made optional inducible lentiviral particles for expressing human target: YAP1 (alternative name: YAP, YAP2, YAP65, YKI). The sub-cloned codon sequence is i |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP444-G |
GFP-Histone 2B fusion lentiviral particles: Pre-made lentiviral particles expressing (GFP-human Histone 2B) fusion contruct under suCMV promoter, provided in DMEM medium with 10 percent FBS and 60ug_ |
1x10e7 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP444-C |
CFP-Histone 2B fusion lentiviral particles: Pre-made lentiviral particles expressing (CFP-human Histone 2B) fusion contruct under suCMV promoter, provided in DMEM medium with 10 percent FBS and 60ug_ |
1x10e7 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP444-R |
RFP-Histone 2B fusion lentiviral particles: Pre-made lentiviral particles expressing (RFP-human Histone 2B) fusion contruct under suCMV promoter, provided in DMEM medium with 10 percent FBS and 60ug_ |
1x10e7 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP492 |
h TPI1 inducible lentiviral particles : Pre-made optional inducible lentiviral particles for expressing human target: TPI1 (alternative name: TIM, TPI). The sub-cloned codon sequence is identical (100 |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP344-RP |
Lentiviral particles, shRNA (lacZ)-( RFP-Puro): Pre-made optional inducible lentiviral shRNA expression particles containing a hairpin insert to knockdown β-Galactosidase (lacZ) gene. It also contains |
1 x107 IFU/ml x 200ul |
436-Eur |
GenTarget |
|
LVP344-GP |
Lentiviral particles, shRNA (lacZ)-( GFP-Puro): Pre-made optional inducible lentiviral shRNA expression particles containing a hairpin insert to knockdown β-Galactosidase (lacZ) gene. It also contains |
1 x107 IFU/ml x 200ul |
436-Eur |
GenTarget |
|
LVP422 |
h LOXL2 inducible lentiviral particles: Pre-made optional inducible lentiviral particles for expressing human target: h LOXL2 (alternative name: LOR2, WS9-14), with ORF sequence 100 percent matching |
1 x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP483 |
h RUNX1 inducible lentiviral particles : Pre-made optional inducible lentiviral particles for expressing human target: RUNX1 (alternative name: ML1, AML1-EVI-1, AMLCR1, CBFA2, EVI-1, PEBP2aB). The sub |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP504 |
h ERBB2 inducible lentiviral particles : Pre-made optional inducible lentiviral particles for expressing human target: ERBB2 (alternative name: NEU; NGL; HER2; TKR1; CD340; HER-2; MLN 19; HER-2_neu). |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP477 |
h CCR9 inducible lentiviral particles : Pre-made optional inducible lentiviral particles for expressing human target: CCR9 (alternative name: CC-CKR-9, CDw199, GPR-9-6, GPR28). The sub-cloned codon se |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP476 |
h CSF1R inducible lentiviral particles : Pre-made optional inducible lentiviral particles for expressing human target: CSF1R (alternative name: C-FMS, CD115, CSF-1R, CSFR, FIM2, FMS, HDLS, M-CSF-R). |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP485 |
m PAX4 inducible lentiviral particles : Pre-made optional inducible lentiviral particles for expressing mouse target: m PAX4 (alternative name: PAX-4). The sub-cloned codon sequence is identical (100& |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP417 |
h MSH3 inducible lentiviral particles: Pre-made optional inducible lentiviral particles for expressing human target: h MSH3 (alternative name: DUP, MRP1), with ORF sequence 100 percent matching to CD |
1 x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP389 |
h BARD1 inducible lentiviral particles: Pre-made inducible lentiviral particles for expressing human target: h BARD1 (alternative name: ), with ORF sequence 100 percent matching to CDS region in NCBI |
1 x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP513 |
h CCR9 inducible lentiviral particles : Pre-made optional inducible lentiviral particles for expressing human target: CCR9 (alternative name: CC-CKR-9, CDw199, GPR-9-6, GPR28). The sub-cloned codon se |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP405 |
h Arf6 inducible lentiviral particles: Pre-made inducible lentiviral particles for expressing human target: Arf6 (alternative name: DKFZp564M0264), with ORF sequence 100 percent matching to CDS regio |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP391 |
m IL10 inducible lentiviral particles: Pre-made inducible lentiviral particles for expressing mouse target: m IL10 (alternative name: CSIF; Il-10), with ORF sequence 100 percent matching to CDS regio |
1 x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP398 |
m Git2 inducible lentiviral particles: Pre-made inducible lentiviral particles for expressing mouse target: m Git2 (alternative name: CAT2; KIAA0148), with ORF sequence 100 percent matching to CDS re |
1 x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP386 |
h GATA4 inducible lentiviral particles: Pre-made inducible lentiviral particles for expressing human target: h GATA4 (alternative name: MGC126629), with ORF sequence 100 percent matching to CDS regio |
1 x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP385 |
h RXRA inducible lentiviral particles: Pre-made inducible lentiviral particles for expressing human target: h RXRA (alternative name: NR2B1), with ORF sequence 100 percent matching to CDS region in N |
1 x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP415 |
h GYG1 inducible lentiviral particles: Pre-made optional inducible lentiviral particles for expressing human target: h GYG1 (alternative name: GYG; GSD15), with ORF sequence 100 percent matching to C |
1 x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP505 |
h RFC1 inducible lentiviral particles : Pre-made optional inducible lentiviral particles for expressing human target: RFC1 (alternative name: A1, MHCBFB, PO-GA, RECC1, RFC, RFC140). The sub-cloned cod |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP500 |
m SNAI1 inducible lentiviral particles : Pre-made optional inducible lentiviral particles for expressing mouse target: m SNAI1 (alternative name: RP23-118A2.5, AI194338, Sna, Sna1, Snail, Snail1). The |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP470 |
h ZDHHC17 inducible lentiviral particles : Pre-made optional inducible lentiviral particles for expressing human target: ZDHHC17 (alternative name: HSPC294, HIP14, HIP3, HYPH, DHHC-17). The sub-clone |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP390 |
h BRAC1 inducible lentiviral particles: Pre-made inducible lentiviral particles for expressing human target: h BRAC1 (alternative name: BRCC1; BROVCA1; IRIS; PNCA4; PSCP), with ORF sequence 100 percen |
1 x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP489 |
h LHX9 inducible lentiviral particles : Pre-made optional inducible lentiviral particles for expressing human target: LHX9 (alternative name: RP11-255O17.2). The sub-cloned codon sequence is identical |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP511 |
h PLK2 inducible lentiviral particles : Pre-made optional inducible lentiviral particles for expressing human target: PLK2 (alternative name: SNK, hPlk2, hSNK). The sub-cloned codon sequence is identi |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP501 |
h NELL1 inducible lentiviral particles : Pre-made optional inducible lentiviral particles for expressing human target: NELL1 (alternative name: IDH3GL, NRP1). The sub-cloned codon sequence is identica |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP449-C |
CFP-Zyxin fusion Lentiviral particles: Pre-made lentiviral particles expressing (CFP-human Zyxin) fusion contruct under suCMV promoter, provided in DMEM medium with 10 percent FBS and 60ug_ml of poly |
1x10e7 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP446-C |
CFP-Actin fusion Lentiviral particles: Pre-made lentiviral particles expressing (CFP-human Actin) fusion contruct under suCMV promoter, provided in DMEM medium with 10 percent FBS and 60ug_ml of poly |
1x10e7 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP487 |
h KLF1 inducible lentiviral particles : Pre-made optional inducible lentiviral particles for expressing human target: KLF1 (alternative name: EKLF, HBFQTL6, INLU). The sub-cloned codon sequence is id |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP446-G |
GFP-Actin fusion Lentiviral particles: Pre-made lentiviral particles expressing (GFP-human Actin) fusion contruct under suCMV promoter, provided in DMEM medium with 10 percent FBS and 60ug_ml of poly |
1x10e7 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP384 |
h LDHA inducible lentiviral particles: Pre-made inducible lentiviral particles for expressing human target: h LDHA (alternative name: LDH1; LDHM; GSD11; PIG19), with ORF sequence 100 percent matching |
1 x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP516 |
h KCNN4 inducible lentiviral particles : Pre-made optional inducible lentiviral particles for expressing human target: KCNN4 (alternative name: IK1, IKCA1, KCA4, KCa3.1, SK4, hIKCa1, hKCa4, hSK4). The |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP495 |
h HSP90AB1 inducible lentiviral particles : Pre-made optional inducible lentiviral particles for expressing human target: HSP90AB1 (alternative name: P1-302G2.1, D6S182, HSP84, HSP90-BETA, HSP90B, HSP |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP421 |
h ANPEP inducible lentiviral particles: Pre-made optional inducible lentiviral particles for expressing human target: h ANPEP (alternative name: APN, CD13, GP150, LAP1, P150, PEPN), with ORF sequence |
1 x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP449-G |
GFP-Zyxin fusion Lentiviral particles: Pre-made lentiviral particles expressing (GFP-human Zyxin) fusion contruct under suCMV promoter, provided in DMEM medium with 10 percent FBS and 60ug_ml of poly |
1x10e7 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP446-R |
RFP-Actin fusion Lentiviral particles: Pre-made lentiviral particles expressing (RFP-human Actin) fusion contruct under suCMV promoter, provided in DMEM medium with 10 percent FBS and 60ug_ml of poly |
1x10e7 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP510 |
h TSHR inducible lentiviral particles : Pre-made optional inducible lentiviral particles for expressing human target: TSHR (alternative name: CHNG1, LGR3, hTSHR-I). The sub-cloned codon sequence is id |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP423 |
h FASLG inducible lentiviral particles: Pre-made optional inducible lentiviral particles for expressing human target: h FASLG (alternative name: APT1LG1, CD178, CD95-L, CD95L, FASL, TNFSF6), with ORF |
1 x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP508 |
m SNCA inducible lentiviral particles : Pre-made optional inducible lentiviral particles for expressing mouse target: m SNCA (alternative name: NACP, alpha SYN, aSYN). The sub-cloned codon sequence i |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP404 |
h SOD2 inducible lentiviral particles: Pre-made inducible lentiviral particles for expressing human target: SOD2 (alternative name: RP1-56L9.2, IPOB, MNSOD, MVCD6), with ORF sequence 100 percent matc |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP506 |
h FZD7 inducible lentiviral particles : Pre-made optional inducible lentiviral particles for expressing human target: FZD7 (alternative name: FzE3, frizzled-7; fz-7; hFz7). The sub-cloned codon seque |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP449-R |
RFP-Zyxin fusion Lentiviral particles: Pre-made lentiviral particles expressing (RFP-human Zyxin) fusion contruct under suCMV promoter, provided in DMEM medium with 10 percent FBS and 60ug_ml of poly |
1x10e7 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP512 |
h WSF1 inducible lentiviral particles : Pre-made optional inducible lentiviral particles for expressing human target: WSF1 (alternative name: WFS; WFRS; WFSL). The sub-cloned codon sequence is identic |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP502 |
h ATP2B2 inducible lentiviral particles : Pre-made optional inducible lentiviral particles for expressing human target: ATP2B2 (alternative name: MCA2, PMCA2a, PMCA2i). The sub-cloned codon sequence i |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP514 |
h TWIST1 inducible lentiviral particles : Pre-made optional inducible lentiviral particles for expressing human target: TWIST1 (alternative name: ACS3, BPES2, BPES3, CRS1, SCS, TWIST, bHLHa38). The su |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP397 |
h TP63 inducible lentiviral particles: Pre-made inducible lentiviral particles for expressing human target: h TP63 (alternative name: AIS; B(p51A); B(p51B); EEC3; KET; LMS; NBP), with ORF sequence 100 |
1 x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP344-RB |
Lentiviral particles, shRNA (lacZ)-( RFP-Bsd): Pre-made optional inducible lentiviral shRNA expression particles containing a hairpin insert to knockdown β-Galactosidase (lacZ) gene. It also contains |
1 x107 IFU/ml x 200ul |
436-Eur |
GenTarget |
|
LVP344-GB |
Lentiviral particles, shRNA (lacZ)-( GFP-Bsd): Pre-made optional inducible lentiviral shRNA expression particles containing a hairpin insert to knockdown β-Galactosidase (lacZ) gene. It also contains |
1 x107 IFU/ml x 200ul |
436-Eur |
GenTarget |
|
LVP387 |
h TBX5 inducible lentiviral particles: Pre-made inducible lentiviral particles for expressing human target: h TBX5 (alternative name: HOS), with ORF sequence 100 percent matching to CDS region in NCB |
1 x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP424 |
m CSF2 inducible lentiviral particles: Pre-made inducible lentiviral particles for expressing mouse target: m CSF2 (alternative name: RP23-309E16.1, Csfgm, Gm-CSf, MGI-IGM), with ORF sequence 100% |
1 x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP488 |
r LRP11 inducible lentiviral particles : Pre-made optional inducible lentiviral particles for expressing rat target: r LRP11 (alternative name: None). The sub-cloned codon sequence is identical (100 |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP473 |
MCPyV small T-antigen lentiviral particles : Pre-made lentiviral particles expressing Small T antigen of Merkel cell polyomavirus under the optional inducible CMV promoter. It also contains a RFP-Bla |
1x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP309 |
RFP (Puro) lentiviral particles: Pre-made RFP lentiviral particles. RFP was expressed under suCMV promoter. A puromycin marker was expressed under RSV promoter. Provided in DMEM medium with 10 percent |
1x10e7 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP475 |
HPyV6 small T-antigen lentiviral particles : Pre-made lentiviral particles expressing Small T antigen of human polyomavirus-6 under the optional inducible CMV promoter. It also contains a RFP-Blastidi |
1x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP474 |
TSPyV small T-antigen lentiviral particles : Pre-made lentiviral particles expressing Small T antigen of Trichodysplasia spinulosa-associated Polyomavirus under the optional inducible CMV promoter. |
1x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP486 |
h PTGES inducible lentiviral particles : Pre-made optional inducible lentiviral particles for expressing human target: PTGES (alternative name: MGST-IV, MGST1-L1, MGST1L1, MPGES, PGES, PIG12, PP102, P |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP406 |
h NPTN inducible lentiviral particles: Pre-made inducible lentiviral particles for expressing human target: NPTN (alternative name: GP55; GP65; SDR1; np55; np65; SDFR1), with ORF sequence 100 percent |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP472 |
h SNAI2 inducible lentiviral particles : Pre-made optional inducible lentiviral particles for expressing human target: SNAI2 (alternative name: SLUG, SLUGH1, SNAIL2, WS2D). The sub-cloned codon sequen |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP322 |
h KLF4 (EF1a) Lentiviral particles: Pre-made serum-free lentiviral particles constitutively expressing human KLF4 gene under EF1a promoter. |
1x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP319 |
h NANOG (EF1a) Lentiviral particles: Pre-made serum-free lentiviral particles constitutively expressing human NANOG gene under EF1a promoter. |
1x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP320 |
h LIN28 (EF1a) Lentiviral particles: Pre-made serum-free lentiviral particles constitutively expressing human LIN28 gene under EF1a promoter. |
1x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP318 |
h SOX2 (EF1a) Lentiviral particles: Pre-made serum-free lentiviral particles constitutively expressing human SOX2 gene under EF1a promoter. |
1x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP307-PBS |
YFP (Neo) lentiviral particles,
in vivo ready: Pre-made lentiviral particles expressing YFP with Neomycin antibiotic marker, provided in PBS as in vivo ready virus. |
1x10e8 IFU/ml x 200ul |
770-Eur |
GenTarget |
|
LVP306-PBS |
CFP (Neo) lentiviral particles,
in vivo ready: Pre-made lentiviral particles expressing CFP with Neomycin antibiotic marker, provided in PBS solution as in vivo ready. |
1x10e8 IFU/ml x 200ul |
770-Eur |
GenTarget |
|
LVP-Null-Puro |
Negative Control lentiviral particles (Puro); premade lentiviral particles |
1 x107 IFU/ml x 200ul |
400-Eur |
GenTarget |
|
EF1a-Null-GP |
EF1a Control lentiviral particles (GFP-Puro), premade lentiviral particles |
1 x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
EF1a-Null-RP |
EF1a Control lentiviral particles (RFP-Puro), premade lentiviral particles |
1 x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP557-Puro |
T-antigen (Puro), EF1a lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP587 |
CFP (CAG)-Neo lentiviral particles, premade lentiviral particles |
1 x 107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP408 |
NLS-CRE-2A-GFP (Neo), lentiviral particles
; premade lentiviral particles |
1x107 IFU/ml x 200ul |
400-Eur |
GenTarget |
|
LVP012 |
YFP (Bsd) lentiviral particles, premade lentiviral particles |
1x10e7 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP299 |
RFP (Neo) lentiviral particles, premade lentiviral particles |
1x10e7 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP306 |
CFP (Neo) lentiviral particles, premade lentiviral particles |
1x10e7 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP307 |
YFP (Neo) lentiviral particles, premade lentiviral particles |
1x10e7 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP583 |
RFP (CAG)-Bsd lentiviral particles, premade lentiviral particles |
1 x 107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP-Ctr-RB |
Lentiviral particles, shRNA (Neg)-( RFP-Bsd); premade lentiviral particles |
1 x107 IFU/ml x 200ul |
400-Eur |
GenTarget |
|
LVP300 |
GFP (Neo) lentiviral particles, premade lentiviral particles |
1x10e7 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP297 |
NLS-CRE (Neo) lentiviral particles
; premade lentiviral particles |
1x107 IFU/ml x 200ul |
400-Eur |
GenTarget |
|
LVP307 |
YFP (Neo) lentiviral particles; premade lentiviral particles |
1x108 IFU/ml x 200ul |
400-Eur |
GenTarget |
|
LVP306 |
CFP (Neo) lentiviral particles; premade lentiviral particles |
1x108 IFU/ml x 200ul |
400-Eur |
GenTarget |
|
LVP300 |
GFP (Neo) lentiviral particles; premade lentiviral particles |
1x108 IFU/ml x 200ul |
400-Eur |
GenTarget |
|
LVP-Ctr-GB |
Lentiviral particles, shRNA (Neg)-( GFP-Bsd); premade lentiviral particles |
1 x107 IFU/ml x 200ul |
400-Eur |
GenTarget |
|
LVP299 |
RFP (Neo) lentiviral particles; premade lentiviral particles |
1x108 IFU/ml x 200ul |
400-Eur |
GenTarget |
|
LVP012 |
YFP (Bsd) lentiviral particles; premade lentiviral particles |
1x108 IFU/ml x 200ul |
400-Eur |
GenTarget |
|
LVP336 |
NLS-CRE (Bsd) lentiviral particles
; premade lentiviral particles |
1x107 IFU/ml x 200ul |
400-Eur |
GenTarget |
|
LVP013 |
NLS-CRE-2A-RFP (Bsd), lentiviral particles
; premade lentiviral particles |
1x107 IFU/ml x 200ul |
400-Eur |
GenTarget |
|
LVP027 |
NLS-CRE-2A-RFP (Neo), lentiviral particles
; premade lentiviral particles |
1x107 IFU/ml x 200ul |
400-Eur |
GenTarget |
|
LVP337 |
NLS-CRE-2A-GFP (Bsd), lentiviral particles
; premade lentiviral particles |
1x107 IFU/ml x 200ul |
400-Eur |
GenTarget |
|
LVP016-Puro |
T-antigen (Puro) lentiviral particles: Pre-made lentiviral particles expressing SV40 large T-antigen with puromycin marker. |
1x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP515 |
h RTN3 inducible lentiviral particles : Pre-made optional inducible lentiviral particles for expressing human target: RTN3 (alternative name: ASYIP, HAP, NSPL2, NSPLII, RTN3-A1). The sub-cloned codon |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP518 |
h CFTR inducible lentiviral particles : Pre-made optional inducible lentiviral particles for expressing human target: CFTR (alternative name: CF; MRP7; ABC35; ABCC7; CFTR_MRP; TNR-CFTR; dJ760C5.1). Th |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP335-Puro |
β-Lactamase (Puro) lentiviral particles: pre-made lentiviral particles expressing β-Lactamase gene. A puromycin marker was expressed under RSV promoter. Particles is provided in DMEM medium with 10 |
1x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP335-Puro-PBS |
β-Lactamase (Puro) lentiviral particles, in vivo ready: pre-made lentiviral particles expressing β-Lactamase gene. A puromycin marker was expressed under RSV promoter. Particles are purified into PBS |
5x10e7 IFU/ml x 200ul |
770-Eur |
GenTarget |
|
LVP335-luc |
β-Lactamase (Luciferase) lentiviral particles: pre-made lentiviral particles expressing β-Lactamase gene. A firefly luciferase marker was expressed under RSV promoter. Particles is provided in DMEM m |
1x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP309-PBS |
RFP (Puro) lentiviral particles, in vivo ready: Pre-made RFP lentiviral particles. RFP was expressed under suCMV promoter. A puromycin marker was expressed under RSV promoter. Particles was concentrat |
1x10e8 IFU/ml x 200ul |
770-Eur |
GenTarget |
|
EF1a-Null-Bsd |
EF1a Control lentiviral particles (Bsd), premade lentiviral particles |
1 x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP335-Puro |
β-Lactamase (Puro) lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
400-Eur |
GenTarget |
|
CMV-Null-Puro |
CMV Control lentiviral particles (Puro), premade lentiviral particles |
1 x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
EF1a-Null-Neo |
EF1a Control lentiviral particles (Neo), premade lentiviral particles |
1 x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
EF1a-Null-GB |
EF1a Control lentiviral particles (GFP-Bsd), premade lentiviral particles |
1 x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP335-Puro |
β-Lactamase (Puro) lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
EF1a-Null-RB |
EF1a Control lentiviral particles (RFP-Bsd), premade lentiviral particles |
1 x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP016-Puro |
T-antigen (Puro), CMV lentiviral particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP016-Puro |
T-antigen (Puro) lentiviral particles; premade lentiviral particles |
1x107 IFU/ml x 200ul |
400-Eur |
GenTarget |
|
LVP108 |
h NR3C1 variant 1 inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, N |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP528 |
h FGF2 inducible lentiviral particles : Pre-made optional inducible lentiviral particles for expressing human target: FGF2 (alternative name: bFGF, BFGF, FGF-2, FGFB, HBGF-2). The sub-cloned codon seq |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP482 |
h HIF1A inducible lentiviral particles : Pre-made optional inducible lentiviral particles for expressing human target: HIF1A (alternative name: HIF1; MOP1; PASD8; HIF-1A; bHLHe78; HIF-1alpha; HIF1-AL |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP353 |
h Kiss1 inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing human Kiss1 gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human ORF of Kiss |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP109 |
h NR3C1 variant 6 inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, N |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP198 |
h MEF2BNB inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, MEF2B, is |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP351 |
m shank3 inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing mouse shank3 gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed mouse ORF of sha |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP349 |
h MAP1LC3B inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human MAP1LC3B with a Blasticidin-RFP fusion marker (Dual selection). The expressed human ORF MAP1LC |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP055 |
h CKM inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, CKM, is fully |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP111 |
h NBN inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, NBN, is fully |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP293 |
h IL2 inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, IL2, is fully |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP172 |
h JUN inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, JUN, is fully |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP074 |
h GBA inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, GBA, is fully |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP077 |
h FYN inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, FYN, is fully |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP163 |
h FGR inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, FGR, is fully |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP067 |
h TXN inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, TXN, is fully |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP241 |
h SP1 inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, SP1, is fully |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP064 |
h RP2 inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, RP2, is fully |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP287 |
h TNF inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, TNF, is fully |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP166 |
h FOS inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, FOS, is fully |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP124 |
h AXL inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, AXL, is fully |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP288 |
h BAX inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, BAX, is fully |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP292 |
h IL3 inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, IL3, is fully |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP095 |
h PBK inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, PBK, is fully |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP127 |
h BTK inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, BTK, is fully |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP031 |
h AK3 inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, AK3, is fully |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP036 |
h BMX inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, BMX, is fully |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP101 |
h LBR inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, LBR, is fully |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP197 |
h MAX inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, MAX, is fully |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP022 |
h UBD inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, UBD, is fully |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP327 |
h PGR inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, PGR, is fully |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP035 |
h CKB inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, CKB, is fully |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP329 |
h OMD inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, OMD, is fully |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP221 |
h RET inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, RET, is fully |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP039 |
h GAK inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, GAK, is fully |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP045 |
h GCK inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, GCK, is fully |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP092 |
h MAK inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, MAK, is fully |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP480 |
h FZD6 inducible lentiviral particles : Pre-made optional inducible lentiviral particles for expressing human target: FZD6 (alternative name: FZ-6, FZ6, HFZ6, NDNC10, frizzled-6, frizzled 6,). The sub |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP350 |
m SRC inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing mouse SRC gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed mouse ORF of SRC gene, |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP356 |
h EPO inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing human EPO gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human ORF of EPO gene, |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP303 |
h HLA-G inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, HLA-G, is f |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP354 |
h RASA3 inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing human RASA3 gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human ORF of RASA3 |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP352 |
h CYC1 inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing human CYC1 gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human ORF of CYC1 ge |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP355 |
h GDF9 inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing human GDF9 gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human ORF of GDF9 ge |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP106 |
h AAK1 inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, AAK1, is ful |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP100 |
h NFIC inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, NFIC, is ful |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP107 |
h STRADB inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, STRADB, is |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP102 |
h PDHA1 inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, PDHA1, is f |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP105 |
h TERT inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, TERT, is ful |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP103 |
h CXCR4 inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, CXCR4, is f |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP110 |
h NPM1 inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, NPM1, is ful |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP104 |
h CXCR7 inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, CXCR7, is f |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP125 |
h PARS2 inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, PARS2, is f |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP126 |
h BCKDK inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, BCKDK, is f |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP130 |
h CAMK1D inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, CAMK1D, is |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP128 |
h TRIB3 inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, TRIB3, is f |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP332 |
h ARID3B inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, ARID3B, is |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP136 |
h CDC2L5 inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, CDC2L5, is |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP129 |
h CAMK1 inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, CAMK1, is f |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP131 |
m Acp2 inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a mouse gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed mouse gene, Acp2, is ful |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP132 |
h SPZ1 inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, SPZ1, is ful |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP134 |
h CCND3 inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, CCND3, is f |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP123 |
h AURKB inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, AURKB, is f |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP121 |
h ARRB2 inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, ARRB2, is f |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP120 |
h SPEG inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, SPEG, is ful |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP122 |
h ATF2 inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, ATF2, is ful |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP112 |
h GPSM3 inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, GPSM3, is f |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP113 |
h CHUK inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, CHUK, is ful |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP114 |
h RNASEH2A inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, RNASEH2A |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP115 |
h TNK2 inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, TNK2, is ful |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP116 |
h ADCK1 inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, ADCK1, is f |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP117 |
h AKT1 inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, AKT1, is ful |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP118 |
h ACVR1C inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, ACVR1C, is |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP140 |
h CDKN1A inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, CDKN1A, is |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP119 |
h CDK15 inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, CDK15, is f |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP133 |
h CAMK4 inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, CAMK4, is f |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP135 |
h CCNH inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, CCNH, is ful |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP208 |
h NFATC3 inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, NFATC3, is |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP043 |
h BUB1 inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, BUB1, is ful |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP044 |
h CDK18 inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, CDK18, is f |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP046 |
h GRK6 inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, GRK6, is ful |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP047 |
h NUAK2 inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, NUAK2, is f |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP048 |
h DAPK2 inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, DAPK2, is f |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP049 |
h CAMK2A inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, CAMK2A, is |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP050 |
h NME1 inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, NME1, is ful |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP051 |
h TYK2 inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, TYK2, is ful |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP052 |
h PDIK1L inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, PDIK1L, is |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP053 |
h CDK5R1 inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, CDK5R1, is |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP054 |
h TGFBR2 inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, TGFBR2, is |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP056 |
h STK17B inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, STK17B, is |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP057 |
h WIF1 inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, WIF1, is ful |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP058 |
h PIP5K1A inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, PIP5K1A, |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP042 |
h TRIB2 inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, TRIB2, is f |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP041 |
h CMPK1 inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, CMPK1, is f |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP138 |
h DNAJC28 inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, DNAJC28, |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP060 |
h PDK3 inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, PDK3, is ful |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP015 |
h GLUL inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, GLUL, is ful |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP025 |
h PFKM inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, PFKM, is ful |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP026 |
h DGKE inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, DGKE, is ful |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP028 |
h NME5 inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, NME5, is ful |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP029 |
h MARK3 inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, MARK3, is f |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP030 |
h MATK inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, MATK, is ful |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP032 |
h MARK2 inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, MARK2, is f |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP033 |
h LIMK2 inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, LIMK2, is f |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP034 |
h PIM2 inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, PIM2, is ful |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP037 |
h PAK6 inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, PAK6, is ful |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP038 |
h CSNK1G1 inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, CSNK1G1, |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP040 |
h GALK2 inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, GALK2, is f |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP059 |
h YES1 inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, YES1, is ful |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP061 |
h DCLK1 inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, DCLK1, is f |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP062 |
h PIM1 inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, PIM1, is ful |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP083 |
h EPHA4 inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, EPHA4, is f |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP084 |
h TSSK1B inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, TSSK1B, is |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP085 |
h CDK3 inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, CDK3, is ful |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP086 |
h RPS6KL1 inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, RPS6KL1, |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP087 |
h TWF1 inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, TWF1, is ful |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP088 |
h RAGE inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, RAGE, is ful |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP089 |
h NEK11 inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, NEK11, is f |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP090 |
h STK11 inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, STK11, is f |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP091 |
h CLK3 inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, CLK3, is ful |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP093 |
h TWF2 inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, TWF2, is ful |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP094 |
h PRKAA2 inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, PRKAA2, is |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP096 |
h TUBA1B inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, TUBA1B, is |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP097 |
h TMEM50B inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, TMEM50B, |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP098 |
h B3GALNT2 inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, B3GALNT2 |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP082 |
h CDKL5 inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, CDKL5, is f |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP081 |
h STK10 inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, STK10, is f |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP063 |
h STK32C inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, STK32C, is |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP065 |
h CLCN2 inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, CLCN2, is f |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP066 |
h FGFR1 inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, FGFR1, is f |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP068 |
h POMP inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, POMP, is ful |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP069 |
h TPT1 inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, TPT1, is ful |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP070 |
h XPO5 inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, XPO5, is ful |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP071 |
h ELAVL1 inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, ELAVL1, is |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP072 |
h PPP1R7 inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, PPP1R7, is |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP073 |
h IL17BR inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, IL17BR, is |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP075 |
h MAPKAPK3 inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, MAPKAPK3 |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP076 |
h GORASP2 inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, GORASP2, |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP078 |
h BRD3 inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, BRD3, is ful |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP079 |
h CDKL3 inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, CDKL3, is f |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP080 |
h STK4 inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, STK4, is ful |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP099 |
h PROM1 inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, PROM1, is f |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP331 |
h TNFAIP6 inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, TNFAIP6, |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP216 |
h PPARg inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, PPARg, is f |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP233 |
h PKMYT1 inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, PKMYT1, is |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP234 |
h PLK1 inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, PLK1, is ful |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP235 |
h PRKACB inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, PRKACB, is |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP236 |
h PRKCG inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, PRKCG, is f |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP237 |
h RELA inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, RELA, is ful |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP238 |
h RPS6KA2 inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, RPS6KA2, |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP239 |
h RPS6KB1 inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, RPS6KB1, |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP240 |
h SGK3 inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, SGK3, is ful |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP242 |
h SPAG9 inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, SPAG9, is f |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP243 |
h SRPK1 inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, SRPK1, is f |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP244 |
h TPTE inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, TPTE, is ful |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP245 |
h TSSK3 inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, TSSK3, is f |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP232 |
h CDK16 inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, CDK16, is f |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP231 |
h PAK4 inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, PAK4, is ful |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP217 |
h PRKAA1 inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, PRKAA1, is |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP218 |
h PRKACA inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, PRKACA, is |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP219 |
h PRKCA inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, PRKCA, is f |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP220 |
h PTK2B inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, PTK2B, is f |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP222 |
h RIPK2 inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, RIPK2, is f |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP224 |
h STAT3 inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, STAT3, is f |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP225 |
h STK16 inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, STK16, is f |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP226 |
h PLK4 inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, PLK4, is ful |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP227 |
h TSSK2 inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, TSSK2, is f |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP228 |
h MAP2K5 inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, MAP2K5, is |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP229 |
h MRE11A inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, MRE11A, is |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP230 |
h NEK6 inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, NEK6, is ful |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP246 |
h STK25 inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, STK25, is f |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP247 |
h BRSK2 inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, BRSK2, is f |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP248 |
h STK3 inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, STK3, is ful |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP263 |
h CDK2 inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, CDK2, is ful |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP264 |
h CDK4 inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, CDK4, is ful |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP265 |
h CDK7 inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, CDK7, is ful |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP266 |
h Rac1 inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, Rac1, is ful |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP267 |
h Rac2 inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, Rac2, is ful |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP268 |
m Mitf inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a mouse gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed mouse gene, Mitf, is ful |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP269 |
m PAX6 inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a mouse gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed mouse gene, PAX6 , is f |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP270 |
m MEF2C inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a mouse gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed mouse gene, MEF2C, is f |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP271 |
m Mesp1 inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a mouse gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed mouse gene, Mesp1, is f |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP272 |
h NRAS inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, NRAS, is ful |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP273 |
h GGA3 inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, GGA3, is ful |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP274 |
h RalBP1 inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, RalBP1, is |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP262 |
h CDKN2B inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, CDKN2B, is |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP261 |
h CCND1 inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, CCND1, is f |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP249 |
h STK38 inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, STK38, is f |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP250 |
h AURKA inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, AURKA, is f |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP251 |
h RIOK3 inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, RIOK3, is f |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP252 |
h WEE1 inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, WEE1, is ful |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP253 |
h TP53 inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, TP53, is ful |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP254 |
h TTBK2 inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, TTBK2, is f |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP255 |
h VRK3 inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, VRK3, is ful |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP256 |
h ZAP70 inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, ZAP70, is f |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP257 |
h ACVR1 inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, ACVR1, is f |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP258 |
h Foxo3 inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, Foxo3, is f |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP259 |
h OXSR1 inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, OXSR1, is f |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP260 |
h RhoA inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, RhoA, is ful |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP275 |
h RanBP1 inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, RanBP1, is |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP215 |
h PIK3R3 inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, PIK3R3, is |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP154 |
h ELK1 inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, ELK1, is ful |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP171 |
h TAOK3 inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, TAOK3, is f |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP173 |
h TNIK inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, TNIK, is ful |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP174 |
h LMNA inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, LMNA, is ful |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP175 |
h SMAD2 inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, SMAD2, is f |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP176 |
h MAP2K2 inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, MAP2K2, is |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP177 |
h MAP2K3 inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, MAP2K3, is |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP178 |
h MAP2K4 inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, MAP2K4, is |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP179 |
m CSN3 inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a mouse gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed mouse gene, CSN3, is ful |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP180 |
h MAP3K12 inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, MAP3K12, |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP181 |
h MAP3K14 inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, MAP3K14, |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP182 |
h MAP3K5 inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, MAP3K5, is |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP183 |
h MAP3K7 inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, MAP3K7, is |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP170 |
h IKBKG inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, IKBKG, is f |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP169 |
h IKBKB inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, IKBKB, is f |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP155 |
h ELK4 inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, ELK4, is ful |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP156 |
h EPHA2 inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, EPHA2, is f |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP157 |
h EPHB3 inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, EPHB3, is f |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP158 |
h ERBB3 inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, ERBB3, is f |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP159 |
h ETS1 inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, ETS1, is ful |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP160 |
h ETS2 inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, ETS2, is ful |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP161 |
h FASTK inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, FASTK, is f |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP162 |
h FGFR2 inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, FGFR2, is f |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP164 |
h ULK4 inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, ULK4 , is f |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP165 |
h NEK10 inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, NEK10, is f |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP167 |
h GSK3B inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, GSK3B, is f |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP168 |
h NFKBIA inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, NFKBIA, is |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP184 |
h MAP3K8 inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, MAP3K8 , |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP185 |
h MAPK1 inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, MAPK1, is f |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP186 |
h MAPK12 inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, MAPK12, is |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP202 |
h STK40 inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, STK40, is f |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP203 |
h CAMKV inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, CAMKV, is f |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP204 |
h MKNK1 inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, MKNK1, is f |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP205 |
h DUSP4 inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, DUSP4, is f |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP206 |
h DUSP6 inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, DUSP6, is f |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP207 |
h MYD88 inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, MYD88, is f |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP152 |
h DYRK2 inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, DYRK2, is f |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP209 |
h IRAK3 inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, IRAK3, is f |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP210 |
h NFkB1 inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, NFkB1, is f |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP211 |
h PAK2 inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, PAK2, is ful |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP212 |
h PDK4 inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, PDK4, is ful |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP213 |
h PHKG2 inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, PHKG2, is f |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP201 |
h NIM1 inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, NIM1, is ful |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP200 |
h CSNK1A1L inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, CSNK1A1L |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP187 |
h MAPK13 inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, MAPK13, is |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP188 |
h MAPK3 inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, MAPK3, is f |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP189 |
h MAPK6 inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, MAPK6, is f |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP190 |
h MAPK7 inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, MAPK7, is f |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP191 |
h MAPK8 inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, MAPK8, is f |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP192 |
h MAPK9 inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, MAPK9, is f |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP153 |
h EEF2K inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, EEF2K, is f |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP193 |
h RPS6KA1 inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, RPS6KA1, |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP194 |
h RPS6KA3 inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, RPS6KA3, |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP195 |
h MAPKAPK5 inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, MAPKAPK5 |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP196 |
h MAST2 inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, MAST2 , is |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP199 |
h MEF2C inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, MEF2C, is f |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP214 |
h PIK3CB inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, PIK3CB, is |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP276 |
h TAPBP inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, TAPBP, is f |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP302 |
h IDO1 inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, IDO1, is ful |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP281 |
h RUVBL2 inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, RUVBL2, is |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP148 |
h CSNK2A1 inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, CSNK2A1, |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP146 |
h CSNK1D inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, CSNK1D, is |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP280 |
h RGS16 inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, RGS16, is f |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP144 |
h COL4A3BP inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, COL4A3BP |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP147 |
m Myd88 inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a mouse gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed mouse gene, Myd88, is f |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP142 |
h CHEK2 inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, CHEK2, is f |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP141 |
m Gadd45a inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a mouse gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed mouse gene, Gadd45a, |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP294 |
h KITLG inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, KITLG, is f |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP282 |
h CTSD inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, CTSD, is ful |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP149 |
h DDIT3 inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, DDIT3, is f |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP296 |
h FGF18 inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, FGF18, is f |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP291 |
h BDKRB1 inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, BDKRB1, is |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP290 |
h KCNJ5 inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, KCNJ5, is f |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP286 |
h NCOA4 inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, NCOA4, is f |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP285 |
h ACTG1 inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, ACTG1, is f |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP284 |
h RASSF5 inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, RASSF5, is |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP150 |
h DDR1 inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, DDR1, is ful |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP151 |
h STYK1 inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, STYK1, is f |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP145 |
h CREB1 inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, CREB1, is f |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP328 |
h PRELP inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, PRELP, is f |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP278 |
h PCBP2 inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, PCBP2, is f |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP137 |
h CDC42 inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, CDC42, is f |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP279 |
h ZFP36 inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, ZFP36, is f |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP277 |
h IFNG inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, IFNG, is ful |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP295 |
h IL20 inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, IL20, is ful |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP139 |
h CDK9 inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, CDK9, is ful |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP143 |
h CLK1 inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, CLK1, is ful |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP330 |
h GRK5 inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, GRK5, is ful |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP223 |
h SGK2 inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, SGK2, is ful |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP289 |
h TGFB1 inducible lentiviral particles: Pre-made tet-inducible lentiviral particles expressing a human gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed human gene, TGFB1, is f |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
EF1a-Null-Puro |
EF1a Control lentiviral particles (Puro), premade lentiviral particles |
1 x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP-LocLight-Null |
LocLight Null Control lentiviral particles: Pre-made negative control LocLight lentiviral particles, provided in DMEM medium with 10 percent FBS and 60ug_ml of polybrene. It is Null virus, does not |
1x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP-LocLight-Null |
LocLight Null Control lentiviral particles; premade lentiviral particles |
1x108 IFU/ml x 1.0 ml |
400-Eur |
GenTarget |
|
LVP580 |
GFP (CAG)-Bsd lentiviral particles |
1 x 107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
G327 |
pLenti_III_HA_CMV lentiviral kit |
Kit |
1184-Eur |
ABM |
assays |
LVP019 |
TAT (His) Lentiviral particles |
5x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
G328 |
pLenti_III_HA_CMV lentiviral kit |
LV022, LV003 |
562-Eur |
ABM |
assays |
LVP018 |
TK (His) Lentiviral particles |
1x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP300 |
GFP (Neo) lentiviral particles |
1x10e7 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP306 |
CFP (Neo) lentiviral particles |
1x10e7 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP581 |
GFP (CAG)-Neo lentiviral particles |
1 x 107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
G329 |
pLenti_III_HA_PGK lentiviral kit |
Kit |
1184-Eur |
ABM |
assays |
G329 |
pLenti_III_HA_PGK lentiviral kit |
G305, LV003, G074, LV010, LV011 |
911-Eur |
ABM |
assays |
G330 |
pLenti_III_HA_PGK lentiviral kit |
G305, LV003 |
562-Eur |
ABM |
assays |
LVP001 |
GFP (Bsd) lentiviral particles |
1x10e7 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
G331 |
pLenti_III_HA_UBC lentiviral kit |
G300, LV003, G074, LV010, LV011 |
911-Eur |
ABM |
assays |
G331 |
pLenti_III_HA_UBC lentiviral kit |
Kit |
1184-Eur |
ABM |
assays |
LVP586 |
CFP (CAG)-Bsd lentiviral particles |
1 x 107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
G332 |
pLenti_III_HA_UBC lentiviral kit |
G300, LV003 |
562-Eur |
ABM |
assays |
LVP012 |
YFP (Bsd) lentiviral particles |
1x10e7 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP299 |
RFP (Neo) lentiviral particles |
1x10e7 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP584 |
RFP (CAG)-Neo lentiviral particles |
1 x 107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
G327 |
pLenti_III_HA_CMV lentiviral kit |
LV022, LV003, G074, LV010, LV011 |
911-Eur |
ABM |
assays |
G330 |
pLenti_III_HA_PGK lentiviral kit |
Kit |
730-Eur |
ABM |
assays |
LVP011 |
CFP (Bsd) lentiviral particles |
1x10e7 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP307 |
YFP (Neo) lentiviral particles |
1x10e7 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP023 |
RFP (Bsd) Lentiviral particles |
1x108 IFU/ml x 200ul |
400-Eur |
GenTarget |
|
LVP011 |
CFP (Bsd) lentiviral particles |
1x108 IFU/ml x 200ul |
400-Eur |
GenTarget |
|
LVP001 |
GFP (Bsd) lentiviral particles |
1x108 IFU/ml x 200ul |
400-Eur |
GenTarget |
|
LTV-700 |
pLentG_KOSM Lentiviral Vector |
100 µL |
2000-Eur |
Cell Biolabs |
Viral System |
LVP583 |
RFP (CAG)-Bsd lentiviral particles |
1 x 107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP587 |
CFP (CAG)-Neo lentiviral particles |
1 x 107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
G328 |
pLenti_III_HA_CMV lentiviral kit |
Kit |
730-Eur |
ABM |
assays |
LVP023 |
RFP (Bsd) Lentiviral particles |
1x10e7 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
G332 |
pLenti_III_HA_UBC lentiviral kit |
Kit |
730-Eur |
ABM |
assays |
LVP172 |
h JUN inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP288 |
h BAX inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP101 |
h LBR inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP287 |
h TNF inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP292 |
h IL3 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP017-Neo |
CMV-TetR (Neo) Lentiviral particles |
1x107 IFU/ml x 200ul |
441-Eur |
GenTarget |
|
LVP465 |
YFP (EF1a)-Bsd lentiviral particles |
1x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP466 |
YFP (EF1a)-Neo lentiviral particles |
1x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP163 |
h FGR inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP303 |
h HLA-G inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP127 |
h BTK inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP468 |
CFP (EF1a)-RB lentiviral particles |
1x107 IFU/ml x 200ul |
552-Eur |
GenTarget |
|
LVP468-PBS |
CFP (EF1a)-RB lentiviral particles |
1x10e8 IFU/ml x 200ul |
770-Eur |
GenTarget |
|
LVP293 |
h IL2 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP124 |
h AXL inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP111 |
h NBN inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP582 |
RFP (CAG)-Puro lentiviral particles |
1 x 107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP074 |
h GBA inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP400-Neo |
rtTA (Neo) , Lentiviral particles |
1x107 IFU/ml x 200ul |
441-Eur |
GenTarget |
|
LVP400-GB |
rtTA (GFP-Bsd), Lentiviral particles |
1x107 IFU/ml x 200ul |
441-Eur |
GenTarget |
|
LVP400-RB |
rtTA (RFP-Bsd), Lentiviral particles |
1x107 IFU/ml x 200ul |
441-Eur |
GenTarget |
|
LVP400-Bsd |
rtTA (Bsd) , Lentiviral particles |
1x107 IFU/ml x 200ul |
441-Eur |
GenTarget |
|
LVP606-C |
ER-GFP, LocLight lentiviral particles
|
1x107 IFU/ml x 200ul |
552-Eur |
GenTarget |
|
LVP540 |
h ID2 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP606-R |
ER-GFP, LocLight lentiviral particles
|
1x107 IFU/ml x 200ul |
552-Eur |
GenTarget |
|
LVP542 |
h BSG inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP606-G |
ER-GFP, LocLight lentiviral particles
|
1x107 IFU/ml x 200ul |
552-Eur |
GenTarget |
|
LVP400-RB-PBS |
rtTA (RFP-Bsd) in PBS, Lentiviral particles |
5x107 IFU/ml x 200ul |
552-Eur |
GenTarget |
|
LVP400-GB-PBS |
rtTA (GFP-Bsd) in PBS, Lentiviral particles |
5x107 IFU/ml x 200ul |
552-Eur |
GenTarget |
|
LVP095 |
h PBK inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP077 |
h FYN inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP092 |
h MAK inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP166 |
h FOS inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP241 |
h SP1 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP400-Neo-PBS |
rtTA (Neo) in PBS, Lentiviral particles |
5x107 IFU/ml x 200ul |
552-Eur |
GenTarget |
|
LVP221 |
h RET inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP197 |
h MAX inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP400-Bsd-PBS |
rtTA (Bsd) in PBS, Lentiviral particles |
5x107 IFU/ml x 200ul |
552-Eur |
GenTarget |
|
LVP598 |
h AR inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP017-Neo-PBS |
CMV-TetR (Neo) Lentiviral particles |
5x107 IFU/ml x 200ul |
552-Eur |
GenTarget |
|
CMV-Null-RB-PBS |
CMV Control lentiviral particles (RFP-Bsd) in PBS |
1 x108 IFU/ml x 200ul |
770-Eur |
GenTarget |
|
VPK-222 |
pSMPUW-U6-GFP Lentiviral Expression Vector |
10 ug |
770-Eur |
Cellbio |
|
CMV-Null-GB-PBS |
CMV Control lentiviral particles (GFP-Bsd) in PBS |
1 x108 IFU/ml x 200ul |
770-Eur |
GenTarget |
|
CMV-Null-Neo-PBS |
CMV Control lentiviral particles (Neo) in PBS |
1 x108 IFU/ml x 200ul |
770-Eur |
GenTarget |
|
CMV-Null-Bsd-PBS |
CMV Control lentiviral particles (Bsd) in PBS |
1 x108 IFU/ml x 200ul |
770-Eur |
GenTarget |
|
CMV-Null-RB |
CMV Control lentiviral particles (RFP-Bsd) |
1 x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
CMV-Null-GB |
CMV Control lentiviral particles (GFP-Bsd) |
1 x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
CMV-Null-Neo |
CMV Control lentiviral particles (Neo) |
1 x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
CMV-Null-Bsd |
CMV Control lentiviral particles (Bsd) |
1 x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP356 |
h EPO inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP350 |
m SRC inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP347 |
lacZ (GFP-Bsd) lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP346 |
lacZ (Bsd) lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP585 |
CFP (CAG)-Puro lentiviral particles |
1 x 107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP499 |
h OPN-c inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP498 |
h OPN-a inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP471 |
YFP (puro) lentiviral particles |
1x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP496 |
m EPO inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP017-Bsd-PBS |
CMV-TetR (Bsd) Lentiviral particles |
5x107 IFU/ml x 200ul |
552-Eur |
GenTarget |
|
LVP017-RB-PBS |
CMV-TetR (RFP-Bsd) Lentiviral particles |
5x107 IFU/ml x 200ul |
552-Eur |
GenTarget |
|
LVP360-C |
Nuc-CFP, LocLight lentiviral particles
|
1x107 IFU/ml x 200ul |
552-Eur |
GenTarget |
|
LVP360-R |
Nuc-RFP, LocLight lentiviral particles
|
1x107 IFU/ml x 200ul |
552-Eur |
GenTarget |
|
LVP360-G |
Nuc-GFP, LocLight lentiviral particles
|
1x107 IFU/ml x 200ul |
552-Eur |
GenTarget |
|
LVP447-R |
RFP-TAT fusion Lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP447-G |
GFP-TAT fusion Lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP399 |
RFP-LC3 fusion lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP413 |
Luciferase-2A-CRE, (RFP-Bsd) lentiviral particles |
1x107 IFU/ml x 200ul |
552-Eur |
GenTarget |
|
LVP411 |
Luciferase-2A-CRE, (GFP-Bsd) lentiviral particles |
1x107 IFU/ml x 200ul |
552-Eur |
GenTarget |
|
LVP410 |
Luciferase-2A-CRE (Neo), lentiviral particles |
1x107 IFU/ml x 200ul |
552-Eur |
GenTarget |
|
LVP345-RB |
Lentiviral particles, shRNA (Luc)-( RFP-Bsd) |
1 x107 IFU/ml x 200ul |
436-Eur |
GenTarget |
|
LVP345-GB |
Lentiviral particles, shRNA (Luc)-( GFP-Bsd) |
1 x107 IFU/ml x 200ul |
436-Eur |
GenTarget |
|
LVP343-RB |
Lentiviral particles, shRNA (h P53)-(RFP-Bsd) |
1 x107 IFU/ml x 200ul |
436-Eur |
GenTarget |
|
LVP304 |
Luciferase-2A-CRE (Bsd), lentiviral particles |
1x107 IFU/ml x 200ul |
552-Eur |
GenTarget |
|
LVP039 |
h GAK inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP045 |
h GCK inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP055 |
h CKM inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP335-Bsd |
β-Lactamase (Bsd) lentiviral particles |
1x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP064 |
h RP2 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP335-Neo |
β-Lactamase (Neo) lentiviral particles |
1x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP335-RB |
β-Lactamase (RFP-Bsd) lentiviral particles |
1x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP335-GB |
β-Lactamase (GFP-Bsd) lentiviral particles |
1x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP329 |
h OMD inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP327 |
h PGR inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP067 |
h TXN inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP579 |
GFP (CAG)-Puro lentiviral particles |
1 x 107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP333 |
lacZ (Neo) lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP036 |
h BMX inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP035 |
h CKB inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP343-GB |
Lentiviral particles, shRNA (h P53)-(GFP-Bsd) |
1 x107 IFU/ml x 200ul |
436-Eur |
GenTarget |
|
LVP342 |
CFP (puro) lentiviral particles |
1x10e7 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP340 |
GFP (puro) lentiviral particles |
1x10e7 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP309 |
RFP (Puro) lentiviral particles |
1x10e7 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP447-C |
CFP-TAT fusion Lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP017-RB |
CMV-TetR (RFP-Bsd) Lentiviral particles |
1x107 IFU/ml x 200ul |
441-Eur |
GenTarget |
|
LVP022 |
h UBD inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP031 |
h AK3 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP592 |
h Myc (EF1a) (RP) Lentiviral particles |
1x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP002 |
GFP-His (bicistronical RFP) Lentiviral particles |
1x10e7 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
G300 |
pLenti_III_HA_UBC lentiviral vector |
5ug |
647-Eur |
ABM |
Viral System |
G305 |
pLenti_III_HA_PGK lentiviral vector |
5ug |
647-Eur |
ABM |
Viral System |
LV900 |
Lentiviral qPCR Titration Kit |
100 rxns |
216-Eur |
ABM |
assays |
LTV-400 |
pLenti_GFP Lentiviral Control Vector |
100 µL |
690-Eur |
Sakura |
|
LTV-400 |
pLenti_GFP Lentiviral Control Vector |
10 µg |
651-Eur |
Cell Biolabs |
Viral System |
LVP430 |
CFP (EF1a)-Bsd lentiviral particles |
1x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LTV-402 |
pSMPUW_MNDnLacZ Lentiviral Control Vector |
10 µg |
651-Eur |
Cell Biolabs |
Viral System |
LTV-400 |
pLenti-GFP Lentiviral Control Vector |
100 |
762-Eur |
Cell Biolabs |
|
LTV-700 |
pLentG-KOSM Lentiviral Vector |
100 |
2322-Eur |
Cell Biolabs |
|
LTV-801 |
pSMPUW-GFP-LC3 Lentiviral Expression Vector |
10 |
1495-Eur |
Cell Biolabs |
|
VPK-213 |
pSMPUW-Neo Lentiviral Expression Vector |
10 |
770-Eur |
Cell Biolabs |
|
LVP431 |
CFP (EF1a)-Neo lentiviral particles |
1x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP428 |
RFP (EF1a)-Neo lentiviral particles |
1x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
G300 |
pLenti_III_HA_UBC lentiviral vector |
5ug |
639-Eur |
ABM |
Viral System |
LTV-403 |
pLenti_RFP_Puro Lentiviral Control Vector |
100 µL |
651-Eur |
Cell Biolabs |
Viral System |
LVP427 |
RFP (EF1a)-Bsd lentiviral particles |
1x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
VPK-219 |
pSMPUW_IRES_Blasticidin Lentiviral Expression Vector |
10 µg |
651-Eur |
Cell Biolabs |
Viral System |
VPK-218 |
pSMPUW_IRES_GFP Lentiviral Expression Vector |
10 µg |
651-Eur |
Cell Biolabs |
Viral System |
LTV-401 |
pSMPUW_GFP_Puro Lentiviral Control Vector |
10 µg |
651-Eur |
Cell Biolabs |
Viral System |
VPK-214 |
pSMPUW_Hygro Lentiviral Expression Vector |
10 µg |
651-Eur |
Cell Biolabs |
Viral System |
LV606VA-1 |
Lentiviral Technology pPS-UBC-GFP-RFP (pre-packaged) |
1x10^6 IFUs |
496-Eur |
SBI |
|
VPK-213 |
pSMPUW_Neo Lentiviral Expression Vector |
10 µg |
651-Eur |
Cell Biolabs |
Viral System |
LV604VA-1 |
Lentiviral Technology pPS-PGK-GFP-RFP (pre-packaged) |
1x10^6 IFUs |
496-Eur |
SBI |
|
LV604PA-1 |
Lentiviral Technology pPS-PGK-GFP-RFP (plasmid) |
10 ug |
621-Eur |
SBI |
|
LV603VA-1 |
Lentiviral Technology pPS-EF1-GFP-RFP (pre-packaged) |
1x10^6 IFUs |
496-Eur |
SBI |
|
LV603PA-1 |
Lentiviral Technology pPS-EF1-GFP-RFP (plasmid) |
10 ug |
621-Eur |
SBI |
|
LVP017-Neo |
CMV-TetR (Bsd) Lentiviral particles |
1x107 IFU/ml x 200ul |
441-Eur |
GenTarget |
|
LVP017-Bsd |
CMV-TetR (Bsd) Lentiviral particles |
1x107 IFU/ml x 200ul |
441-Eur |
GenTarget |
|
VPK-215 |
pSMPUW_IRES_Puro Lentiviral Expression Vector |
10 µg |
651-Eur |
Cell Biolabs |
Viral System |
LVP017-Bsd-RFP |
CMV-TetR (Bsd) Lentiviral particles |
1x107 IFU/ml x 200ul |
441-Eur |
GenTarget |
|
LV606PA-1 |
Lentiviral Technology pPS-UBC-GFP-RFP (plasmid) |
10 ug |
621-Eur |
SBI |
|
VPK-212 |
pSMPUW_Puro Lentiviral Expression Vector |
10 µg |
651-Eur |
Cell Biolabs |
Viral System |
VPK-216 |
pSMPUW_IRES_Neo Lentiviral Expression Vector |
10 µg |
651-Eur |
Cell Biolabs |
Viral System |
VPK-217 |
pSMPUW_IRES_Hygro Lentiviral Expression Vector |
10 µg |
651-Eur |
Cell Biolabs |
Viral System |
CD526A-1 |
Lentiviral Technology pCDH-EF1-MCS*-T2A-GFP |
10 ug |
618-Eur |
SBI |
|
LVP310 |
GFP (EF1a)-Bsd lentiviral particles |
1x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP425 |
GFP (EF1a)-Neo lentiviral particles |
1x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP017-Bsd |
TetR (Bsd) Lentiviral particles |
1x107 IFU/ml x 200ul |
463-Eur |
GenTarget |
|
LTV-801 |
pSMPUW_GFP_LC3 Lentiviral Expression Vector |
10 µg |
1233-Eur |
Cell Biolabs |
Viral System |
LVP017-Neo |
TetR (Bsd) Lentiviral particles |
1x107 IFU/ml x 200ul |
463-Eur |
GenTarget |
|
LVP010 |
lacZ (RFP-Bsd) lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP021 |
GFP-lacZ (His) Lentiviral particles |
1x107 IFU/ml x 200ul |
606-Eur |
GenTarget |
|
LVP017-PBS-Bsd-RFP |
CMV-TetR (Bsd) Lentiviral particles |
5x107 IFU/ml x 200ul |
552-Eur |
GenTarget |
|
G310 |
pLenti_III_HA_CMV lentiviral vector |
5ug |
840-Eur |
ABM |
Viral System |
LVP017-PBS-Bsd |
CMV-TetR (Bsd) Lentiviral particles |
5x107 IFU/ml x 200ul |
552-Eur |
GenTarget |
|
G305 |
pLenti_III_HA_PGK lentiviral vector |
5ug |
639-Eur |
ABM |
Viral System |
LVP017-PBS-Neo |
CMV-TetR (Bsd) Lentiviral particles |
5x107 IFU/ml x 200ul |
552-Eur |
GenTarget |
|
LVP014 |
Flp recombinase (RFP-Bsd) lentiviral particles |
1x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP017-Bsd-RFP |
TetR (Bsd) Lentiviral particles |
1x107 IFU/ml x 200ul |
463-Eur |
GenTarget |
|
LVP002 |
GFP-His (bicistronical RFP) Lentiviral particles |
1x108 IFU/ml x 200ul |
400-Eur |
GenTarget |
|
LVP086 |
h RPS6KL1 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP412 |
Luciferase-2A-CRE, (GFP-Puro) lentiviral particles |
1x107 IFU/ml x 200ul |
552-Eur |
GenTarget |
|
LVP084 |
h TSSK1B inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP090 |
h STK11 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP089 |
h NEK11 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP161 |
h FASTK inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP085 |
h CDK3 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP418 |
h KDM5A inducible lentiviral particles |
1 x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP076 |
h GORASP2 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP087 |
h TWF1 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP160 |
h ETS2 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP416 |
h FII (thrombin) inducible lentiviral particles |
1 x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP098 |
h B3GALNT2 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP097 |
h TMEM50B inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
TR012VA-N |
Lentiviral Technology pGreenFire1-NF-kB (virus) + EF1-Neo |
>2 x 10^6 IFUs |
759-Eur |
SBI |
|
TR012VA-1 |
Lentiviral Technology pGreenFire1-NF-kB (virus) |
>2 x 10^6 IFUs |
759-Eur |
SBI |
|
LVP096 |
h TUBA1B inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
TR029VA-N |
Lentiviral Technology pGreenFire1-SRF (virus) + EF1-Neo |
>2 x 10^6 IFUs |
759-Eur |
SBI |
|
TR012PA-N |
Lentiviral Technology pGreenFire1-NF-kB (plasmid)+ EF1-Neo |
10 ug |
759-Eur |
SBI |
|
LVP158 |
h ERBB3 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
TR012PA-1 |
Lentiviral Technology pGreenFire1-NF-kB (plasmid) |
10 ug |
759-Eur |
SBI |
|
LVP415 |
h GYG1 inducible lentiviral particles |
1 x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP159 |
h ETS1 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP094 |
h PRKAA2 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP414 |
Luciferase-2A-CRE, (RFP-Puro) lentiviral particles |
1x107 IFU/ml x 200ul |
552-Eur |
GenTarget |
|
LVP093 |
h TWF2 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP091 |
h CLK3 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP417 |
h MSH3 inducible lentiviral particles |
1 x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP082 |
h CDKL5 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP162 |
h FGFR2 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP405 |
h Arf6 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP070 |
h XPO5 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP404 |
h SOD2 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP069 |
h TPT1 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
CMV-Null-RP-PBS |
CMV Control lentiviral particles (RFP-Puro) in PBS |
1 x108 IFU/ml x 200ul |
770-Eur |
GenTarget |
|
CMV-Null-GP-PBS |
CMV Control lentiviral particles (GFP-Puro) in PBS |
1 x108 IFU/ml x 200ul |
770-Eur |
GenTarget |
|
LVP068 |
h POMP inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP066 |
h FGFR1 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP169 |
h IKBKB inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP065 |
h CLCN2 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
VPK-213-PAN |
ViraSafe™ Lentiviral Expression System (Neo), Pantropic |
1 kit |
1440-Eur |
Cell Biolabs |
Viral System |
LVP063 |
h STK32C inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP062 |
h PIM1 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP061 |
h DCLK1 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP406 |
h NPTN inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP071 |
h ELAVL1 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP072 |
h PPP1R7 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
VPK-213-ECO |
ViraSafe™ Lentiviral Expression System (Neo) Ecotropic |
1 kit |
1440-Eur |
Cell Biolabs |
Viral System |
LVP081 |
h STK10 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP080 |
h STK4 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP079 |
h CDKL3 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP078 |
h BRD3 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP409 |
Luciferase-2A-CRE (Puro), lentiviral particles |
1x107 IFU/ml x 200ul |
552-Eur |
GenTarget |
|
VPK-205 |
ViraSafe™ Lentiviral Packaging System, Ecotropic |
1 kit |
1113-Eur |
Cell Biolabs |
Viral System |
LVP164 |
h ULK4 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP165 |
h NEK10 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP075 |
h MAPKAPK3 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP167 |
h GSK3B inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP088 |
h RAGE inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP168 |
h NFKBIA inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP073 |
h IL17BR inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP060 |
h PDK3 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP419 |
h KDM5B inducible lentiviral particles |
1 x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
TR027VA-N |
Lentiviral Technology pGreenFire1-GAS (virus) + EF1-Neo |
>2 x 10^6 IFUs |
759-Eur |
SBI |
|
LVP139 |
h CDK9 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP138 |
h DNAJC28 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP137 |
h CDC42 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP153 |
h EEF2K inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP154 |
h ELK1 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP136 |
h CDC2L5 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP135 |
h CCNH inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP155 |
h ELK4 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP134 |
h CCND3 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP133 |
h CAMK4 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP132 |
h SPZ1 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP131 |
m Acp2 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP130 |
h CAMK1D inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP129 |
h CAMK1 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP140 |
h CDKN1A inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP141 |
m Gadd45a inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP142 |
h CHEK2 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
TR027VA-1 |
Lentiviral Technology pGreenFire1-GAS (virus) |
>2 x 10^6 IFUs |
759-Eur |
SBI |
|
LVP149 |
h DDIT3 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
TR027PA-N |
Lentiviral Technology pGreenFire1-GAS (plasmid)+ EF1-Neo |
10 ug |
759-Eur |
SBI |
|
TR027PA-1 |
Lentiviral Technology pGreenFire1-GAS (plasmid) |
10 ug |
759-Eur |
SBI |
|
LVP148 |
h CSNK2A1 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP150 |
h DDR1 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP170 |
h IKBKG inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP147 |
m Myd88 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP151 |
h STYK1 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP146 |
h CSNK1D inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP145 |
h CREB1 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP152 |
h DYRK2 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP144 |
h COL4A3BP inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP143 |
h CLK1 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP128 |
h TRIB3 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
VPK-206 |
ViraSafe™ Lentiviral Packaging System, Pantropic |
1 kit |
1113-Eur |
Cell Biolabs |
Viral System |
LVP126 |
h BCKDK inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP157 |
h EPHB3 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP106 |
h AAK1 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
TR029VA-1 |
Lentiviral Technology pGreenFire1-SRF (virus) |
>2 x 10^6 IFUs |
759-Eur |
SBI |
|
LVP105 |
h TERT inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP104 |
h CXCR7 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP103 |
h CXCR4 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP102 |
h PDHA1 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP100 |
h NFIC inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP424 |
m CSF2 inducible lentiviral particles |
1 x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP423 |
h FASLG inducible lentiviral particles |
1 x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP099 |
h PROM1 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP112 |
h GPSM3 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP422 |
h LOXL2 inducible lentiviral particles |
1 x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP421 |
h ANPEP inducible lentiviral particles |
1 x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP107 |
h STRADB inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP110 |
h NPM1 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
TR029PA-N |
Lentiviral Technology pGreenFire1-SRF (plasmid)+ EF1-Neo |
10 ug |
759-Eur |
SBI |
|
LVP125 |
h PARS2 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP123 |
h AURKB inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP122 |
h ATF2 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP121 |
h ARRB2 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP120 |
h SPEG inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP119 |
h CDK15 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP118 |
h ACVR1C inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP117 |
h AKT1 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP116 |
h ADCK1 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP115 |
h TNK2 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP114 |
h RNASEH2A inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP113 |
h CHUK inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP156 |
h EPHA2 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
TR029PA-1 |
Lentiviral Technology pGreenFire1-SRF (plasmid) |
10 ug |
759-Eur |
SBI |
|
LVP420 |
h CSF1 inducible lentiviral particles |
1 x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP059 |
h YES1 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
CS960A-1 |
Lentiviral Packaging Custom Service |
>10^7 IFU/mL |
1710-Eur |
SBI |
Viral System |
VPK-212 |
pSMPUW-Puro Lentiviral Expression Vector |
10 |
770-Eur |
Cell Biolabs |
|
VPK-214 |
pSMPUW-Hygro Lentiviral Expression Vector |
10 |
770-Eur |
Cell Biolabs |
|
LVP353 |
h Kiss1 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
VPK-216 |
pSMPUW-IRES-Neo Lentiviral Expression Vector |
10 |
770-Eur |
Cell Biolabs |
|
LVP586-PBS |
CFP (CAG)-Bsd lentiviral particles, in vivo ready |
5 x 107 IFU/ml x 200ul |
770-Eur |
GenTarget |
|
LVP432 |
CFP (EF1a)-Puro lentiviral particles |
1x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP294 |
h KITLG inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP429 |
RFP (EF1a)-Puro lentiviral particles |
1x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
VPK-218 |
pSMPUW-IRES-GFP Lentiviral Expression Vector |
10 |
770-Eur |
Cell Biolabs |
|
LVP352 |
h CYC1 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
VPK-220 |
pSMPUW miR-GFP_Puro Lentiviral Expression Vector |
10 μg |
592-Eur |
Cell Biolabs |
|
LVP335-RP |
β-Lactamase (RFP-Puro) lentiviral particles |
1x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP583-PBS |
RFP (CAG)-Bsd lentiviral particles, in vivo ready |
5 x 107 IFU/ml x 200ul |
770-Eur |
GenTarget |
|
LVP335-luc |
β-Lactamase (Luciferase) lentiviral particles |
1x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP351 |
m shank3 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP354 |
h RASA3 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LTV-451 |
pLenti-p53 (Human) shRNA Lentiviral Vector |
100 |
976-Eur |
Cell Biolabs |
rna |
VPK-220 |
pSMPUW miR_GFP_Puro Lentiviral Expression Vector |
10 ìg |
690-Eur |
Sakura |
|
LVP408 |
CRE-2A-GFP (Neo), CMV lentivirus, premade lentiviral particles |
1x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP335-GP |
β-Lactamase (GFP-Puro) lentiviral particles |
1x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
ABP-CS-LVPGN2 |
Lentiviral Packaging Service; 2 ml at 10^8 TU_ml |
1 |
2470-Eur |
Allele |
|
ABP-CS-LVPGN4 |
Lentiviral Packaging Service; 4 ml at 10^8 TU_ml |
1 |
3213-Eur |
Allele |
|
ABP-CS-LVPGN10 |
Lentiviral Packaging Service; 10 ml at 10^8 TU_ml |
1 |
5443-Eur |
Allele |
|
ABP-CS-LVPGN100 |
Lentiviral Packaging Service; 100 ml at 10^8 TU_ml |
1 |
27926-Eur |
Allele |
|
ABP-CS-LVPGH0.1 |
Lentiviral Packaging Service; 0.1 ml at 10^9~10^10 TU_ml |
1 |
3028-Eur |
Allele |
|
ABP-CS-LVPGH0.2 |
Lentiviral Packaging Service; 0.2 ml at 10^9~10^10 TU_ml |
1 |
4328-Eur |
Allele |
|
ABP-CS-LVPGH0.5 |
Lentiviral Packaging Service; 0.5 ml at 10^9~10^10 TU_ml |
1 |
8230-Eur |
Allele |
|
ABP-CS-LVPGH1.0 |
Lentiviral Packaging Service; 1.0 ml at 10^9~10^10 TU_ml |
1 |
14733-Eur |
Allele |
|
LVP355 |
h GDF9 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LTV-401 |
pSMPUW-GFP-Puro Lentiviral Control Vector |
10 |
762-Eur |
Cell Biolabs |
|
LTV-402 |
pSMPUW-MNDnLacZ Lentiviral Control Vector |
10 |
762-Eur |
Cell Biolabs |
|
LTV-403 |
pLenti-RFP-Puro Lentiviral Control Vector |
100 |
762-Eur |
Cell Biolabs |
|
LVP301 |
lacZ (Puro) lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP334 |
lacZ (luciferase) lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP577-PBS |
CRE (RFP-Bsd),
CAG lentivirus in PBS, premade lentiviral particles |
5 x107 IFU/ml x 200ul |
770-Eur |
GenTarget |
|
LVP343-GP |
Lentiviral particles, shRNA (h P53)-(GFP-Puro) |
1 x107 IFU/ml x 200ul |
436-Eur |
GenTarget |
|
LVP343-RP |
Lentiviral particles, shRNA (h P53)-(RFP-Puro) |
1 x107 IFU/ml x 200ul |
436-Eur |
GenTarget |
|
LVP344-GB |
Lentiviral particles, shRNA (lacZ)-( GFP-Bsd) |
1 x107 IFU/ml x 200ul |
436-Eur |
GenTarget |
|
LVP344-RB |
Lentiviral particles, shRNA (lacZ)-( RFP-Bsd) |
1 x107 IFU/ml x 200ul |
436-Eur |
GenTarget |
|
LVP345-GP |
Lentiviral particles, shRNA (Luc)-( GFP-Puro) |
1 x107 IFU/ml x 200ul |
436-Eur |
GenTarget |
|
LVP297-PBS |
NLS-CRE (Neo) lentiviral particles , in vivo ready |
5 x107 IFU/ml x 200ul |
808-Eur |
GenTarget |
|
LVP336-PBS |
NLS-CRE (Bsd) lentiviral particles , in vivo ready |
5 x107 IFU/ml x 200ul |
808-Eur |
GenTarget |
|
LVP001-PBS |
GFP (Bsd) lentiviral particles, in vivo ready |
1x109 IFU/ml x 200ul |
808-Eur |
GenTarget |
|
LVP349 |
h MAP1LC3B inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP348 |
lacZ (RFP-puro) lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP248 |
h STK3 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP345-RP |
Lentiviral particles, shRNA (Luc)-( RFP-Puro) |
1 x107 IFU/ml x 200ul |
436-Eur |
GenTarget |
|
LVP011-PBS |
CFP (Bsd) lentiviral particles, in vivo ready |
1x109 IFU/ml x 200ul |
808-Eur |
GenTarget |
|
LVP012-PBS |
YFP (Bsd) lentiviral particles, in vivo ready |
1x109 IFU/ml x 200ul |
808-Eur |
GenTarget |
|
LVP023-PBS |
RFP (Bsd) lentiviral particles, in vivo ready |
1x109 IFU/ml x 200ul |
808-Eur |
GenTarget |
|
LVP017-Hygro |
TetR (Bsd) Lentiviral particles |
1x107 IFU/ml x 200ul |
463-Eur |
GenTarget |
|
LVP017-Puro |
TetR (Bsd) Lentiviral particles |
1x107 IFU/ml x 200ul |
463-Eur |
GenTarget |
|
LVP577 |
CRE (RFP-Bsd),
CAG lentivirus, premade lentiviral particles |
1x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP426 |
GFP (EF1a)-Puro lentiviral particles |
1x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP575-PBS |
CRE (Neo),
CAG lentivirus, in PBS, premade lentiviral particles |
5 x107 IFU/ml x 200ul |
770-Eur |
GenTarget |
|
LVP401 |
h ROR2; premade lentiviral particles |
1 x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP400 |
h MSH3; premade lentiviral particles |
1 x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP393 |
h CTNNB1; premade lentiviral particles |
1 x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP392 |
h EDNRB; premade lentiviral particles |
1 x107 IFU/ml x 200ul |
515-Eur |
GenTarget |
|
LVP575 |
CRE (Neo), CAG lentivirus, premade lentiviral particles |
1x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP574-PBS |
CRE (Bsd),
CAG lentivirus in PBS, premade lentiviral particles |
5 x107 IFU/ml x 200ul |
770-Eur |
GenTarget |
|
LVP574 |
CRE (Bsd), CAG lentivirus, premade lentiviral particles |
1x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP299-PBS |
RFP (Neo) lentiviral particles, in vivo ready |
1x10e8 IFU/ml x 200ul |
770-Eur |
GenTarget |
|
LVP300-PBS |
GFP (Neo) lentiviral particles, in vivo ready |
1x10e8 IFU/ml x 200ul |
770-Eur |
GenTarget |
|
LVP306-PBS |
CFP (Neo) lentiviral particles,
in vivo ready |
1x10e8 IFU/ml x 200ul |
770-Eur |
GenTarget |
|
LVP307-PBS |
YFP (Neo) lentiviral particles,
in vivo ready |
1x10e8 IFU/ml x 200ul |
770-Eur |
GenTarget |
|
LVP024 |
GFP inducible control lentiviral particles |
1x108 IFU/ml x 200ul |
400-Eur |
GenTarget |
|
LVP357 |
YFP inducible control lentiviral particles |
1x108 IFU/ml x 200ul |
400-Eur |
GenTarget |
|
VPK-220 |
pSMPUW miRNA Lentiviral Expression Vector |
10 |
651-Eur |
Cell Biolabs |
rna |
LVP058 |
h PIP5K1A inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP044 |
h CDK18 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LV605VA-1 |
Lentiviral Technology pPS-MSCV-GFP-RFP (pre-packaged) |
1x10^6 IFUs |
496-Eur |
SBI |
|
LV605PA-1 |
Lentiviral Technology pPS-MSCV-GFP-RFP (plasmid) |
10 ug |
621-Eur |
SBI |
|
LVP043 |
h BUB1 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP042 |
h TRIB2 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP041 |
h CMPK1 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP040 |
h GALK2 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
CMV-Null-RP |
CMV Control lentiviral particles (RFP-Puro) |
1 x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP038 |
h CSNK1G1 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP037 |
h PAK6 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
CMV-Null-GP |
CMV Control lentiviral particles (GFP-Puro) |
1 x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP034 |
h PIM2 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP033 |
h LIMK2 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP032 |
h MARK2 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP030 |
h MATK inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP046 |
h GRK6 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LV801A-1 |
Lentiviral Technology LentiMag Reagent |
10 transductions |
472-Eur |
SBI |
|
LVP057 |
h WIF1 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP013 |
CRE-2A-RFP (Bsd), CMV lentivirus, premade lentiviral particles |
1x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP027 |
CRE-2A-RFP (Neo), CMV lentivirus, premade lentiviral particles |
1x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP297 |
CRE (Neo), CMV lentivirus, premade lentiviral particles |
1x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP056 |
h STK17B inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP336 |
CRE (Bsd), CMV lentivirus, premade lentiviral particles |
1x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP337 |
CRE-2A-GFP (Bsd), CMV lentivirus, premade lentiviral particles |
1x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP054 |
h TGFBR2 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP053 |
h CDK5R1 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP052 |
h PDIK1L inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP051 |
h TYK2 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP050 |
h NME1 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP049 |
h CAMK2A inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP048 |
h DAPK2 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP047 |
h NUAK2 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP398 |
m Git2 inducible lentiviral particles |
1 x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP397 |
h TP63 inducible lentiviral particles |
1 x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP396 |
h CEBPB inducible lentiviral particles |
1 x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP387 |
h TBX5 inducible lentiviral particles |
1 x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP386 |
h GATA4 inducible lentiviral particles |
1 x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP385 |
h RXRA inducible lentiviral particles |
1 x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP392 |
h EDNRB, premade lentiviral particles |
1 x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP393 |
h CTNNB1, premade lentiviral particles |
1 x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP400 |
h MSH3, premade lentiviral particles |
1 x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP401 |
h ROR2, premade lentiviral particles |
1 x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP384 |
h LDHA inducible lentiviral particles |
1 x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP383 |
h Stat3 inducible lentiviral particles |
1 x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP395 |
h MMP9 inducible lentiviral particles |
1 x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP029 |
h MARK3 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP394 |
h Flt3 inducible lentiviral particles |
1 x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP391 |
m IL10 inducible lentiviral particles |
1 x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP028 |
h NME5 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP390 |
h BRAC1 inducible lentiviral particles |
1 x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP026 |
h DGKE inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP025 |
h PFKM inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP389 |
h BARD1 inducible lentiviral particles |
1 x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP015 |
h GLUL inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP388 |
h VEGFA inducible lentiviral particles |
1 x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP083 |
h EPHA4 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP282 |
h CTSD inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP514 |
h TWIST1 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP512 |
h WSF1 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP511 |
h PLK2 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP270 |
m MEF2C inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP510 |
h TSHR inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP509 |
h SPP1 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP508 |
m SNCA inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP507 |
h SNCA inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP506 |
h FZD7 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP505 |
h RFC1 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP504 |
h ERBB2 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP503 |
h TRPV1 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP502 |
h ATP2B2 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP501 |
h NELL1 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP500 |
m SNAI1 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP269 |
m PAX6 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP515 |
h RTN3 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP516 |
h KCNN4 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP517 |
h TRPC3 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP281 |
h RUVBL2 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP581-PBS |
GFP (CAG)-Neo lentiviral particles, in vivo ready |
5 x 107 IFU/ml x 200ul |
770-Eur |
GenTarget |
|
LVP280 |
h RGS16 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP279 |
h ZFP36 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
VPK-221 |
pSMPUW-U6-Puro Lentiviral Expression Vector |
10 ug |
770-Eur |
Cellbio |
|
LVP278 |
h PCBP2 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP277 |
h IFNG inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP580-PBS |
GFP (CAG)-Bsd lentiviral particles, in vivo ready |
5 x 107 IFU/ml x 200ul |
770-Eur |
GenTarget |
|
LVP276 |
h TAPBP inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP275 |
h RanBP1 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP274 |
h RalBP1 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP273 |
h GGA3 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP272 |
h NRAS inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP271 |
m Mesp1 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP528 |
h FGF2 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP518 |
h CFTR inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP268 |
m Mitf inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP497 |
h MSX2 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP267 |
h Rac2 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP470 |
h ZDHHC17 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP469 |
h ZDHHC13 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP266 |
h Rac1 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP265 |
h CDK7 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP264 |
h CDK4 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP263 |
h CDK2 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP262 |
h CDKN2B inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP261 |
h CCND1 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP260 |
h RhoA inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP259 |
h OXSR1 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP459-Neo-PBS |
EF1a-TetR (Neo) Lentiviral particles |
5x107 IFU/ml x 200ul |
552-Eur |
GenTarget |
|
LVP459-Bsd-PBS |
EF1a-TetR (Bsd) Lentiviral particles |
5x107 IFU/ml x 200ul |
552-Eur |
GenTarget |
|
LVP357 |
YFP inducible control lentiviral particles |
1x10e7 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP258 |
h Foxo3 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP459-RB-PBS |
EF1a-TetR (RFP-Bsd) Lentiviral particles |
5x107 IFU/ml x 200ul |
552-Eur |
GenTarget |
|
LVP459-GB-PBS |
EF1a-TetR (GFP-Bsd) Lentiviral particles |
5x107 IFU/ml x 200ul |
552-Eur |
GenTarget |
|
LVP472 |
h SNAI2 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP476 |
h CSF1R inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP477 |
h CCR9 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP495 |
h HSP90AB1 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP494 |
h ENO1 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP493 |
h MDH2 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP492 |
h TPI1 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP490 |
h MMP8 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP489 |
h LHX9 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP488 |
r LRP11 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP487 |
h KLF1 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP486 |
h PTGES inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP485 |
m PAX4 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP484 |
h PAX4 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP483 |
h RUNX1 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP482 |
h HIF1A inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP481 |
h BMP2 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP480 |
h FZD6 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP177 |
h MAP2K3 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP257 |
h ACVR1 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP284 |
h RASSF5 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP478 |
h YAP1 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP017-PBS-Puro |
CMV-TetR (Bsd) Lentiviral particles |
5x107 IFU/ml x 200ul |
552-Eur |
GenTarget |
|
LVP594 |
h TACC3 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP459-PBS-Neo |
EF1a-TetR (Neo) Lentiviral particles |
5x107 IFU/ml x 200ul |
552-Eur |
GenTarget |
|
LVP459-PBS-Bsd |
EF1a-TetR (Bsd) Lentiviral particles |
5x107 IFU/ml x 200ul |
552-Eur |
GenTarget |
|
LVP555 |
h SMAD4 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP459-PBS-RFP-Bsd |
EF1a-TetR (RFP-Bsd) Lentiviral particles |
5x107 IFU/ml x 200ul |
552-Eur |
GenTarget |
|
LVP459-PBS-GFP-Bsd |
EF1a-TetR (GFP-Bsd) Lentiviral particles |
5x107 IFU/ml x 200ul |
552-Eur |
GenTarget |
|
LVP553 |
h BCL2 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP459-Neo |
EF1a-TetR (Neo) Lentiviral particles |
1x107 IFU/ml x 200ul |
441-Eur |
GenTarget |
|
LVP459-Bsd |
EF1a-TetR (Bsd) Lentiviral particles |
1x107 IFU/ml x 200ul |
441-Eur |
GenTarget |
|
LVP549 |
h Snai1 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP459-RFP-Bsd |
EF1a-TetR (RFP-Bsd) Lentiviral particles |
1x107 IFU/ml x 200ul |
441-Eur |
GenTarget |
|
LVP459-GFP-Bsd |
EF1a-TetR (GFP-Bsd) Lentiviral particles |
1x107 IFU/ml x 200ul |
441-Eur |
GenTarget |
|
LVP605 |
h ASAH1 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP548 |
h PPARG2 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP547 |
m SAA1 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP595 |
h ICAM1 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP596 |
h GNRHR inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP597 |
h SLC2A4 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP400-GP-PBS |
rtTA (GFP-Puro) in PBS, Lentiviral particles |
5x107 IFU/ml x 200ul |
552-Eur |
GenTarget |
|
LVP400-RP-PBS |
rtTA (RFP-Puro) in PBS, Lentiviral particles |
5x107 IFU/ml x 200ul |
552-Eur |
GenTarget |
|
LVP593 |
h KLF4 (EF1a) (RP) Lentiviral particles |
1x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP400-GP |
rtTA (GFP-Puro) , Lentiviral particles |
1x107 IFU/ml x 200ul |
441-Eur |
GenTarget |
|
LVP400-RP |
rtTA (RFP-Puro), Lentiviral particles |
1x107 IFU/ml x 200ul |
441-Eur |
GenTarget |
|
LVP467 |
YFP (EF1a)-Puro lentiviral particles |
1x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP328 |
h PRELP inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP591 |
h LIN28 (EF1a) (RP) Lentiviral particles |
1x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP017-PBS-Hygro |
CMV-TetR (Bsd) Lentiviral particles |
5x107 IFU/ml x 200ul |
552-Eur |
GenTarget |
|
LVP590 |
h NANOG (EF1a) (RP) Lentiviral particles |
1x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP589 |
h SOX2 (EF1a) (RP) Lentiviral particles |
1x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP531-PBS |
RFP inducible control lentiviral particles |
5x107 IFU/ml x 200ul |
770-Eur |
GenTarget |
|
LVP357-PBS |
YFP inducible control lentiviral particles |
5x107 IFU/ml x 200ul |
770-Eur |
GenTarget |
|
LVP024-PBS |
GFP inducible control lentiviral particles in PBS |
5x107 IFU/ml x 200ul |
770-Eur |
GenTarget |
|
LVP599 |
h IL13RA2 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP588 |
h OCT4 (EF1a) (RP) Lentiviral particles |
1x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP546 |
m CD74 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP545 |
m mmp7 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP544 |
h CCL20 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP554-R |
RFP-TRPC3 fusion lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP552-R |
RFP-TRPV1 fusion lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP551-R |
RFP-KCNN4 fusion lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP550-R |
RFP-CLCN2 fusion lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP587-PBS |
CFP (CAG)-Neo lentiviral particles, in vivo ready |
5 x 107 IFU/ml x 200ul |
770-Eur |
GenTarget |
|
LVP584-PBS |
RFP (CAG)-Neo lentiviral particles, in vivo ready |
5 x 107 IFU/ml x 200ul |
770-Eur |
GenTarget |
|
LVP330 |
h GRK5 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP331 |
h TNFAIP6 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP332 |
h ARID3B inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP302 |
h IDO1 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP296 |
h FGF18 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP295 |
h IL20 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP291 |
h BDKRB1 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP290 |
h KCNJ5 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP289 |
h TGFB1 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP286 |
h NCOA4 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP556-R |
RFP-CSF1 fusion lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP550-C |
CFP-CLCN2 fusion lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP551-C |
CFP-KCNN4 fusion lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP543 |
h SLC16A1 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP541 |
h LMNB1 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP321 |
h Myc (EF1a) (Puro) Lentiviral particles |
1x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP539 |
h CDCD1 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP537 |
h MCR4 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP535 |
h Raptor inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP534 |
h PTEN inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP533 |
h Foxo1 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP479 |
h MITF inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP513 |
h CCR6 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP491 |
h PAX3 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP530 |
m Gulo inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP529 |
h SLC2A10 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP556-C |
CFP-CSF1 fusion lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP554-C |
CFP-TRPC3 fusion lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP552-C |
CFP-TRPV1 fusion lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP285 |
h ACTG1 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP459-RB |
EF1a-TetR (RFP-Bsd) Lentiviral particles |
1x107 IFU/ml x 200ul |
441-Eur |
GenTarget |
|
LVP206 |
h DUSP6 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP217 |
h PRKAA1 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP218 |
h PRKACA inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP219 |
h PRKCA inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP220 |
h PTK2B inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP222 |
h RIPK2 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP223 |
h SGK2 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP224 |
h STAT3 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP225 |
h STK16 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP216 |
h PPARg inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP215 |
h PIK3R3 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP207 |
h MYD88 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP208 |
h NFATC3 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP209 |
h IRAK3 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP210 |
h NFkB1 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP211 |
h PAK2 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP212 |
h PDK4 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP213 |
h PHKG2 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP214 |
h PIK3CB inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP226 |
h PLK4 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP227 |
h TSSK2 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP228 |
h MAP2K5 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP239 |
h RPS6KB1 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP240 |
h SGK3 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP242 |
h SPAG9 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP243 |
h SRPK1 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP244 |
h TPTE inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP245 |
h TSSK3 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP246 |
h STK25 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP442 |
GFP-RFP fusion control lentiviral particles |
1x10e7 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP238 |
h RPS6KA2 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP237 |
h RELA inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP229 |
h MRE11A inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP230 |
h NEK6 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP231 |
h PAK4 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP232 |
h CDK16 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP233 |
h PKMYT1 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP234 |
h PLK1 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP235 |
h PRKACB inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP236 |
h PRKCG inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP443 |
CFP-RFP fusion control lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP205 |
h DUSP4 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
TR032PA-N |
Lentiviral Technology pGreenFire1-ERE (plasmid)+ EF1-Neo |
10 ug |
759-Eur |
SBI |
|
TR036PA-1 |
Lentiviral Technology pGreenFire1-SP1 (plasmid) |
10 ug |
759-Eur |
SBI |
|
LVP179 |
m CSN3 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
TR036PA-N |
Lentiviral Technology pGreenFire1-SP1 (plasmid)+ EF1-Neo |
10 ug |
759-Eur |
SBI |
|
LVP180 |
h MAP3K12 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
TR036VA-1 |
Lentiviral Technology pGreenFire1-SP1 (virus) |
>2 x 10^6 IFUs |
759-Eur |
SBI |
|
TR036VA-N |
Lentiviral Technology pGreenFire1-SP1 (virus) + EF1-Neo |
>2 x 10^6 IFUs |
759-Eur |
SBI |
|
LVP181 |
h MAP3K14 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP182 |
h MAP3K5 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP178 |
h MAP2K4 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
TR032PA-1 |
Lentiviral Technology pGreenFire1-ERE (plasmid) |
10 ug |
759-Eur |
SBI |
|
LVP171 |
h TAOK3 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
TR032VA-1 |
Lentiviral Technology pGreenFire1-ERE (virus) |
>2 x 10^6 IFUs |
759-Eur |
SBI |
|
TR032VA-N |
Lentiviral Technology pGreenFire1-ERE (virus) + EF1-Neo |
>2 x 10^6 IFUs |
759-Eur |
SBI |
|
LTV-451 |
pLenti_p53 (Human) shRNA Lentiviral Vector |
100 µL |
784-Eur |
Cell Biolabs |
rna |
LVP173 |
h TNIK inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP174 |
h LMNA inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP175 |
h SMAD2 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP176 |
h MAP2K2 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP183 |
h MAP3K7 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP184 |
h MAP3K8 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP185 |
h MAPK1 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP196 |
h MAST2 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP198 |
h MEF2BNB inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP199 |
h MEF2C inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
TR050pa-N |
Lentiviral Technology pGreenFire1-Gli-EF1-Neo (plasmid) |
10 ug |
759-Eur |
SBI |
|
LVP200 |
h CSNK1A1L inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP201 |
h NIM1 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP202 |
h STK40 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP203 |
h CAMKV inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP195 |
h MAPKAPK5 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP194 |
h RPS6KA3 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP186 |
h MAPK12 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP187 |
h MAPK13 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP188 |
h MAPK3 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP189 |
h MAPK6 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP190 |
h MAPK7 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP191 |
h MAPK8 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP192 |
h MAPK9 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP193 |
h RPS6KA1 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP204 |
h MKNK1 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP453-C |
Nuc-membrane-CFP, LocLight lentiviral particles
|
1x107 IFU/ml x 200ul |
552-Eur |
GenTarget |
|
LVP017-Puro |
CMV-TetR (Bsd) Lentiviral particles |
1x107 IFU/ml x 200ul |
441-Eur |
GenTarget |
|
LVP251 |
h RIOK3 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP449-C |
CFP-Zyxin fusion Lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP531 |
RFP inducible control lentiviral particles |
1x10e7 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP024 |
GFP inducible control lentiviral particles |
1x10e7 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP456-G |
Microtubule-GFP, LocLight lentiviral particles
|
1x107 IFU/ml x 200ul |
552-Eur |
GenTarget |
|
LVP255 |
h VRK3 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP449-R |
RFP-Zyxin fusion Lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP454-G |
Peroxisome-GFP, LocLight lentiviral particles
|
1x107 IFU/ml x 200ul |
552-Eur |
GenTarget |
|
LVP449-G |
GFP-Zyxin fusion Lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP456-C |
Microtubule-CFP, LocLight lentiviral particles
|
1x107 IFU/ml x 200ul |
552-Eur |
GenTarget |
|
LVP457-G |
Lysosomes-GFP, LocLight lentiviral particles
|
1x107 IFU/ml x 200ul |
552-Eur |
GenTarget |
|
LVP457-R |
Lysosomes-GFP, LocLight lentiviral particles
|
1x107 IFU/ml x 200ul |
552-Eur |
GenTarget |
|
LVP457-C |
Lysosomes-GFP, LocLight lentiviral particles
|
1x107 IFU/ml x 200ul |
552-Eur |
GenTarget |
|
LVP456-R |
Microtubule-RFP, LocLight lentiviral particles
|
1x107 IFU/ml x 200ul |
552-Eur |
GenTarget |
|
LVP458-G |
Endosomes-GFP, LocLight lentiviral particles
|
1x107 IFU/ml x 200ul |
552-Eur |
GenTarget |
|
LVP458-R |
Endosomes-GFP, LocLight lentiviral particles
|
1x107 IFU/ml x 200ul |
552-Eur |
GenTarget |
|
LVP455-C |
Plasma-mem-CFP, LocLight lentiviral particles
|
1x107 IFU/ml x 200ul |
552-Eur |
GenTarget |
|
LVP252 |
h WEE1 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP453-R |
Nuc-membrane-RFP, LocLight lentiviral particles
|
1x107 IFU/ml x 200ul |
552-Eur |
GenTarget |
|
LVP453-G |
Nuc-membrane-GFP, LocLight lentiviral particles
|
1x107 IFU/ml x 200ul |
552-Eur |
GenTarget |
|
LVP452-C |
Mito-GFP, LocLight lentiviral particles
|
1x107 IFU/ml x 200ul |
552-Eur |
GenTarget |
|
LVP452-R |
Mito-GFP, LocLight lentiviral particles
|
1x107 IFU/ml x 200ul |
552-Eur |
GenTarget |
|
LVP452-G |
Mito-GFP, LocLight lentiviral particles
|
1x107 IFU/ml x 200ul |
552-Eur |
GenTarget |
|
LVP451-C |
Golgoi-CFP, LocLight lentiviral particles
|
1x107 IFU/ml x 200ul |
552-Eur |
GenTarget |
|
LVP454-R |
Peroxisome-GFP, LocLight lentiviral particles
|
1x107 IFU/ml x 200ul |
552-Eur |
GenTarget |
|
LVP451-R |
Golgoi-RFP, LocLight lentiviral particles
|
1x107 IFU/ml x 200ul |
552-Eur |
GenTarget |
|
LVP451-G |
Golgoi-GFP, LocLight lentiviral particles
|
1x107 IFU/ml x 200ul |
552-Eur |
GenTarget |
|
LVP450-C |
Cyto-CFP, LocLight lentiviral particles
|
1x107 IFU/ml x 200ul |
552-Eur |
GenTarget |
|
LVP450-R |
Cyto-RFP, LocLight lentiviral particles
|
1x107 IFU/ml x 200ul |
552-Eur |
GenTarget |
|
LVP450-G |
Cyto-GFP, LocLight lentiviral particles
|
1x107 IFU/ml x 200ul |
552-Eur |
GenTarget |
|
LVP454-C |
Peroxisome-GFP, LocLight lentiviral particles
|
1x107 IFU/ml x 200ul |
552-Eur |
GenTarget |
|
LVP455-G |
Plasma-mem-GFP, LocLight lentiviral particles
|
1x107 IFU/ml x 200ul |
552-Eur |
GenTarget |
|
LVP253 |
h TP53 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP455-R |
Plasma-mem-RFP, LocLight lentiviral particles
|
1x107 IFU/ml x 200ul |
552-Eur |
GenTarget |
|
LVP254 |
h TTBK2 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP448-C |
CFP-hP53 fusion Lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP448-R |
RFP-hP53 fusion Lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP011-PBS |
CFP (Bsd) lentiviral particles, in vivo ready |
1x10e8 IFU/ml x 200ul |
770-Eur |
GenTarget |
|
LVP012-PBS |
YFP (Bsd) lentiviral particles, in vivo ready |
1x10e8 IFU/ml x 200ul |
770-Eur |
GenTarget |
|
LVP446-C |
CFP-Actin fusion Lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP444-C |
CFP-Histone 2B fusion lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP445-C |
CFP-Annexin5 fusion Lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP249 |
h STK38 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP446-G |
GFP-Actin fusion Lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP023-PBS |
RFP (Bsd) lentiviral particles, in vivo ready |
1x10e8 IFU/ml x 200ul |
770-Eur |
GenTarget |
|
LVP459-GB |
EF1a-TetR (GFP-Bsd) Lentiviral particles |
1x107 IFU/ml x 200ul |
441-Eur |
GenTarget |
|
LVP256 |
h ZAP70 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP446-R |
RFP-Actin fusion Lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP445-R |
RFP-Annexin5 fusion Lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP445-G |
GFP-Annexin5 fusion Lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP448-G |
GFP-hP53 fusion Lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP247 |
h BRSK2 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP444-G |
GFP-Histone 2B fusion lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP250 |
h AURKA inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP458-C |
Endosomes-GFP, LocLight lentiviral particles
|
1x107 IFU/ml x 200ul |
552-Eur |
GenTarget |
|
LVP001-PBS |
GFP (Bsd) lentiviral particles, in vivo ready |
1x10e8 IFU/ml x 200ul |
770-Eur |
GenTarget |
|
LVP444-R |
RFP-Histone 2B fusion lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP002-PBS |
GFP-His (bicistronical RFP) Lentiviral particles, in vivo ready |
1x109 IFU/ml x 200ul |
808-Eur |
GenTarget |
|
LVP571 |
CAG-Luciferase (firefly)
(RFP-Bsd)
, premade lentiviral particles |
1x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP016-Bsd |
SV40 large T-antigen (Bsd), CMV lentiviral particles |
1x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP569 |
CAG-Luciferase (firefly)
(Neo)
, premade lentiviral particles |
1x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
VPK-214-PAN |
ViraSafe™ Lentiviral Expression System (Hygro), Pantropic |
1 kit |
1440-Eur |
Cell Biolabs |
Viral System |
LVP344-GP |
Lentiviral particles, shRNA (lacZ)-( GFP-Puro) |
1 x107 IFU/ml x 200ul |
436-Eur |
GenTarget |
|
LVP568 |
CAG-Luciferase (firefly)
(Bsd)
, premade lentiviral particles |
1x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP557-GB |
SV40 large T-antigen (GFP-Bsd), CMV lentiviral particles |
1x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP016-GB |
SV40 large T-antigen (GFP-Bsd), CMV lentiviral particles |
1x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP519 |
CRE (Bsd), EF1a lentivirus, premade lentiviral particles |
1x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP521 |
CRE (Neo), EF1a lentivirus, premade lentiviral particles |
1x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP009 |
Luciferase (firefly)-2A-RFP (Bsd)
; premade lentiviral particles |
1x107 IFU/ml x 200ul |
400-Eur |
GenTarget |
|
LVP344-RP |
Lentiviral particles, shRNA (lacZ)-( RFP-Puro) |
1 x107 IFU/ml x 200ul |
436-Eur |
GenTarget |
|
VPK-214-ECO |
ViraSafe™ Lentiviral Expression System (Hygro), Ecotropic |
1 kit |
1440-Eur |
Cell Biolabs |
Viral System |
LVP326 |
Luciferase (firefly) (Bsd); premade lentiviral particles |
1 x107 IFU/ml x 200ul |
400-Eur |
GenTarget |
|
LVP342-PBS |
CFP (Puro) lentiviral particles, in vivo ready |
1x10e8 IFU/ml x 200ul |
770-Eur |
GenTarget |
|
LVP340-PBS |
GFP (Puro) lentiviral particles, in vivo ready |
1x10e8 IFU/ml x 200ul |
770-Eur |
GenTarget |
|
LVP339-PBS |
NLS-CRE (Puro) lentiviral particles , in vivo ready |
5 x107 IFU/ml x 200ul |
808-Eur |
GenTarget |
|
LVP326-PBS |
Luciferase (Bsd) lentiviral particles, in vivo ready |
5 x108 IFU/ml x 200ul |
808-Eur |
GenTarget |
|
VPK-211-PAN |
ViraSafe™ Universal Lentiviral Expression System, Pantropic |
1 kit |
1440-Eur |
Cell Biolabs |
Viral System |
LVP016-RB |
SV40 large T-antigen (RFP-Bsd), CMV lentiviral particles |
1x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
TR016VA-N |
Lentiviral Technology pGreenFire1-ISRE (virus) + EF1-Neo |
>2 x 10^6 IFUs |
759-Eur |
SBI |
|
LVP283 |
Luciferase (firefly), (Neo); premade lentiviral particles |
5 x107 IFU/ml x 200ul |
400-Eur |
GenTarget |
|
LVP527 |
CRE-2A-GFP (Neo), EF1a lentivirus, premade lentiviral particles |
1x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP525 |
CRE-2A-GFP (Bsd), EF1a lentivirus, premade lentiviral particles |
1x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP524 |
CRE-2A-RFP (Neo), EF1a lentivirus, premade lentiviral particles |
1x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP016-Neo |
SV40 large T-antigen (Neo), CMV lentiviral particles |
1x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP522 |
CRE-2A-RFP (Bsd), EF1a lentivirus, premade lentiviral particles |
1x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP323 |
Luciferase (firefly)-2A-GFP (Bsd); premade lentiviral particles |
1x107 IFU/ml x 200ul |
400-Eur |
GenTarget |
|
LVP573 |
CRE (Puro), CAG lentivirus, premade lentiviral particles |
1x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
VPK-211-ECO |
ViraSafe™ Universal Lentiviral Expression System, Ecotropic |
1 kit |
1440-Eur |
Cell Biolabs |
Viral System |
LVP317 |
h OCT4 (EF1a) (Puro) Lentiviral particles |
1x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP318 |
h SOX2 (EF1a) (Puro) Lentiviral particles |
1x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP319 |
h NANOG (EF1a) (Puro) Lentiviral particles |
1x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP320 |
h LIN28 (EF1a) (Puro) Lentiviral particles |
1x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP109 |
h NR3C1 variant 6 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP108 |
h NR3C1 variant 1 inducible lentiviral particles |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
VPK-212-ECO |
ViraSafe™ Lentiviral Expression System (Puro), Ecotropic |
1 kit |
1440-Eur |
Cell Biolabs |
Viral System |
VPK-218-ECO |
ViraSafe™ Lentiviral Bicistronic Expression System (GFP), Ecotropic |
1 kit |
1440-Eur |
Cell Biolabs |
Viral System |
VPK-218-PAN |
ViraSafe™ Lentiviral Bicistronic Expression System (GFP), Pantropic |
1 kit |
1440-Eur |
Cell Biolabs |
Viral System |
VPK-220-ECO |
ViraSafe™ miRNA Lentiviral Expression System, Ecotropic |
1 kit |
1100-Eur |
Cell Biolabs |
rna |
VPK-220-PAN |
ViraSafe™ miRNA Lentiviral Expression System, Pantropic |
1 kit |
1100-Eur |
Cell Biolabs |
rna |
CS970A-1 |
Ultra_highTiter Lentiviral Packaging Custom Service |
>10^9 IFU/mL |
3203-Eur |
SBI |
Viral System |
CS965A-1 |
High_titer Lentiviral Packaging Custom Service |
>10^8 IFU/mL |
2556-Eur |
SBI |
Viral System |
457-control |
pLenti-GIII-CMV-hMPO Lentiviral Vector |
|
----Eur |
Gentaur |
|
VPK-211 |
pSMPUW Universal Lentiviral Expression Vector (Promoterless) |
10 |
770-Eur |
Cell Biolabs |
|
LVP582-PBS |
RFP (CAG)-Puro lentiviral particles, in vivo ready |
5 x 107 IFU/ml x 200ul |
770-Eur |
GenTarget |
|
LVP304-PBS |
Luciferase-2A-CRE (Bsd), lentiviral particles, in vivo ready |
5 x107 IFU/ml x 200ul |
933-Eur |
GenTarget |
|
LVP322 |
h KLF4 (EF1a) (Puro) Lentiviral particles |
1x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP579-PBS |
GFP (CAG)-Puro lentiviral particles, in vivo ready |
5 x 107 IFU/ml x 200ul |
770-Eur |
GenTarget |
|
LVP578-PBS |
CRE (RFP-Puro),
CAG lentivirus in PBS, premade lentiviral particles |
5 x107 IFU/ml x 200ul |
770-Eur |
GenTarget |
|
LVP578 |
CRE (RFP-Puro),
CAG lentivirus, premade lentiviral particles |
1x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
VPK-212-PAN |
ViraSafe™ Lentiviral Expression System (Puro), Pantropic |
1 kit |
1440-Eur |
Cell Biolabs |
Viral System |
LVP576-PBS |
CRE (GFP-Puro),
CAG lentivirus in PBS, premade lentiviral particles |
5 x107 IFU/ml x 200ul |
770-Eur |
GenTarget |
|
LVP576 |
CRE (GFP-Puro),
CAG lentivirus, premade lentiviral particles |
1x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
VPK-216-PAN |
ViraSafe™ Lentiviral Bicistronic Expression System (Neo), Pantropic |
1 kit |
1440-Eur |
Cell Biolabs |
Viral System |
VPK-219 |
pSMPUW-IRES-Blasticidin Lentiviral Expression Vector |
10 |
770-Eur |
Cell Biolabs |
|
LVP585-PBS |
CFP (CAG)-Puro lentiviral particles, in vivo ready |
5 x 107 IFU/ml x 200ul |
770-Eur |
GenTarget |
|
LVP021-PBS |
GFP-lacZ (His) Lentiviral particles, invivo ready |
5x107 IFU/ml x 200ul |
933-Eur |
GenTarget |
|
VPK-215 |
pSMPUW-IRES-Puro Lentiviral Expression Vector |
10 |
770-Eur |
Cell Biolabs |
|
VPK-211 |
pSMPUW Universal Lentiviral Expression Vector (Promoterless) |
10 µg |
651-Eur |
Cell Biolabs |
Viral System |
VPK-217 |
pSMPUW-IRES-Hygro Lentiviral Expression Vector |
10 |
770-Eur |
Cell Biolabs |
|
VPK-216-ECO |
ViraSafe™ Lentiviral Bicistronic Expression System (Neo), Ecotropic |
1 kit |
1440-Eur |
Cell Biolabs |
Viral System |
LVP573-PBS |
CRE (Puro),
CAG lentivirus in PBS , premade lentiviral particles |
5 x107 IFU/ml x 200ul |
770-Eur |
GenTarget |
|
TR019PA-1 |
Lentiviral Technology pGreenFire1-Nanog (plasmid) |
10 ug |
759-Eur |
SBI |
|
TR028PA-1 |
Lentiviral Technology pGreenFire1-SREBP (plasmid) |
10 ug |
759-Eur |
SBI |
|
TR028PA-N |
Lentiviral Technology pGreenFire1-SREBP (plasmid)+ EF1-Neo |
10 ug |
759-Eur |
SBI |
|
TR028VA-1 |
Lentiviral Technology pGreenFire1-SREBP (virus) |
>2 x 10^6 IFUs |
759-Eur |
SBI |
|
TR028VA-N |
Lentiviral Technology pGreenFire1-SREBP (virus) + EF1-Neo |
>2 x 10^6 IFUs |
759-Eur |
SBI |
|
TR029PA-P |
Lentiviral Technology pGreenFire1-SRF (plasmid)+ EF1-Puro |
10 ug |
759-Eur |
SBI |
|
TR029VA-P |
Lentiviral Technology pGreenFire1-SRF (virus) + EF1-Puro |
>2 x 10^6 IFUs |
759-Eur |
SBI |
|
TR030PA-1 |
Lentiviral Technology pGreenFire1-MEF2 (plasmid) |
10 ug |
759-Eur |
SBI |
|
LVP402 |
Luciferase (firefly)-2A-RFP (Neo)
, premade lentiviral particles |
1x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP403 |
Luciferase (firefly)-2A-GFP (Neo)
, premade lentiviral particles |
1x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
TR030PA-N |
Lentiviral Technology pGreenFire1-MEF2 (plasmid)+ EF1-Neo |
10 ug |
759-Eur |
SBI |
|
TR027PA-P |
Lentiviral Technology pGreenFire1-GAS (plasmid)+ EF1-Puro |
10 ug |
759-Eur |
SBI |
|
TR026VA-N |
Lentiviral Technology pGreenFire1-HIF1 (virus) + EF1-Neo |
>2 x 10^6 IFUs |
759-Eur |
SBI |
|
TR019PA-N |
Lentiviral Technology pGreenFire1-Nanog (plasmid)+ EF1-Neo |
10 ug |
759-Eur |
SBI |
|
TR019VA-1 |
Lentiviral Technology pGreenFire1-Nanog (virus) |
>2 x 10^6 IFUs |
759-Eur |
SBI |
|
TR019VA-N |
Lentiviral Technology pGreenFire1-Nanog (virus) + EF1-Neo |
>2 x 10^6 IFUs |
759-Eur |
SBI |
|
TR020PA-1 |
Lentiviral Technology pGreenFire1-Notch (plasmid) |
10 ug |
759-Eur |
SBI |
|
TR020PA-N |
Lentiviral Technology pGreenFire1-Notch (plasmid)+ EF1-Neo |
10 ug |
759-Eur |
SBI |
|
TR020VA-1 |
Lentiviral Technology pGreenFire1-Notch (virus) |
>2 x 10^6 IFUs |
759-Eur |
SBI |
|
TR020VA-N |
Lentiviral Technology pGreenFire1-Notch (virus) + EF1-Neo |
>2 x 10^6 IFUs |
759-Eur |
SBI |
|
TR026PA-1 |
Lentiviral Technology pGreenFire1-HIF1 (plasmid) |
10 ug |
759-Eur |
SBI |
|
TR026PA-N |
Lentiviral Technology pGreenFire1-HIF1 (plasmid)+ EF1-Neo |
10 ug |
759-Eur |
SBI |
|
TR026VA-1 |
Lentiviral Technology pGreenFire1-HIF1 (virus) |
>2 x 10^6 IFUs |
759-Eur |
SBI |
|
TR030VA-1 |
Lentiviral Technology pGreenFire1-MEF2 (virus) |
>2 x 10^6 IFUs |
759-Eur |
SBI |
|
LVP407 |
CRE-2A-GFP (Puro), CMV lentivirus, premade lentiviral particles |
1x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
TR033VA-N |
Lentiviral Technology pGreenFire1-cJun (virus) + EF1-Neo |
>2 x 10^6 IFUs |
759-Eur |
SBI |
|
LVP431-PBS |
CFP (EF1a)-Neo lentiviral particles, in vivo ready |
1x108 IFU/ml x 200ul |
770-Eur |
GenTarget |
|
TR036PA-P |
Lentiviral Technology pGreenFire1-SP1 (plasmid)+ EF1-Puro |
10 ug |
759-Eur |
SBI |
|
TR036VA-P |
Lentiviral Technology pGreenFire1-SP1 (virus) + EF1-Puro |
>2 x 10^6 IFUs |
759-Eur |
SBI |
|
TR037PA-1 |
Lentiviral Technology pGreenFire1-RARE (plasmid) |
10 ug |
759-Eur |
SBI |
|
TR037PA-N |
Lentiviral Technology pGreenFire1-RARE (plasmid)+ EF1-Neo |
10 ug |
759-Eur |
SBI |
|
TR037VA-1 |
Lentiviral Technology pGreenFire1-RARE (virus) |
>2 x 10^6 IFUs |
759-Eur |
SBI |
|
TR037VA-N |
Lentiviral Technology pGreenFire1-RARE (virus) + EF1-Neo |
>2 x 10^6 IFUs |
759-Eur |
SBI |
|
TR039PA-1 |
Lentiviral Technology pGreenFire1-Oct4 (plasmid) |
10 ug |
759-Eur |
SBI |
|
TR039PA-N |
Lentiviral Technology pGreenFire1-Oct4 (plasmid)+ EF1-Neo |
10 ug |
759-Eur |
SBI |
|
TR033VA-1 |
Lentiviral Technology pGreenFire1-cJun (virus) |
>2 x 10^6 IFUs |
759-Eur |
SBI |
|
LVP309-PBS |
RFP (Puro) lentiviral particles, in vivo ready |
1x10e8 IFU/ml x 200ul |
770-Eur |
GenTarget |
|
TR030VA-N |
Lentiviral Technology pGreenFire1-MEF2 (virus) + EF1-Neo |
>2 x 10^6 IFUs |
759-Eur |
SBI |
|
TR031PA-1 |
Lentiviral Technology pGreenFire1-Pax6 (plasmid) |
10 ug |
759-Eur |
SBI |
|
TR031PA-N |
Lentiviral Technology pGreenFire1-Pax6 (plasmid)+ EF1-Neo |
10 ug |
759-Eur |
SBI |
|
TR031VA-1 |
Lentiviral Technology pGreenFire1-Pax6 (virus) |
>2 x 10^6 IFUs |
759-Eur |
SBI |
|
TR031VA-N |
Lentiviral Technology pGreenFire1-Pax6 (virus) + EF1-Neo |
>2 x 10^6 IFUs |
759-Eur |
SBI |
|
TR032PA-P |
Lentiviral Technology pGreenFire1-ERE (plasmid)+ EF1-Puro |
10 ug |
759-Eur |
SBI |
|
TR032VA-P |
Lentiviral Technology pGreenFire1-ERE(virus) + EF1-Puro |
>2 x 10^6 IFUs |
759-Eur |
SBI |
|
TR033PA-1 |
Lentiviral Technology pGreenFire1-cJun (plasmid) |
10 ug |
759-Eur |
SBI |
|
TR033PA-N |
Lentiviral Technology pGreenFire1-cJun (plasmid)+ EF1-Neo |
10 ug |
759-Eur |
SBI |
|
TR027VA-P |
Lentiviral Technology pGreenFire1-GAS (virus) + EF1-Puro |
>2 x 10^6 IFUs |
759-Eur |
SBI |
|
TR039VA-1 |
Lentiviral Technology pGreenFire1-Oct4 (virus) |
>2 x 10^6 IFUs |
759-Eur |
SBI |
|
QM522A-1 |
Lentiviral Technology pCDH-CuO-MCS-T2A-RFP co-inducible T2A lentivector |
10 ug |
644-Eur |
SBI |
|
LVP411-PBS |
Luciferase-2A-CRE, (GFP-Bsd) lentiviral particles, in vivo ready |
5 x107 IFU/ml x 200ul |
933-Eur |
GenTarget |
|
LVP413-PBS |
Luciferase-2A-CRE, (RFP-Bsd) lentiviral particles, in vivo ready |
5 x107 IFU/ml x 200ul |
933-Eur |
GenTarget |
|
LV510A-1 |
Lentiviral Technology pPACKH1-XL HIV Lentivector Packaging Kit |
50 transfections |
1281-Eur |
SBI |
|
LV500A-1 |
Lentiviral Technology pPACKH1 HIV Lentivector Packaging Kit |
10 transfections |
603-Eur |
SBI |
|
LV300B-1 |
Lentiviral Technology LentiSuiteâ„¢ For FIV-based System |
10 reactions |
1360-Eur |
SBI |
|
LV300A-1 |
Lentiviral Technology LentiSuiteâ„¢ For HIV-based System |
10 reactions |
1360-Eur |
SBI |
|
TR012PA-P |
Lentiviral Technology pGreenFire1-NF-kB (plasmid)+ EF1-Puro |
10 ug |
759-Eur |
SBI |
|
TR012VA-P |
Lentiviral Technology pGreenFire1-NF-kB (virus) + EF1-Puro |
>2 x 10^6 IFUs |
759-Eur |
SBI |
|
LV100A-1 |
Lentiviral Technology pPACKF1 FIV Lentivector Packaging Kit |
10 transfections |
603-Eur |
SBI |
|
LVP310-PBS |
GFP (EF1a)-Bsd lentiviral particles, in vivo ready |
1x108 IFU/ml x 200ul |
770-Eur |
GenTarget |
|
LV750A-1 |
Lentiviral Technology PureFection Transfection Reagent |
1 ml |
349-Eur |
SBI |
|
LVP410-PBS |
Luciferase-2A-CRE (Neo), lentiviral particles, in vivo ready |
5 x107 IFU/ml x 200ul |
933-Eur |
GenTarget |
|
QM800A-1 |
Lentiviral Technology pCDH-Cuo-MCS-EF1-CymR-T2A-Puro |
10 ug |
1230-Eur |
SBI |
|
QM400VA-2 |
Lentiviral Technology pCDH-EF1-CymR-T2A-Neo (virus) |
>1 x 10^6 IFUs |
590-Eur |
SBI |
|
QM400PA-2 |
Lentiviral Technology pCDH-EF1-CymR-T2A-Neo (plasmid) |
10 ug |
553-Eur |
SBI |
|
LVP326 |
Luciferase (firefly) (Bsd), premade lentiviral particles |
1 x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
QM300VA-1 |
Lentiviral Technology pCDH-EF1-CymR-T2A-RFP (virus) |
>1 x 10^6 IFUs |
604-Eur |
SBI |
|
QM300PA-1 |
Lentiviral Technology pCDH-EF1-CymR-T2A-RFP (plasmid) |
10 ug |
567-Eur |
SBI |
|
LVP338 |
CRE-2A-RFP (Puro), CMV lentivirus, premade lentiviral particles |
1x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP339 |
CRE (Puro), CMV lentivirus, premade lentiviral particles |
1x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP323 |
Luciferase (firefly)-2A-GFP (Bsd), premade lentiviral particles |
1x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LV800A-1 |
Lentiviral Technology LentiMag Magneto Transduction Kit |
10 transductions |
732-Eur |
SBI |
|
LVP425-PBS |
GFP (EF1a)-Neo lentiviral particles, in vivo ready |
1x10e8 IFU/ml x 200ul |
770-Eur |
GenTarget |
|
LV050A-1 |
Lentiviral Technology LentiStarter Kit (pPACK-H1, PEG-it, TransDux) |
2 reactions |
502-Eur |
SBI |
|
LVP370 |
Luciferase (Renilla), (Neo) , premade lentiviral particles |
1 x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
TR016PA-1 |
Lentiviral Technology pGreenFire1-ISRE (plasmid) |
10 ug |
759-Eur |
SBI |
|
TR016PA-N |
Lentiviral Technology pGreenFire1-ISRE (plasmid)+ EF1-Neo |
10 ug |
759-Eur |
SBI |
|
TR016VA-1 |
Lentiviral Technology pGreenFire1-ISRE (virus) |
>2 x 10^6 IFUs |
759-Eur |
SBI |
|
LVP283 |
Luciferase (firefly), (Neo), premade lentiviral particles |
5 x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP430-PBS |
CFP (EF1a)-Bsd lentiviral particles, in vivo ready |
1x108IFU/ml x 200ul |
770-Eur |
GenTarget |
|
LVP372 |
Luciferase (Renilla), (Bsd) , premade lentiviral particles |
1 x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
TR017PA-1 |
Lentiviral Technology pGreenFire1-Gal4 (plasmid) |
10 ug |
759-Eur |
SBI |
|
TR017PA-N |
Lentiviral Technology pGreenFire1-Gal4 (plasmid)+ EF1-Neo |
10 ug |
759-Eur |
SBI |
|
TR017VA-1 |
Lentiviral Technology pGreenFire1-Gal4 (virus) |
>2 x 10^6 IFUs |
759-Eur |
SBI |
|
TR015VA-N |
Lentiviral Technology pGreenFire1-STAT (virus) + EF1-Neo |
>2 x 10^6 IFUs |
759-Eur |
SBI |
|
TR015VA-1 |
Lentiviral Technology pGreenFire1-STAT (virus) |
>2 x 10^6 IFUs |
759-Eur |
SBI |
|
LVP427-PBS |
RFP (EF1a)-Bsd lentiviral particles, in vivo ready |
1x10e8 IFU/ml x 200ul |
770-Eur |
GenTarget |
|
LVP428-PBS |
RFP (EF1a)-Neo lentiviral particles, in vivo ready |
1x10e8 IFU/ml x 200ul |
770-Eur |
GenTarget |
|
TR013PA-1 |
Lentiviral Technology pGreenFire1-TCF_LEF1 (plasmid) |
10 ug |
759-Eur |
SBI |
|
TR013PA-N |
Lentiviral Technology pGreenFire1-TCF_LEF1 (plasmid)+ EF1-Neo |
10 ug |
759-Eur |
SBI |
|
TR013VA-1 |
Lentiviral Technology pGreenFire1-TCF_LEF1 (virus) |
>2 x 10^6 IFUs |
759-Eur |
SBI |
|
LVP367 |
Luciferase (Renilla)
(RFP-Bsd)
, premade lentiviral particles |
1 x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
TR013VA-N |
Lentiviral Technology pGreenFire1-TCF_LEF1 (virus) + EF1-Neo |
>2 x 10^6 IFUs |
759-Eur |
SBI |
|
LVP368 |
Luciferase (Renilla), (GFP-Bsd), premade lentiviral particles |
1 x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
TR015PA-1 |
Lentiviral Technology pGreenFire1-STAT1 (plasmid) |
10 ug |
759-Eur |
SBI |
|
TR015PA-N |
Lentiviral Technology pGreenFire1-STAT1 (plasmid)+ EF1-Neo |
10 ug |
759-Eur |
SBI |
|
TR017VA-N |
Lentiviral Technology pGreenFire1-Gal4 (virus) + EF1-Neo |
>2 x 10^6 IFUs |
759-Eur |
SBI |
|
TR039VA-N |
Lentiviral Technology pGreenFire1-Oct4 (virus) + EF1-Neo |
>2 x 10^6 IFUs |
759-Eur |
SBI |
|
VPK-222-ECO |
ViraSafe" shRNA Lentiviral Expression System (GFP), Ecotropic |
1 kit |
1440-Eur |
Cellbio |
|
LVP326-PBS |
Luciferase (Bsd) lentiviral particles, in vivo ready |
5 x107 IFU/ml x 200ul |
770-Eur |
GenTarget |
|
LVP373 |
Luciferase (Cypridina)
(RFP-Bsd)
; premade lentiviral particles |
1 x107 IFU/ml x 200ul |
400-Eur |
GenTarget |
|
QM521A-1 |
Lentiviral Technology pCDH-CuO-MCS-T2A-GFP co-inducible T2A lentivector |
10 ug |
644-Eur |
SBI |
|
LVP374 |
Luciferase (Cypridina), (GFP-Bsd); premade lentiviral particles |
1 x107 IFU/ml x 200ul |
400-Eur |
GenTarget |
|
LVP367 |
Luciferase (Renilla)
(RFP-Bsd)
; premade lentiviral particles |
1 x107 IFU/ml x 200ul |
400-Eur |
GenTarget |
|
LVP376 |
Luciferase (Cypridina), (Neo) ; premade lentiviral particles |
1 x107 IFU/ml x 200ul |
400-Eur |
GenTarget |
|
LVP364 |
Luciferase (Gaussia), (Neo) ; premade lentiviral particles |
1 x107 IFU/ml x 200ul |
400-Eur |
GenTarget |
|
BLIV201PA-1 |
Lentiviral Dual Reporter: UBC-GFP-T2A-Luciferase plasmid (10 ug) |
10 ug |
751-Eur |
SBI |
|
TR201va-p |
Lentiviral Technology pGF-AP1-mCMV-EF1-Puro (virus) |
>2 x 10^6 IFUs |
759-Eur |
SBI |
|
LVP362 |
Luciferase (Gaussia), (GFP-Bsd); premade lentiviral particles |
1 x107 IFU/ml x 200ul |
400-Eur |
GenTarget |
|
TR201pa-p |
Lentiviral Technology pGF-AP1-mCMV-EF1-Puro (plasmid) |
10 ug |
759-Eur |
SBI |
|
TR200va-p |
Lentiviral Technology pGF-p53-mCMV-EF1-Puro (virus) |
>2 x 10^6 IFUs |
759-Eur |
SBI |
|
TR200pa-p |
Lentiviral Technology pGF-p53-mCMV-EF1-Puro (plasmid) |
10 ug |
759-Eur |
SBI |
|
LVP361 |
Luciferase (Gaussia)
(RFP-Bsd)
; premade lentiviral particles |
1 x107 IFU/ml x 200ul |
400-Eur |
GenTarget |
|
LVP372 |
Luciferase (Renilla), (Bsd) ; premade lentiviral particles |
1 x107 IFU/ml x 200ul |
400-Eur |
GenTarget |
|
LVP002-PBS |
GFP-His (bicistronical RFP) Lentiviral particles, in vivo ready |
1x10e8 IFU/ml x 200ul |
770-Eur |
GenTarget |
|
LVP368 |
Luciferase (Renilla), (GFP-Bsd); premade lentiviral particles |
1 x107 IFU/ml x 200ul |
400-Eur |
GenTarget |
|
VPK-222-PAN |
ViraSafe™ shRNA Lentiviral Expression System (GFP), Pantropic |
1 kit |
1440-Eur |
Cellbio |
|
LVP475 |
HPyV6 small T-antigen lentiviral particles |
1x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP298 |
TSPyV large T-antigen lentiviral particles |
1x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP474 |
TSPyV small T-antigen lentiviral particles |
1x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP473 |
MCPyV small T-antigen lentiviral particles |
1x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP366 |
Luciferase (Gaussia), (Bsd) ; premade lentiviral particles |
1 x107 IFU/ml x 200ul |
400-Eur |
GenTarget |
|
LVP009 |
Luciferase (firefly)-2A-RFP (Bsd)
, premade lentiviral particles |
1x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP466-PBS |
YFP (EF1a)-Neo lentiviral particles, in vivo ready |
1x10e8 IFU/ml x 200ul |
770-Eur |
GenTarget |
|
LVP370 |
Luciferase (Renilla), (Neo) ; premade lentiviral particles |
1 x107 IFU/ml x 200ul |
400-Eur |
GenTarget |
|
BLIV530PA-1 |
Lentiviral Dual Reporter: UBC-GFP-Luciferase Plasmid (10 ug) |
10 ug |
751-Eur |
SBI |
|
BLIV502PA-1 |
Lentiviral Triple Reporter: EF1-Luciferase-RFP-TK plasmid (10 ug) |
10 ug |
751-Eur |
SBI |
|
LVP459-RP-PBS |
EF1a-TetR (RFP-Puro) Lentiviral particles |
5x107 IFU/ml x 200ul |
552-Eur |
GenTarget |
|
LVP459-RP |
EF1a-TetR (RFP-Puro) Lentiviral particles |
1x107 IFU/ml x 200ul |
441-Eur |
GenTarget |
|
BLIV200PA-1 |
Lentiviral Dual Reporter: UBC-RFP-T2A-Luciferase plasmid (10 ug) |
10 ug |
751-Eur |
SBI |
|
BLIV100PA-1 |
Lentiviral Dual Reporter: CMV-RFP-T2A-Luciferase plasmid (10 ug) |
10 ug |
781-Eur |
SBI |
|
LVP402 |
Luciferase (firefly)-2A-RFP (Neo)
; premade lentiviral particles |
1x107 IFU/ml x 200ul |
400-Eur |
GenTarget |
|
LVP403 |
Luciferase (firefly)-2A-GFP (Neo)
; premade lentiviral particles |
1x107 IFU/ml x 200ul |
400-Eur |
GenTarget |
|
LVP471-PBS |
YFP (Puro) lentiviral particles, in vivo ready |
1x10e8 IFU/ml x 200ul |
770-Eur |
GenTarget |
|
LVP461 |
Luciferase (firefly)-
2A-GFP (RFP-Bsd)
, premade lentiviral particles |
1x107 IFU/ml x 200ul |
552-Eur |
GenTarget |
|
TR101PA-P |
Lentiviral Technology pGreenFire1-PPRE (plasmid) |
10 ug |
759-Eur |
SBI |
|
LVP465-PBS |
YFP (EF1a)-Bsd lentiviral particles, in vivo ready |
1x10e8 IFU/ml x 200ul |
770-Eur |
GenTarget |
|
TR051va-1 |
Lentiviral Technology pGreenFire1-4x-NFAT (virus) |
>2 x 10^6 IFUs |
759-Eur |
SBI |
|
TR051pa-1 |
Lentiviral Technology pGreenFire1-4x-NFAT (plasmid) |
10 ug |
759-Eur |
SBI |
|
TR101VA-P |
Lentiviral Technology pGreenFire1-PPRE (virus) |
>2 x 10^6 IFUs |
759-Eur |
SBI |
|
BLIV101PA-1 |
Lentiviral Dual Reporter: CMV-GFP-T2A-Luciferase plasmid (10 ug) |
10 ug |
751-Eur |
SBI |
|
LVP463 |
EF1a-Luc (firefly)-
2A-GFP (RFP-Bsd)
, premade lentiviral particles |
1x107 IFU/ml x 200ul |
552-Eur |
GenTarget |
|
BLIV102PA-1 |
Lentiviral Triple Reporter: CMV-Luciferase-RFP-TK plasmid (10 ug) |
10 ug |
751-Eur |
SBI |
|
BLIV202PA-1 |
Lentiviral Triple Reporter: UBC-Luciferase-RFP-TK plasmid (10 ug) |
10 ug |
751-Eur |
SBI |
|
LVP378 |
Luciferase (Cypridina), (Bsd) ; premade lentiviral particles |
1 x107 IFU/ml x 200ul |
400-Eur |
GenTarget |
|
VPK-221-PAN |
ViraSafe™ shRNA Lentiviral Expression System (Puro), Pantropic |
1 kit |
1440-Eur |
Cellbio |
|
LVP324 |
Luciferase (firefly)-2A-RFP (Puromycin), premade lentiviral particles |
1x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
TR015PA-P |
Lentiviral Technology pGreenFire1-STAT1 (plasmid)+ EF1-Puro |
10 ug |
759-Eur |
SBI |
|
LVP557-RB |
SV40 large T-antigen (RFP-Bsd), EF1a lentiviral particles |
1x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP016-GP |
SV40 large T-antigen (GFP-Puro), CMV lentiviral particles |
1x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
BLIV200VA-1 |
Lentiviral Dual Reporter: UBC-RFP-T2A-Luciferase pre-packaged virus |
>1 x10^6 IFUs |
751-Eur |
SBI |
|
VPK-221-ECO |
ViraSafe™ shRNA Lentiviral Expression System (Puro), Ecotropic |
1 kit |
1440-Eur |
Cellbio |
|
LVP523 |
CRE-2A-RFP (Puro), EF1a lentivirus, premade lentiviral particles |
1x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
TR013VA-P |
Lentiviral Technology pGreenFire1-TCF_LEF1 (virus) + EF1-Puro |
>2 x 10^6 IFUs |
759-Eur |
SBI |
|
LVP557-Bsd |
SV40 large T-antigen (Bsd), EF1a lentiviral particles |
1x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP016-RP |
SV40 large T-antigen (RFP-Puro), CMV lentiviral particles |
1x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP325 |
Luciferase (firefly)
(Puro), premade lentiviral particles |
1 x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP557-Neo |
SV40 large T-antigen (Neo), EF1a lentiviral particles |
1x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
BLIV102VA-1 |
Lentiviral Triple Reporter: CMV-Luciferase-RFP-TK pre-packaged virus |
>1 x10^6 IFUs |
751-Eur |
SBI |
|
LVP412-PBS |
Luciferase-2A-CRE, (GFP-Puro) lentiviral particles, in vivo ready |
5 x107 IFU/ml x 200ul |
933-Eur |
GenTarget |
|
BLIV302PA-1 |
Lentiviral Triple Reporter: MSCV-Luciferase-RFP-TK plasmid (10 ug) |
10 ug |
751-Eur |
SBI |
|
BLIV201VA-1 |
Lentiviral Dual Reporter: UBC-GFP-T2A-Luciferase pre-packaged virus |
>1 x10^6 IFUs |
751-Eur |
SBI |
|
ABP-SC-LVIP53S |
Validated p53 shRNA Lentiviral Particles (average 10^8TU_ml ) |
5 x 100µl |
1302-Eur |
Allele |
rna |
ABP-SC-LVIOCT3 |
Validated hOCT3_4 Lentiviral Particles (average 10^8TU_ml) |
5 x 100µl |
1302-Eur |
Allele |
Viral System |
TR020VA-P |
Lentiviral Technology pGreenFire1-Notch (virus) + EF1-Puro |
>2 x 10^6 IFUs |
759-Eur |
SBI |
|
ABP-SC-LVITERT |
Validated hTERT Lentiviral Particles (average 10^8TU_ml ) |
5 x 100µl |
1302-Eur |
Allele |
Viral System |
LVP426-PBS |
GFP (EF1a)-Puro lentiviral particles, in vivo ready |
1x10e8 IFU/ml x 200ul |
770-Eur |
GenTarget |
|
LVP409-PBS |
Luciferase-2A-CRE (Puro), lentiviral particles, in vivo ready |
5 x107 IFU/ml x 200ul |
933-Eur |
GenTarget |
|
BLIV301PA-1 |
Lentiviral Dual Reporter: MSCV-GFP-T2A-Luciferase plasmid (10 ug) |
10 ug |
751-Eur |
SBI |
|
BLIV202VA-1 |
Lentiviral Triple Reporter: UBC-Luciferase-RFP-TK pre-packaged virus |
>1 x10^6 IFUs |
751-Eur |
SBI |
|
BLIV300PA-1 |
Lentiviral Dual Reporter: MSCV-RFP-T2A-Luciferase plasmid (10 ug) |
10 ug |
751-Eur |
SBI |
|
LVP414-PBS |
Luciferase-2A-CRE, (RFP-Puro) lentiviral particles, in vivo ready |
5 x107 IFU/ml x 200ul |
933-Eur |
GenTarget |
|
ABP-SC-LVISOX2 |
Validated hSOX2 Lentiviral Particles (average 10^8TU_ml) |
5 x 100µl |
1302-Eur |
Allele |
Viral System |
SI506A-1 |
Lentiviral Technology pGreenPuro shRNA expression lentivector (EF1) |
10 ug |
621-Eur |
SBI |
|
BLIV100VA-1 |
Lentiviral Dual Reporter: CMV-RFP-T2A-Luciferase pre-packaged virus |
>1 x10^6 IFUs |
751-Eur |
SBI |
|
G306 |
pLenti_III_HA_PGK lentiviral vector expressing human KLF4cDNA |
5ug |
840-Eur |
ABM |
dna |
TR013PA-P |
Lentiviral Technology pGreenFire1-TCF_LEF1 (plasmid)+ EF1-Puro |
10 ug |
759-Eur |
SBI |
|
BLIV101VA-1 |
Lentiviral Dual Reporter: CMV-GFP-T2A-Luciferase pre-packaged virus |
>1 x10^6 IFUs |
751-Eur |
SBI |
|
SI505A-1 |
Lentiviral Technology pGreenPuro shRNA expression lentivector (CMV) |
10 ug |
621-Eur |
SBI |
|
TR204pa-p |
Lentiviral Technology pGF-EGR1-mCMV-EF1-Puro (plasmid) |
10 ug |
759-Eur |
SBI |
|
TR039VA-P |
Lentiviral Technology pGreenFire1-Oct4 (virus) + EF1-Puro |
>2 x 10^6 IFUs |
759-Eur |
SBI |
|
TR105PA-P |
Lentiviral Technology pGreenFire1-LXRE in Cyp7A1(plasmid) |
10 ug |
759-Eur |
SBI |
|
TR031VA-P |
Lentiviral Technology pGreenFire1-Pax6 (virus) + EF1-Puro |
>2 x 10^6 IFUs |
759-Eur |
SBI |
|
TR105VA-P |
Lentiviral Technology pGreenFire1-LXRE in Cyp7A1(virus) |
>2 x 10^6 IFUs |
759-Eur |
SBI |
|
TR106PA-P |
Lentiviral Technology pGreenFire1-LXRE in ABCA1(plasmid) |
10 ug |
759-Eur |
SBI |
|
TR031PA-P |
Lentiviral Technology pGreenFire1-Pax6 (plasmid)+ EF1-Puro |
10 ug |
759-Eur |
SBI |
|
TR106VA-P |
Lentiviral Technology pGreenFire1-LXRE in ABCA1(virus) |
>2 x 10^6 IFUs |
759-Eur |
SBI |
|
TR107PA-P |
Lentiviral Technology pGreenFire1-LXRE in ABCG1(plasmid) |
10 ug |
759-Eur |
SBI |
|
TR030VA-P |
Lentiviral Technology pGreenFire1-MEF2 (virus) + EF1-Puro |
>2 x 10^6 IFUs |
759-Eur |
SBI |
|
TR107VA-P |
Lentiviral Technology pGreenFire1-LXRE in ABCG1(virus) |
>2 x 10^6 IFUs |
759-Eur |
SBI |
|
TR108PA-P |
Lentiviral Technology pGreenFire1-LXRE in ApoE(plasmid) |
10 ug |
759-Eur |
SBI |
|
TR104VA-P |
Lentiviral Technology pGreenFire1-LXRE in ApoA1(virus) |
>2 x 10^6 IFUs |
759-Eur |
SBI |
|
TR104PA-P |
Lentiviral Technology pGreenFire1-LXRE in ApoA1(plasmid) |
10 ug |
759-Eur |
SBI |
|
TR039PA-P |
Lentiviral Technology pGreenFire1-Oct4 (plasmid)+ EF1-Puro |
10 ug |
759-Eur |
SBI |
|
TR040PA-1 |
Lentiviral Technology pGreenFire1-C_EBP-alpha (plasmid) |
10 ug |
759-Eur |
SBI |
|
TR040PA-N |
Lentiviral Technology pGreenFire1-C_EBP-alpha (plasmid)+ EF1-Neo |
10 ug |
759-Eur |
SBI |
|
TR037VA-P |
Lentiviral Technology pGreenFire1-RARE (virus) + EF1-Puro |
>2 x 10^6 IFUs |
759-Eur |
SBI |
|
TR040VA-1 |
Lentiviral Technology pGreenFire1-C_EBP-alpha (virus) |
>2 x 10^6 IFUs |
759-Eur |
SBI |
|
TR040VA-N |
Lentiviral Technology pGreenFire1-C_EBP-alpha (virus) + EF1-Neo |
>2 x 10^6 IFUs |
759-Eur |
SBI |
|
TR037PA-P |
Lentiviral Technology pGreenFire1-RARE (plasmid)+ EF1-Puro |
10 ug |
759-Eur |
SBI |
|
TR100VA-P |
Lentiviral Technology pGreenFire1-LXRE in SREBP1c (virus) |
>2 x 10^6 IFUs |
759-Eur |
SBI |
|
TR033VA-P |
Lentiviral Technology pGreenFire1-cJun (virus) + EF1-Puro |
>2 x 10^6 IFUs |
759-Eur |
SBI |
|
TR102PA-P |
Lentiviral Technology pGreenFire1-LXRE in LXR alpha (plasmid) |
10 ug |
759-Eur |
SBI |
|
TR030PA-P |
Lentiviral Technology pGreenFire1-MEF2 (plasmid)+ EF1-Puro |
10 ug |
759-Eur |
SBI |
|
TR108VA-P |
Lentiviral Technology pGreenFire1-LXRE in ApoE(virus) |
>2 x 10^6 IFUs |
759-Eur |
SBI |
|
TR109PA-P |
Lentiviral Technology pGreenFire1-LXRE in CETP(plasmid) |
10 ug |
759-Eur |
SBI |
|
LVP429-PBS |
RFP (EF1a)-Puro lentiviral particles, in vivo ready |
1x10e8 IFU/ml x 200ul |
770-Eur |
GenTarget |
|
TR020PA-P |
Lentiviral Technology pGreenFire1-Notch (plasmid)+ EF1-Puro |
10 ug |
759-Eur |
SBI |
|
TR019VA-P |
Lentiviral Technology pGreenFire1-Nanog (virus) + EF1-Puro |
>2 x 10^6 IFUs |
759-Eur |
SBI |
|
TR019PA-P |
Lentiviral Technology pGreenFire1-Nanog (plasmid)+ EF1-Puro |
10 ug |
759-Eur |
SBI |
|
TR017VA-P |
Lentiviral Technology pGreenFire1-Gal4 (virus) + EF1-Puro |
>2 x 10^6 IFUs |
759-Eur |
SBI |
|
TR102VA-P |
Lentiviral Technology pGreenFire1-LXRE in LXR alpha (virus) |
>2 x 10^6 IFUs |
759-Eur |
SBI |
|
TR017PA-P |
Lentiviral Technology pGreenFire1-Gal4 (plasmid)+ EF1-Puro |
10 ug |
759-Eur |
SBI |
|
LVP467-PBS |
YFP (EF1a)-Puro lentiviral particles, in vivo ready |
1x10e8 IFU/ml x 200ul |
770-Eur |
GenTarget |
|
TR016VA-P |
Lentiviral Technology pGreenFire1-ISRE (virus) + EF1-Puro |
>2 x 10^6 IFUs |
759-Eur |
SBI |
|
TR016PA-P |
Lentiviral Technology pGreenFire1-ISRE (plasmid)+ EF1-Puro |
10 ug |
759-Eur |
SBI |
|
LVP432-PBS |
CFP (EF1a)-Puro lentiviral particles, in vivo ready |
1x108 IFU/ml x 200ul |
770-Eur |
GenTarget |
|
TR204va-p |
Lentiviral Technology pGF-EGR1-mCMV-EF1-Puro (virus) |
>2 x 10^6 IFUs |
759-Eur |
SBI |
|
TR109VA-P |
Lentiviral Technology pGreenFire1-LXRE in CETP(virus) |
>2 x 10^6 IFUs |
759-Eur |
SBI |
|
TR028VA-P |
Lentiviral Technology pGreenFire1-SREBP (virus) + EF1-Puro |
>2 x 10^6 IFUs |
759-Eur |
SBI |
|
TR202pa-p |
Lentiviral Technology pGF-CREB-mCMV-EF1-Puro (plasmid) |
10 ug |
759-Eur |
SBI |
|
TR028PA-P |
Lentiviral Technology pGreenFire1-SREBP (plasmid)+ EF1-Puro |
10 ug |
759-Eur |
SBI |
|
TR202va-p |
Lentiviral Technology pGF-CREB-mCMV-EF1-Puro (virus) |
>2 x 10^6 IFUs |
759-Eur |
SBI |
|
TR203pa-p |
Lentiviral Technology pGF-SMAD2_3_4-mCMV-EF1-Puro (plasmid) |
10 ug |
759-Eur |
SBI |
|
TR033PA-P |
Lentiviral Technology pGreenFire1-cJun (plasmid)+ EF1-Puro |
10 ug |
759-Eur |
SBI |
|
TR026VA-P |
Lentiviral Technology pGreenFire1-HIF1 (virus) + EF1-Puro |
>2 x 10^6 IFUs |
759-Eur |
SBI |
|
TR203va-p |
Lentiviral Technology pGF-SMAD2_3_4-mCMV-EF1-Puro (virus) |
>2 x 10^6 IFUs |
759-Eur |
SBI |
|
TR026PA-P |
Lentiviral Technology pGreenFire1-HIF1 (plasmid)+ EF1-Puro |
10 ug |
759-Eur |
SBI |
|
TR015VA-P |
Lentiviral Technology pGreenFire1-STAT (virus) + EF1-Puro |
>2 x 10^6 IFUs |
759-Eur |
SBI |
|
LVP570 |
CAG-Luciferase (firefly)
(GFP-Puro)
, premade lentiviral particles |
1x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP441 |
EF1a-Luciferase (firefly)-2A-RFP (Neo); premade lentiviral particles |
1x107 IFU/ml x 200ul |
400-Eur |
GenTarget |
|
LVP020 |
Luciferase (firefly)-2A-GFP (Puro)
, premade lentiviral particles |
1x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP439 |
EF1a-Luciferase (firefly)-2A-RFP (Bsd) ; premade lentiviral particles |
1x107 IFU/ml x 200ul |
400-Eur |
GenTarget |
|
LVP438 |
EF1a-Luciferase (firefly)-2A-GFP (Neo); premade lentiviral particles |
1x107 IFU/ml x 200ul |
400-Eur |
GenTarget |
|
LVP436 |
EF1a-Luciferase (firefly)-2A-GFP (Bsd); premade lentiviral particles |
1x107 IFU/ml x 200ul |
400-Eur |
GenTarget |
|
LVP435 |
EF1a-Luciferase (firefly) (Neo); premade lentiviral particles |
1x107 IFU/ml x 200ul |
400-Eur |
GenTarget |
|
LVP433 |
EF1a-Luciferase (firefly) (Bsd); premade lentiviral particles |
1x107 IFU/ml x 200ul |
400-Eur |
GenTarget |
|
LVP433 |
EF1a-Luciferase (firefly) (Bsd), premade lentiviral particles |
1x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP435 |
EF1a-Luciferase (firefly) (Neo), premade lentiviral particles |
1x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP436 |
EF1a-Luciferase (firefly)-2A-GFP (Bsd), premade lentiviral particles |
1x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP358-RP |
Chained human iPS (MKOS) (RFP-Puro) lentiviral particles |
1x106 IFU/ml x 0.5 ml |
1130-Eur |
GenTarget |
|
VPK-219-PAN |
ViraSafe™ Lentiviral Bicistronic Expression System (Blasticidin), Pantropic |
1 kit |
1440-Eur |
Cell Biolabs |
Viral System |
LVP371 |
Luciferase (Renilla), (Puro), premade lentiviral particles |
1 x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP379 |
Inducible chained human iPS (RFP-Bsd), premade lentiviral particles |
0.5 ml x (1 x106 IFU/ml) |
709-Eur |
GenTarget |
|
LVP381 |
Inducible chained mouse iPS (RFP-Bsd), premade lentiviral particles |
0.5 ml x (1 x106 IFU/ml) |
709-Eur |
GenTarget |
|
LVP382 |
Inducible chained mouse iPS (GFP-Bsd), premade lentiviral particles |
0.5 ml x (1 x106 IFU/ml) |
709-Eur |
GenTarget |
|
VPK-217-ECO |
ViraSafe™ Lentiviral Bicistronic Expression System (Hygro), Ecotropic |
1 kit |
1440-Eur |
Cell Biolabs |
Viral System |
VPK-217-PAN |
ViraSafe™ Lentiviral Bicistronic Expression System (Hygro), Pantropic |
1 kit |
1440-Eur |
Cell Biolabs |
Viral System |
LVP359-RP |
Chained mouse iPS (MKOS) (RFP-Puro) lentiviral particles |
1x106 IFU/ml x 0.5 ml |
1130-Eur |
GenTarget |
|
VPK-219-ECO |
ViraSafe™ Lentiviral Bicistronic Expression System (Blasticidin), Ecotropic |
1 kit |
1440-Eur |
Cell Biolabs |
Viral System |
ABP-SC-LVINANO |
Validated hNANOG Lentiviral Particles (average 10^8TU_ml) |
5 x 100µl |
1302-Eur |
Allele |
Viral System |
LVP438 |
EF1a-Luciferase (firefly)-2A-GFP (Neo), premade lentiviral particles |
1x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
TR100PA-P |
Lentiviral Technology pGreenFire1-LXRE in SREBP1c (plasmid) |
10 ug |
759-Eur |
SBI |
|
LVP375 |
Luciferase (Cypridina), (RFP-Puro); premade lentiviral particles |
1 x107 IFU/ml x 200ul |
400-Eur |
GenTarget |
|
LVP371 |
Luciferase (Renilla), (Puro); premade lentiviral particles |
1 x107 IFU/ml x 200ul |
400-Eur |
GenTarget |
|
LVP464 |
EF1a-Luc (firefly)-
2A-GFP (RFP-Puro)
, premade lentiviral particles |
1x107 IFU/ml x 200ul |
552-Eur |
GenTarget |
|
LVP369 |
Luciferase (Renilla), (RFP-Puro); premade lentiviral particles |
1 x107 IFU/ml x 200ul |
400-Eur |
GenTarget |
|
LVP365 |
Luciferase (Gaussia), (Puro); premade lentiviral particles |
1 x107 IFU/ml x 200ul |
400-Eur |
GenTarget |
|
LVP324 |
Luciferase (firefly)-2A-RFP (Puromycin); premade lentiviral particles |
1x107 IFU/ml x 200ul |
400-Eur |
GenTarget |
|
LVP325 |
Luciferase (firefly)
(Puro); premade lentiviral particles |
1 x107 IFU/ml x 200ul |
400-Eur |
GenTarget |
|
LVP363 |
Luciferase (Gaussia), (RFP-Puro); premade lentiviral particles |
1 x107 IFU/ml x 200ul |
400-Eur |
GenTarget |
|
LVP526 |
CRE-2A-GFP (Puro), EF1a lentivirus, premade lentiviral particles |
1x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP520 |
CRE (Puro), EF1a lentivirus, premade lentiviral particles |
1x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
ABP-SC-LVICMYC |
Validated hc_MYC Lentiviral Particles (average 10^8TU_ml ) |
5 x 100µl |
1302-Eur |
Allele |
Viral System |
LVP567 |
CAG-Luciferase (firefly)
(Puro)
, premade lentiviral particles |
1x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
ABP-SC-LVILN28 |
Validated hLIN28 Lentiviral Particles (average 10^8TU_ml) |
5 x 100µl |
1302-Eur |
Allele |
Viral System |
LVP439 |
EF1a-Luciferase (firefly)-2A-RFP (Bsd) , premade lentiviral particles |
1x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
ABP-SC-LVIKLF4 |
Validated hKLF4 Lentiviral Particles (average 10^8TU_ml ) |
5 x 100µl |
1302-Eur |
Allele |
Viral System |
LVP441 |
EF1a-Luciferase (firefly)-2A-RFP (Neo), premade lentiviral particles |
1x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP020 |
Luciferase (firefly)-2A-GFP (Puro)
; premade lentiviral particles |
1x107 IFU/ml x 200ul |
400-Eur |
GenTarget |
|
LVP382 |
Inducible chained mouse iPS (GFP-Bsd); premade lentiviral particles |
0.5 ml x (1 x106 IFU/ml) |
744-Eur |
GenTarget |
|
LVP381 |
Inducible chained mouse iPS (RFP-Bsd); premade lentiviral particles |
0.5 ml x (1 x106 IFU/ml) |
744-Eur |
GenTarget |
|
LVP380 |
Inducible chained human iPS (GFP-Bsd); premade lentiviral particles |
0.5 ml x (1 x106 IFU/ml) |
744-Eur |
GenTarget |
|
LVP379 |
Inducible chained human iPS (RFP-Bsd); premade lentiviral particles |
0.5 ml x (1 x106 IFU/ml) |
744-Eur |
GenTarget |
|
LVP572 |
CAG-Luciferase (firefly)
(RFP-Puro)
, premade lentiviral particles |
1x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP377 |
Luciferase (Cypridina), (Puro); premade lentiviral particles |
1 x107 IFU/ml x 200ul |
400-Eur |
GenTarget |
|
LVP462 |
Luciferase (firefly)-
2A-GFP (RFP-Puro)
, premade lentiviral particles |
1x107 IFU/ml x 200ul |
552-Eur |
GenTarget |
|
VPK-215-ECO |
ViraSafe™ Lentiviral Bicistronic Expression System (Puro), Ecotropic |
1 kit |
1440-Eur |
Cell Biolabs |
Viral System |
QM350VA-1 |
Lentiviral Technology pCDH-Cuo-RFP-T2A-GFP (positive control virus) |
>1 x 10^6 IFUs |
604-Eur |
SBI |
|
LV100A-5 |
Lentiviral Technology pPACKF1 FIV Lentivector Packaging Kit (50 reactions) |
50 transfections |
1245-Eur |
SBI |
|
LV900A-1 |
Lentiviral Technology 293TN Producer Cell Line |
2 x 10^6 cells |
388-Eur |
SBI |
|
QM512B-1 |
Lentiviral Technology pCDH-CuO-MCS-EF1-RFP dual promoter lentivector |
10 ug |
644-Eur |
SBI |
|
QM200VA-2 |
Lentiviral Technology pCDH-EF1-CymR-T2A-Puro (virus) |
>1 x 10^6 IFUs |
604-Eur |
SBI |
|
QM511B-1 |
Lentiviral Technology pCDH-CuO-MCS-EF1-GFP dual promoter lentivector |
10 ug |
644-Eur |
SBI |
|
QM200PA-2 |
Lentiviral Technology pCDH-EF1-CymR-T2A-Puro (plasmid) |
10 ug |
567-Eur |
SBI |
|
QM500A-1 |
Lentiviral Technology pCDH-CuO-MCS empty cloning lentivector |
10 ug |
582-Eur |
SBI |
|
QM350PA-1 |
Lentiviral Technology pCDH-Cuo-RFP-T2A-GFP (positive control plasmid) |
10 ug |
567-Eur |
SBI |
|
QM100A-1 |
Lentiviral Technology Cumate solution (1000x), 500ul |
500 ul |
156-Eur |
SBI |
|
LV825A-1 |
Lentiviral Technology PEG-it Virus Precipitation Solution (250 mL aliquot) |
250 ml |
769-Eur |
SBI |
|
LVP380 |
Inducible chained human iPS (GFP-Bsd), premade lentiviral particles |
0.5 ml x (1 x106 IFU/ml) |
709-Eur |
GenTarget |
|
VPK-215-PAN |
ViraSafe™ Lentiviral Bicistronic Expression System (Puro), Pantropic |
1 kit |
1440-Eur |
Cell Biolabs |
Viral System |
LV750A-5 |
Lentiviral Technology PureFection™ Transfection reagent |
5 ml |
1281-Eur |
SBI |
|
LV810A-1 |
Lentiviral Technology PEG-it Virus Precipitation Solution (100 mL aliquot) |
100 ml |
385-Eur |
SBI |
|
LVP369 |
Luciferase (Renilla), (RFP-Puro), premade lentiviral particles |
1 x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP372-PBS |
Luciferase (Renilla), (Bsd), in vivo ready ; premade lentiviral particles |
5 x107 IFU/ml x 200ul |
808-Eur |
GenTarget |
|
LVP323-PBS |
Luciferase (firefly)-2A-GFP (Bsd), in vivo ready, premade lentiviral particles |
5x107 IFU/ml x 200ul |
770-Eur |
GenTarget |
|
TR850A-1 |
Lentiviral Technology NF-kB_Jurkat_GFP Transcriptional Reporter Cell Line |
>2 x 10^6 cells |
3670-Eur |
SBI |
|
ABP-RP-TLCLUCS |
Validated Luc Expression Lentiviral Particles (average 1x10^8TU_ml ) |
100ul x 1vial |
309-Eur |
Allele |
Viral System |
TR860A-1 |
Lentiviral Technology NF-kB_293_GFP-Luc Transcriptional Reporter Cell Line |
>2 x 10^6 cells |
3118-Eur |
SBI |
|
LVP374-PBS |
Luciferase (Cypridina), (GFP-Bsd), in vivo ready; premade lentiviral particles |
5 x107 IFU/ml x 200ul |
808-Eur |
GenTarget |
|
ABP-RP-TLCRFPL |
Validated RFP Expression Lentiviral Particles (average 1x10^8TU_ml ) |
100ul x 5vial |
873-Eur |
Allele |
Viral System |
ABP-RP-TLCRFPS |
Validated RFP Expression Lentiviral Particles (average 1x10^8TU_ml ) |
100ul x 1vial |
309-Eur |
Allele |
Viral System |
LVP373-PBS |
Luciferase (Cypridina), (RFP-Bsd), in vivo ready; premade lentiviral particles |
5 x107 IFU/ml x 200ul |
808-Eur |
GenTarget |
|
ABP-RP-TLCLUCL |
Validated Luc Expression Lentiviral Particles (average 1x10^8TU_ml ) |
100ul x 5vial |
873-Eur |
Allele |
Viral System |
LVP569-PBS |
CAG-Luciferase (firefly)
(Neo), in vivo ready
, premade lentiviral particles |
5x107 IFU/ml x 200ul |
770-Eur |
GenTarget |
|
TR040VA-P |
Lentiviral Technology pGreenFire1-C_EBP-alpha (virus) + EF1-Puro |
>2 x 10^6 IFUs |
759-Eur |
SBI |
|
TR101A-P |
Lentiviral Technology pGreenFire1- PPRE (HepG2 cell line) |
>2 x 10^6 cells |
3118-Eur |
SBI |
|
LVP440 |
EF1a-Luciferase (firefly)-2A-RFP (Puro), premade lentiviral particles |
1x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LV850A-1 |
Lentiviral Technology TransDux virus transduction reagent (200x) |
80 transductions |
304-Eur |
SBI |
|
LVP378-PBS |
Luciferase (Cypridina), (Bsd), in vivo ready ; premade lentiviral particles |
5 x107 IFU/ml x 200ul |
808-Eur |
GenTarget |
|
LVP460-Neo |
LoxP GFP_RFP ColorSwitch (Neo) lentivirus, premade lentiviral particles |
1x107 IFU/ml x 200ul |
770-Eur |
GenTarget |
|
LVP571-PBS |
CAG-Luciferase (firefly)
(RFP-Bsd), in vivo ready
, premade lentiviral particles |
5x107 IFU/ml x 200ul |
770-Eur |
GenTarget |
|
LVP437 |
EF1a-Luciferase (firefly)-2A-GFP (Puro), premade lentiviral particles |
1x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP568-PBS |
CAG-Luciferase (firefly)
(Bsd), in vivo ready
, premade lentiviral particles |
5x107 IFU/ml x 200ul |
770-Eur |
GenTarget |
|
TR201a-p |
Lentiviral Technology pGF-AP1-mCMV-EF1-Puro (293 stable cell line) |
>2 x 10^6 cells |
3118-Eur |
SBI |
|
TR040PA-P |
Lentiviral Technology pGreenFire1-C_EBP-alpha (plasmid)+ EF1-Puro |
10 ug |
759-Eur |
SBI |
|
LVP283-PBS |
Luciferase (firefly), (Neo), in vivo ready; premade lentiviral particles |
1 x107 IFU/ml x 200ul |
808-Eur |
GenTarget |
|
ABP-RP-TLCGFPL |
Validated GFP Expression Lentiviral Particles (average 1x10^8TU_ml ) |
100ul x 5vial |
873-Eur |
Allele |
Viral System |
G313 |
pLenti_III_HA_CMV lentiviral vector expressing human Nanog cDNA |
5ug |
840-Eur |
ABM |
dna |
G312 |
pLenti_III_HA_CMV lentiviral vector expressing human Lin28 cDNA |
5ug |
840-Eur |
ABM |
dna |
G311 |
pLenti_III_HA_CMV lentiviral vector expressing human KLF4 cDNA |
5ug |
840-Eur |
ABM |
dna |
G309 |
pLenti_III_HA_PGK lentiviral vector expressing human Oct4 cDNA |
5ug |
840-Eur |
ABM |
dna |
G308 |
pLenti_III_HA_PGK lentiviral vector expressing human Nanog cDNA |
5ug |
840-Eur |
ABM |
dna |
G307 |
pLenti_III_HA_PGK lentiviral vector expressing human Lin28 cDNA |
5ug |
840-Eur |
ABM |
dna |
G304 |
pLenti_III_HA_UBC lentiviral vector expressing human Oct4 cDNA |
5ug |
840-Eur |
ABM |
dna |
G303 |
pLenti_III_HA_UBC lentiviral vector expressing human Nanog cDNA |
5ug |
840-Eur |
ABM |
dna |
G302 |
pLenti_III_HA_UBC lentiviral vector expressing human Lin28 cDNA |
5ug |
840-Eur |
ABM |
dna |
G301 |
pLenti_III_HA_UBC lentiviral vector expressing human KLF4 cDNA |
5ug |
840-Eur |
ABM |
dna |
LVP461-PBS |
Luciferase (firefly)-
2A-GFP (RFP-Bsd), in vivo ready, premade lentiviral particles |
5x107 IFU/ml x 200ul |
770-Eur |
GenTarget |
|
LVP463-PBS |
EF1a-Luc (firefly)-
2A-GFP (RFP-Bsd), in vivo ready, premade lentiviral particles |
5x107 IFU/ml x 200ul |
770-Eur |
GenTarget |
|
LVP557-RP |
SV40 large T-antigen (RFP-Puro), EF1a lentiviral particles |
1x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
G314 |
pLenti_III_HA_CMV lentiviral vector expressing human Oct4 cDNA |
5ug |
840-Eur |
ABM |
dna |
LVP460-Bsd |
LoxP GFP_RFP ColorSwitch (Bsd) lentivirus, premade lentiviral particles |
1x107 IFU/ml x 200ul |
770-Eur |
GenTarget |
|
LVP361-PBS |
Luciferase (Gaussia), (RFP-Bsd), in vivo ready; premade lentiviral particles |
5 x107 IFU/ml x 200ul |
808-Eur |
GenTarget |
|
ABP-RP-TLCGFPS |
Validated GFP Expression Lentiviral Particles (average 1x10^8TU_ml ) |
100ul x 1vial |
309-Eur |
Allele |
Viral System |
LVP370-PBS |
Luciferase (Renilla), (Neo), in vivo ready; premade lentiviral particles |
5 x107 IFU/ml x 200ul |
808-Eur |
GenTarget |
|
LVP376-PBS |
Luciferase (Cypridina), (Neo), in vivo ready; premade lentiviral particles |
5 x107 IFU/ml x 200ul |
808-Eur |
GenTarget |
|
LVP323-PBS |
Luciferase (firefly)-2A-GFP (Bsd), in vivo ready; premade lentiviral particles |
5x107 IFU/ml x 200ul |
808-Eur |
GenTarget |
|
LVP368-PBS |
Luciferase (Renilla), (GFP-Bsd), in vivo ready; premade lentiviral particles |
5 x107 IFU/ml x 200ul |
808-Eur |
GenTarget |
|
LVP367-PBS |
Luciferase (Renilla), (RFP-Bsd), in vivo ready; premade lentiviral particles |
5 x107 IFU/ml x 200ul |
808-Eur |
GenTarget |
|
LVP366-PBS |
Luciferase (Gaussia), (Bsd), in vivo ready ; premade lentiviral particles |
5 x107 IFU/ml x 200ul |
808-Eur |
GenTarget |
|
LV961A-1 |
UltraRapid Lentiviral Global Titering Kit (Human and Mouse compatible) |
42 reactions |
610-Eur |
SBI |
|
BLIV302VA-1 |
Lentiviral Triple Reporter: MSCV-Luciferase-RFP-TK pre-packaged virus |
>1 x10^6 IFUs |
751-Eur |
SBI |
|
BLIV301VA-1 |
Lentiviral Dual Reporter: MSCV-GFP-Luciferase pre-packaged virus |
>1 x10^6 IFUs |
751-Eur |
SBI |
|
BLIV300VA-1 |
Lentiviral Dual Reporter: MSCV-RFP-Luciferase pre-packaged virus |
>1 x10^6 IFUs |
751-Eur |
SBI |
|
LVP364-PBS |
Luciferase (Gaussia), (Neo), in vivo ready; premade lentiviral particles |
5 x107 IFU/ml x 200ul |
808-Eur |
GenTarget |
|
LVP362-PBS |
Luciferase (Gaussia), (GFP-Bsd), in vivo ready; premade lentiviral particles |
5 x107 IFU/ml x 200ul |
808-Eur |
GenTarget |
|
LVP557-GP |
SV40 large T-antigen (GFP-Puro), EF1a lentiviral particles |
1x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
CD500B-1 |
Lentiviral Technology pCDH-CMV-MCS cDNA Cloning and Expression Vector |
10 ug |
518-Eur |
SBI |
|
BLIV200PA-1 |
Bioluminescent Imaging Lentiviral Dual Reporter UBC-RFP-T2A-Luciferase plasmid (10 ug) |
10 ug |
759-Eur |
SBI |
|
CD514B-1 |
Lentiviral Technology pCDH-CMV-MCS-EF1-Neo cDNA Cloning and Expression Vector |
10 ug |
603-Eur |
SBI |
|
LVP434 |
EF1a-Luciferase (firefly) (Puro); premade lentiviral particles |
1x107 IFU/ml x 200ul |
400-Eur |
GenTarget |
|
BLIV102PA-1 |
Bioluminescent Imaging Lentiviral Triple Reporter CMV-Luciferase-RFP-TK plasmid (10 ug) |
10 ug |
759-Eur |
SBI |
|
CD512B-1 |
Lentiviral Technology pCDH-CMV-MCS-EF1-RFP cDNA Cloning and Expression Vector |
10 ug |
589-Eur |
SBI |
|
LVP437 |
EF1a-Luciferase (firefly)-2A-GFP (Puro); premade lentiviral particles |
1x107 IFU/ml x 200ul |
400-Eur |
GenTarget |
|
LV961A-1 |
UltraRapid Lentiviral Global Titering Kit (Human and Mouse compatible) |
42 individual titers |
559-Eur |
SBI |
assays |
LVP440 |
EF1a-Luciferase (firefly)-2A-RFP (Puro); premade lentiviral particles |
1x107 IFU/ml x 200ul |
400-Eur |
GenTarget |
|
BLIV502PA-1 |
Bioluminescent Imaging Lentiviral Triple Reporter EF1-Luciferase-RFP-TK plasmid (10 ug) |
10 ug |
759-Eur |
SBI |
|
BLIV100PA-1 |
Bioluminescent Imaging Lentiviral Dual Reporter CMV-RFP-T2A-Luciferase plasmid (10 ug) |
10 ug |
759-Eur |
SBI |
|
CD502A-1 |
Lentiviral Technology pCDH-EF1-MCS cDNA Cloning and Expression Vector |
10 ug |
518-Eur |
SBI |
|
BLIV503PA-1 |
Bioluminescent Imaging Lentiviral Dual Reporter EF1-GFP-T2A-Luciferase Plasmid (10 ug) |
10 ug |
759-Eur |
SBI |
|
BLIV530PA-1 |
Bioluminescent Imaging Lentiviral Dual Reporter UBC-GFP-Luciferase Plasmid (10 ug) |
10 ug |
759-Eur |
SBI |
|
LVP367-PBS |
Luciferase (Renilla), (RFP-Bsd), in vivo ready, premade lentiviral particles |
5 x107 IFU/ml x 200ul |
770-Eur |
GenTarget |
|
TR011VA-1 |
Lentiviral Technology pGreenFire1-CMV Virus (pTRH1 CMV dscGFP T2A Fluc) |
>2 x 10^6 IFUs |
759-Eur |
SBI |
|
BLIV202PA-1 |
Bioluminescent Imaging Lentiviral Triple Reporter UBC-Luciferase-RFP-TK plasmid (10 ug) |
10 ug |
759-Eur |
SBI |
|
LVP434 |
EF1a-Luciferase (firefly) (Puro), premade lentiviral particles |
1x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP283-PBS |
Luciferase (firefly), (Neo), in vivo ready, premade lentiviral particles |
5 x107 IFU/ml x 200ul |
770-Eur |
GenTarget |
|
LVP370-PBS |
Luciferase (Renilla), (Neo), in vivo ready, premade lentiviral particles |
5 x107 IFU/ml x 200ul |
770-Eur |
GenTarget |
|
BLIV201PA-1 |
Bioluminescent Imaging Lentiviral Dual Reporter UBC-GFP-T2A-Luciferase plasmid (10 ug) |
10 ug |
759-Eur |
SBI |
|
LVP368-PBS |
Luciferase (Renilla), (GFP-Bsd), in vivo ready, premade lentiviral particles |
5 x107 IFU/ml x 200ul |
770-Eur |
GenTarget |
|
BLIV101PA-1 |
Bioluminescent Imaging Lentiviral Dual Reporter CMV-GFP-T2A-Luciferase plasmid (10 ug) |
10 ug |
759-Eur |
SBI |
|
LVP372-PBS |
Luciferase (Renilla), (Bsd), in vivo ready , premade lentiviral particles |
5 x107 IFU/ml x 200ul |
770-Eur |
GenTarget |
|
LVP-stems-m-RB |
Full set (6 mouse stem factors with RFP-Bsd marker); premade lentiviral particles |
200ul x 6 |
1186-Eur |
GenTarget |
|
BLIV302PA-1 |
Bioluminescent Imaging Lentiviral Triple Reporter MSCV-Luciferase-RFP-TK plasmid (10 ug) |
10 ug |
759-Eur |
SBI |
|
ABP-RP-TLCIL3S |
Validated IL_3 Expression Lentiviral Particles (average 1x10^8TU_ml ) |
100ul x 1vial |
309-Eur |
Allele |
Viral System |
LVP365-PBS |
Luciferase (Gaussia), (Puro), in vivo ready; premade lentiviral particles |
5 x107 IFU/ml x 200ul |
808-Eur |
GenTarget |
|
LVP324-PBS |
Luciferase (firefly)-2A-RFP (Puro), in vivo ready, premade lentiviral particles |
5x107 IFU/ml x 200ul |
770-Eur |
GenTarget |
|
CD533A-2 |
Lentiviral Technology pCDH-EF1-MCS-IRES-Neo cDNA Cloning and Expression Vector |
10 ug |
618-Eur |
SBI |
|
CD615B-1 |
Lentiviral Technology pCDH-UbC-MCS-EF1-Hygro cDNA Cloning and Expression Vector |
10 ug |
603-Eur |
SBI |
|
CD711B-1 |
Lentiviral Technology pCDH-MSCV-MCS-EF1-GFP cDNA Cloning and Expression Vector |
10 ug |
603-Eur |
SBI |
|
LVP439-PBS |
EF1a-Luciferase (firefly)-2A-RFP (Bsd), in vivo ready; premade lentiviral particles |
1x108 IFU/ml x 200ul |
808-Eur |
GenTarget |
|
ABP-RP-TLCIL6L |
Validated IL_6 Expression Lentiviral Particles (average 1x10^8TU_ml ) |
100ul x 5vial |
873-Eur |
Allele |
Viral System |
BLIV301PA-1 |
Bioluminescent Imaging Lentiviral Dual Reporter MSCV-GFP-T2A-Luciferase plasmid (10 ug) |
10 ug |
759-Eur |
SBI |
|
CD630A-1 |
Lentiviral Technology pCDH-UbC-MCS-IRES-GFP cDNA Cloning and Expression Vector |
10 ug |
618-Eur |
SBI |
|
ABP-RP-TLCIL6S |
Validated IL_6 Expression Lentiviral Particles (average 1x10^8TU_ml ) |
100ul x 1vial |
309-Eur |
Allele |
Viral System |
ABP-RP-TLCIL15S |
Validated IL_15 Expression Lentiviral Particles (average 1x10^8TU_ml ) |
100ul x 1vial |
309-Eur |
Allele |
Viral System |
LVP369-PBS |
Luciferase (Renilla), (RFP-Puro), in vivo ready; premade lentiviral particles |
5 x107 IFU/ml x 200ul |
808-Eur |
GenTarget |
|
LVP-stems-h-RB |
Full set (6 human stem factors-with RFP-Bsd marker); premade lentiviral particles |
200ul x 6 |
1186-Eur |
GenTarget |
|
ABP-RP-TLCIL3L |
Validated IL_3 Expression Lentiviral Particles (average 1x10^8TU_ml ) |
100ul x 5vial |
873-Eur |
Allele |
Viral System |
LVP572-PBS |
CAG-Luciferase (firefly)
(RFP-Puro), in vivo ready
, premade lentiviral particles |
5x107 IFU/ml x 200ul |
770-Eur |
GenTarget |
|
CD100A-1 |
Lentiviral Technology pCDF1-MCS1 cDNA Cloning and Expression Vector |
10 ug |
518-Eur |
SBI |
|
CD513B-1 |
Lentiviral Technology pCDH-CMV-MCS-EF1-GreenPuro cDNA Cloning and Expression Vector |
10 ug |
774-Eur |
SBI |
|
CD515B-1 |
Lentiviral Technology pCDH-CMV-MCS-EF1-Hygro cDNA Cloning and Expression Vector |
10 ug |
603-Eur |
SBI |
|
CD527A-1 |
Lentiviral Technology pCDH-EF1-MCS-T2A-Puro cDNA Cloning and Expression Vector 10 ug |
10 ug |
618-Eur |
SBI |
|
CD516B-2 |
Lentiviral Technology pCDH-CMV-MCS-EF1-RFP+Puro cDNA Cloning and Expression Vector |
10 ug |
603-Eur |
SBI |
|
ABP-RP-TLCRFPLOXL |
Validated RFP_loxP Expression Lentiviral Particles (average 1x10^8TU_ml ) |
100ul x 5vial |
938-Eur |
Allele |
Viral System |
ABP-RP-TLCGMCSFS |
Validated GM_CSF Expression Lentiviral Particles (average 1x10^8TU_ml ) |
100ul x 1vial |
309-Eur |
Allele |
Viral System |
CD523A-1 |
Lentiviral Technology pCDH-MCS-T2A-copGFP-MSCV Cloning and Expression Vector |
10 ug |
618-Eur |
SBI |
|
CD524A-1 |
Lentiviral Technology pCDH-CMV-MCS-t2A-copGFP cDNA Cloning and Expression Vector |
10 ug |
618-Eur |
SBI |
|
LVP371-PBS |
Luciferase (Renilla), (Puro), in vivo ready, premade lentiviral particles |
5 x107 IFU/ml x 200ul |
770-Eur |
GenTarget |
|
LVP462-PBS |
Luciferase (firefly)-
2A-GFP (RFP-Puro), in vivo ready, premade lentiviral particles |
5x107 IFU/ml x 200ul |
770-Eur |
GenTarget |
|
CD512VA-1 |
Lentiviral Technology pCDH-CMV-MCS-EF1-aRFP cDNA Clon_Exp Vector [pre-packaged] |
>1 x 10^6 IFUs |
759-Eur |
SBI |
|
LVP460-Bsd-PBS |
LoxP GFP_RFP ColorSwitch (Bsd) lentivirus (concentrated), premade lentiviral particles |
5x107 IFU/ml x 200ul |
933-Eur |
GenTarget |
|
LVP460-Neo-PBS |
LoxP GFP_RFP ColorSwitch (Neo) lentivirus (concentrated), premade lentiviral particles |
5x107 IFU/ml x 200ul |
933-Eur |
GenTarget |
|
CD501A-1 |
Lentiviral Technology pCDH-CMV-MCS2 cDNA Cloning and Expression Vector |
10 ug |
518-Eur |
SBI |
|
LVP324-PBS |
Luciferase (firefly)-2A-RFP (Puro), in vivo ready; premade lentiviral particles |
5x107 IFU/ml x 200ul |
808-Eur |
GenTarget |
|
ABP-RP-TLCRFPLOXS |
Validated RFP_loxP Expression Lentiviral Particles (average 1x10^8TU_ml ) |
100ul x 1vial |
342-Eur |
Allele |
Viral System |
LVP363-PBS |
Luciferase (Gaussia), (RFP-Puro), in vivo ready; premade lentiviral particles |
5 x107 IFU/ml x 200ul |
808-Eur |
GenTarget |
|
SI500A-1 |
Lentiviral Technology pSIH1-H1-Puro shRNA Cloning and Expression Vector |
10 ug |
540-Eur |
SBI |
|
CD530A-2 |
Lentiviral Technology pCDH-EF1-MCS-IRES-GFP cDNA Cloning and Expression Vector |
10 ug |
618-Eur |
SBI |
|
CD510B-1 |
Lentiviral Technology pCDH-CMV-MCS-EF1-Puro cDNA Cloning and Expression Vector |
10 ug |
603-Eur |
SBI |
|
ABP-RP-TLCIL2S |
Validated IL_2 Expression Lentiviral Particles (average 1x10^8TU_ml ) |
100ul x 1vial |
309-Eur |
Allele |
Viral System |
CD511B-1 |
Lentiviral Technology pCDH-CMV-MCS-EF1-copGFP cDNA Cloning and Expression Vector |
10 ug |
603-Eur |
SBI |
|
ABP-RP-TLCIL2L |
Validated IL_2 Expression Lentiviral Particles (average 1x10^8TU_ml ) |
100ul x 5vial |
873-Eur |
Allele |
Viral System |
LVP464-PBS |
EF1a-Luc (firefly)-
2A-GFP (RFP-Puro), in vivo ready, premade lentiviral particles |
5x107 IFU/ml x 200ul |
770-Eur |
GenTarget |
|
BLIV300PA-1 |
Bioluminescent Imaging Lentiviral Dual Reporter MSCV-RFP-T2A-Luciferase plasmid (10 ug) |
10 ug |
759-Eur |
SBI |
|
ABP-RP-TLCTREGFPL |
Validated TRE_GFP Expression Lentiviral Particles (average 1x10^8TU_ml ) |
100ul x 5vial |
938-Eur |
Allele |
Viral System |
TR104A-P |
Lentiviral Technology pGreenFire1-LXRE in ApoA1(HepG2 cell line) |
>2 x 10^6 cells |
3118-Eur |
SBI |
|
SI502A-1 |
Lentiviral Technology pSIH1-H1-H2Kk shRNA Cloning and Expression Vector |
10 ug |
540-Eur |
SBI |
|
TR105A-P |
Lentiviral Technology pGreenFire1-LXRE in Cyp7A1(HepG2 cell line) |
>2 x 10^6 cells |
3118-Eur |
SBI |
|
LVP435-PBS |
EF1a-Luciferase (firefly), (Neo), in vivo ready; premade lentiviral particles |
1x108 IFU/ml x 200ul |
808-Eur |
GenTarget |
|
SI501A-1 |
Lentiviral Technology pSIH1-H1-copGFP shRNA Cloning and Expression Vector |
10 ug |
540-Eur |
SBI |
|
TR106A-P |
Lentiviral Technology pGreenFire1-LXRE in ABCA1(HepG2 cell line) |
>2 x 10^6 cells |
3118-Eur |
SBI |
|
LVP436-PBS |
EF1a-Luciferase (firefly)-2A-GFP (Bsd), in vivo ready; premade lentiviral particles |
1x108 IFU/ml x 200ul |
808-Eur |
GenTarget |
|
TR107A-P |
Lentiviral Technology pGreenFire1-LXRE in ABCG1(HepG2 cell line) |
>2 x 10^6 cells |
3118-Eur |
SBI |
|
LVP-stems-m-RB |
Full set (6 mouse stem factors with RFP-Bsd marker), premade lentiviral particles |
200ul x 6 |
1130-Eur |
GenTarget |
|
ABP-RP-TLCTRERFPL |
Validated TRE_RFP Expression Lentiviral Particles (average 1x10^8TU_ml ) |
100ul x 5vial |
938-Eur |
Allele |
Viral System |
TR108A-P |
Lentiviral Technology pGreenFire1-LXRE in ApoE(HepG2 cell line) |
>2 x 10^6 cells |
3118-Eur |
SBI |
|
LVP438-PBS |
EF1a-Luciferase (firefly)-2A-GFP (Neo), in vivo ready; premade lentiviral particles |
1x108 IFU/ml x 200ul |
808-Eur |
GenTarget |
|
LVP570-PBS |
CAG-Luciferase (firefly)
(GFP-Puro), in vivo ready
, premade lentiviral particles |
5x107 IFU/ml x 200ul |
770-Eur |
GenTarget |
|
LVP441-PBS |
EF1a-Luciferase (firefly)-2A-RFP (Neo), in vivo ready, premade lentiviral particles |
5x107 IFU/ml x 200ul |
770-Eur |
GenTarget |
|
SI505VA-1 |
Lentiviral Technology pGreenPuro shRNA expression lentivector (CMV) [packaged virus] |
>1 x 10^6 IFUs |
678-Eur |
SBI |
|
TR102A-P |
Lentiviral Technology pGreenFire1-LXRE in LXR alpha (HepG2 cell line) |
>2 x 10^6 cells |
3118-Eur |
SBI |
|
LVP436-PBS |
EF1a-Luciferase (firefly)-2A-GFP (Bsd), in vivo ready, premade lentiviral particles |
5x107 IFU/ml x 200ul |
770-Eur |
GenTarget |
|
LVP435-PBS |
EF1a-Luciferase (firefly), (Neo), in vivo ready, premade lentiviral particles |
5x107 IFU/ml x 200ul |
770-Eur |
GenTarget |
|
ABP-RP-TLCIFNGS |
Validated IFN_g Expression Lentiviral Particles (average 1x10^8TU_ml ) |
100ul x 1vial |
309-Eur |
Allele |
Viral System |
LV600A-1 |
Lentiviral Technology pSIH1-copGFP Packaged Positive Transduction Control |
>1 x 10^6 IFUs |
678-Eur |
SBI |
|
ABP-RP-TLCGMCSFL |
Validated GM_CSF Expression Lentiviral Particles (average 1x10^8TU_ml ) |
100ul x 5vial |
873-Eur |
Allele |
Viral System |
LVP438-PBS |
EF1a-Luciferase (firefly)-2A-GFP (Neo), in vivo ready, premade lentiviral particles |
5x107 IFU/ml x 200ul |
770-Eur |
GenTarget |
|
ABP-RP-TLCTRERFPS |
Validated TRE_RFP Expression Lentiviral Particles (average 1x10^8TU_ml ) |
100ul x 1vial |
342-Eur |
Allele |
Viral System |
LVP433-PBS |
EF1a-Luciferase (firefly), (Bsd), in vivo ready, premade lentiviral particles |
5x107 IFU/ml x 200ul |
770-Eur |
GenTarget |
|
TR100A-P |
Lentiviral Technology pGreenFire1-LXRE in SREBP1c (HepG2 cell line) |
>2 x 10^6 cells |
3118-Eur |
SBI |
|
LVP439-PBS |
EF1a-Luciferase (firefly)-2A-RFP (Bsd), in vivo ready, premade lentiviral particles |
5x107 IFU/ml x 200ul |
770-Eur |
GenTarget |
|
ABP-RP-TLCGMCSFL |
Validated IFN_g Expression Lentiviral Particles (average 1x10^8TU_ml ) |
100ul x 5vial |
873-Eur |
Allele |
Viral System |
LVP433-PBS |
EF1a-Luciferase (firefly), (Bsd), in vivo ready; premade lentiviral particles |
1x108 IFU/ml x 200ul |
808-Eur |
GenTarget |
|
ABP-RP-TLCIL15L |
Validated IL_15 Expression Lentiviral Particles (average 1x10^8TU_ml ) |
100ul x 5vial |
873-Eur |
Allele |
Viral System |
TR109A-P |
Lentiviral Technology pGreenFire1-LXRE in CETP(HepG2 cell line) |
>2 x 10^6 cells |
3118-Eur |
SBI |
|
Product-In-Demand |
HiTiter™ Lentiviral Fluorescent Protein Controls with Drug Resistance |
5 vials |
----Eur |
Allele |
|
LVP369-PBS |
Luciferase (Renilla), (RFP-Puro), in vivo ready, premade lentiviral particles |
5 x107 IFU/ml x 200ul |
770-Eur |
GenTarget |
|
BLIV101VA-1 |
Bioluminescent Imaging Lentiviral Dual Reporter CMV-GFP-T2A-Luciferase pre-packaged virus |
>1 x10^6 IFUs |
759-Eur |
SBI |
|
ABP-RP-TLCTREGFPS |
Validated TRE_GFP Expression Lentiviral Particles (average 1x10^8TU_ml ) |
100ul x 1vial |
342-Eur |
Allele |
Viral System |
BLIV102VA-1 |
Bioluminescent Imaging Lentiviral Triple Reporter CMV-Luciferase-RFP-TK pre-packaged virus |
>1 x10^6 IFUs |
759-Eur |
SBI |
|
BLIV200VA-1 |
Bioluminescent Imaging Lentiviral Dual Reporter UBC-RFP-T2A-Luciferase pre-packaged virus |
>1 x10^6 IFUs |
759-Eur |
SBI |
|
BLIV100VA-1 |
Bioluminescent Imaging Lentiviral Dual Reporter CMV-RFP-T2A-Luciferase pre-packaged virus |
>1 x10^6 IFUs |
759-Eur |
SBI |
|
ABP-RP-TLCIL12L |
Validated IL_12 Expression Lentiviral Particles (average 1x10^8TU_ml ) |
100ul x 5vial |
873-Eur |
Allele |
Viral System |
ABP-RP-TLCLACZL |
Validated LacZ Expression Lentiviral Particles (average 1x10^8TU_ml ) |
100ul x 5vial |
873-Eur |
Allele |
Viral System |
ABP-RP-TLCLACZS |
Validated LacZ Expression Lentiviral Particles (average 1x10^8TU_ml ) |
100ul x 1vial |
309-Eur |
Allele |
Viral System |
BLIV201VA-1 |
Bioluminescent Imaging Lentiviral Dual Reporter UBC-GFP-T2A-Luciferase pre-packaged virus |
>1 x10^6 IFUs |
759-Eur |
SBI |
|
LVP371-PBS |
Luciferase (Renilla), (Puro), in vivo ready; premade lentiviral particles |
5 x107 IFU/ml x 200ul |
808-Eur |
GenTarget |
|
BLIV202VA-1 |
Bioluminescent Imaging Lentiviral Triple Reporter UBC-Luciferase-RFP-TK pre-packaged virus |
>1 x10^6 IFUs |
759-Eur |
SBI |
|
TR204a-p |
Lentiviral Technology pGF-EGR1-mCMV-EF1-Puro (293 stable cell line) |
>2 x 10^6 cells |
3118-Eur |
SBI |
|
TR202a-p |
Lentiviral Technology pGF-CREB-mCMV-EF1-Puro (293 stable cell line) |
>2 x 10^6 cells |
3118-Eur |
SBI |
|
LVP441-PBS |
EF1a-Luciferase (firefly)-2A-RFP (Neo), in vivo ready; premade lentiviral particles |
1x108 IFU/ml x 200ul |
808-Eur |
GenTarget |
|
ABP-RP-TLCIL12S |
Validated IL_12 Expression Lentiviral Particles (average 1x10^8TU_ml ) |
100ul x 1vial |
309-Eur |
Allele |
Viral System |
LVP377-PBS |
Luciferase (Cypridina), (Puro), in vivo ready; premade lentiviral particles |
5 x107 IFU/ml x 200ul |
808-Eur |
GenTarget |
|
SI101B-1 |
Lentiviral Technology pSIF1-H1-copGFP FIV siRNA Cloning and Expression Vector |
10 ug |
608-Eur |
SBI |
|
LVP567-PBS |
CAG-Luciferase (firefly)
(Puro), in vivo ready
, premade lentiviral particles |
5x107 IFU/ml x 200ul |
770-Eur |
GenTarget |
|
SI100C-1 |
Lentiviral Technology pSIF1-H1-Puro FIV siRNA Cloning and Expression Vector |
10 ug |
540-Eur |
SBI |
|
TR203a-p |
Lentiviral Technology pGF-SMAD2_3_4-mCMV-EF1-Puro (293 stable cell line) |
>2 x 10^6 cells |
3118-Eur |
SBI |
|
LVP375-PBS |
Luciferase (Cypridina), (RFP-Puro), in vivo ready; premade lentiviral particles |
5 x107 IFU/ml x 200ul |
808-Eur |
GenTarget |
|
TR200a-p |
Lentiviral Technology pGF-p53-mCMV-EF1-Puro (HT1080 stable cell line)) |
>2 x 10^6 cells |
3118-Eur |
SBI |
|
LVP-stems-h-RB |
Full set (6 human stem factors-with RFP-Bsd marker), premade lentiviral particles |
200ul x 6 |
1130-Eur |
GenTarget |
|
ABP-SC-RREX2R1 |
Validated Rex1 Promoter Reporter Lentiviral Particles (typically ~1x10^8TU_ml) |
1x10^7 TU each |
309-Eur |
Allele |
Viral System |
ABP-SC-ROCT4G5 |
Validated Oct_4 Promoter Reporter Lentiviral Particles (typically ~1x10^8TU_ml) |
5x(1x10^7 TU) |
807-Eur |
Allele |
Viral System |
ABP-SC-VILEOSN |
Virus Mix OSNL (Oct3_4, Sox2, Nanog and Lin28) LentiViral Particles Mix (10^9 TU_ml each) |
5 x 10µl |
2039-Eur |
Allele |
Viral System |
ABP-SC-RNANOG1 |
Validated Nanog Promoter Reporter Lentiviral Particles (typically ~1x10^8TU_ml) |
1x10^7 TU each |
309-Eur |
Allele |
Viral System |
ABP-SC-RNANOG5 |
Validated Nanog Promoter Reporter Lentiviral Particles (typically ~1x10^8TU_ml) |
5x(1x10^7 TU) |
807-Eur |
Allele |
Viral System |
ABP-SC-LVIOSKM |
Set OSKM (Oct3_4, Sox2, Klf4 and c_Myc) Lentiviral Particles Set (average 10^8TU_ml ) |
100ul each |
1136-Eur |
Allele |
Viral System |
ABP-SC-VILEOSK |
Virus Mix OSKM (Oct3_4, Sox2, Klf4 and c_Myc) Lentiviral Particles Mix (10^9 TU_ml each) |
5 x 10µl |
2039-Eur |
Allele |
Viral System |
ABP-SC-ROCT4G1 |
Validated Oct_4 Promoter Reporter Lentiviral Particles (typically ~1x10^8TU_ml) |
1x10^7 TU each |
309-Eur |
Allele |
Viral System |
ABP-SC-LVIOSNL |
Set OSNL (Oct3_4, Sox2, Nanog and Lin28) LentiViral Particles Set ( average 10^8TU_ml) |
100ul each |
1136-Eur |
Allele |
Viral System |
ABP-SC-RREXR5 |
Validated Rex1 Promoter Reporter Lentiviral Particles (typically ~1x10^8TU_ml) |
5x(1x10^7 TU) |
807-Eur |
Allele |
Viral System |
LVP440-PBS |
EF1a-Luciferase (firefly)-2A-RFP (Puro), in vivo ready, premade lentiviral particles |
5x10e7 IFU/ml x 200ul |
770-Eur |
GenTarget |
|
CD731B-1 |
Lentiviral Technology pCDH-MSCV-MCS-IRES-GFP cDNA Cloning and Expression Vector |
10 ug |
618-Eur |
SBI |
|
LVP434-PBS |
EF1a-Luciferase (firefly), (Puro), in vivo ready; premade lentiviral particles |
1x108 IFU/ml x 200ul |
808-Eur |
GenTarget |
|
BLIV302VA-1 |
Bioluminescent Imaging Lentiviral Triple Reporter MSCV-Luciferase-RFP-TK pre-packaged virus |
>1 x10^6 IFUs |
759-Eur |
SBI |
|
CD710B-1 |
Lentiviral Technology pCDH-MSCV-MCS-EF1-Puro cDNA Cloning and Expression Vector |
10 ug |
603-Eur |
SBI |
|
CD532A-2 |
Lentiviral Technology pCDH-EF1-MCS-IRES-Puro cDNA Cloning and Expression Vector |
10 ug |
618-Eur |
SBI |
|
CD522A-1 |
Lentiviral Technology pCDH-MCS-T2A-Puro-MSCV cDNA Cloning and Expression Vector |
10 ug |
618-Eur |
SBI |
|
CD511VB-1 |
Lentiviral Technology pCDH-CMV-MCS-EF1-copGFP cDNA Clon_Exp Vector [pre-packaged virus] |
>1 x 10^6 IFUs |
759-Eur |
SBI |
|
CD111B-1 |
Lentiviral Technology pCDF1-MCS2-EF1-copGFP cDNA Cloning and Expression Vector |
10 ug |
603-Eur |
SBI |
|
LVP-stems-h-N |
Full set (6 human stem factors-with Neomycin marker); premade lentiviral particles |
200ul x 6 |
1186-Eur |
GenTarget |
|
CD110B-1 |
Lentiviral Technology pCDF1-MCS2-EF1-Puro cDNA Cloning and Expression Lentivector |
10 ug |
603-Eur |
SBI |
|
BLIV301VA-1 |
Bioluminescent Imaging Lentiviral Dual Reporter MSCV-GFP-Luciferase pre-packaged virus |
>1 x10^6 IFUs |
759-Eur |
SBI |
|
BLIV300VA-1 |
Bioluminescent Imaging Lentiviral Dual Reporter MSCV-RFP-Luciferase pre-packaged virus |
>1 x10^6 IFUs |
759-Eur |
SBI |
|
LVP440-PBS |
EF1a-Luciferase (firefly)-2A-RFP (Puro), in vivo ready; premade lentiviral particles |
1x108 IFU/ml x 200ul |
808-Eur |
GenTarget |
|
LVP437-PBS |
EF1a-Luciferase (firefly)-2A-GFP (Puro), in vivo ready; premade lentiviral particles |
1x108 IFU/ml x 200ul |
808-Eur |
GenTarget |
|
LVP-stems-m-N |
Full set (6 mouse stem factors with Neomycin marker); premade lentiviral particles |
200ul x 6 |
1186-Eur |
GenTarget |
|
LVP434-PBS |
EF1a-Luciferase (firefly), (Puro), in vivo ready, premade lentiviral particles |
5x107 IFU/ml x 200ul |
770-Eur |
GenTarget |
|
LVP437-PBS |
EF1a-Luciferase (firefly)-2A-GFP (Puro), in vivo ready, premade lentiviral particles |
5x107 IFU/ml x 200ul |
770-Eur |
GenTarget |
|
LV601B-1 |
Lentiviral Technology pSIH1-H1-siLuc-copGFP Packaged Positive Transduction Control |
>1 x 10^6 IFUs |
678-Eur |
SBI |
|
LV601PB-1 |
Lentiviral Technology pSIH1-H1-siLuc-copGFP positive transduction control, plasmid |
10 ug |
595-Eur |
SBI |
|
LVP-stems-h-N |
Full set (6 human stem factors-with Neomycin marker), premade lentiviral particles |
200ul x 6 |
1130-Eur |
GenTarget |
|
TR011PA-1 |
Lentiviral Technology pGreenFire1-CMV Plasmid (pTRH1 CMV dscGFP T2A Fluc, positive control) |
10 ug |
618-Eur |
SBI |
|
Product-In-Demand |
HiTiter™Lentiviral Fluorescent Protein Controls (Driven by Other Common Promoters) |
5 vials |
----Eur |
Allele |
|
SI111A-1 |
Lentiviral Technology pFIV-H1_U6-copGFP siRNA Cloning and Expression Vector |
10 ug |
608-Eur |
SBI |
|
SI110A-1 |
Lentiviral Technology pFIV-H1_U6-Puro siRNA Cloning and Expression Vector |
10 ug |
540-Eur |
SBI |
|
ABP-SC-LEIOSKM |
Set OSKM (Oct3_1, Sox2, Klf4 and c_Myc) Lentiviral Particles Set (average 10^8TU_ml ) |
100ul each |
1136-Eur |
Allele |
Viral System |
QMSH810A-1 |
Lentiviral Technology pCDH-CuO(H1)-MCS-IRES-GFP-EF1-CymR-T2A-Puro All-in-one inducible shRNA lentivector |
10 ug |
1655-Eur |
SBI |
|
CD713B-1 |
Lentiviral Technology pCDH-MSCV-MCS-EF1-GFP+Puro cDNA Cloning and Expression Vector |
10 ug |
603-Eur |
SBI |
|
LV201PB-1 |
Lentiviral Technology pSIF1-H1-siLuc-copGFP Positive Transduction Control (plasmid) |
10 ug |
595-Eur |
SBI |
|
ABP-SC-LEIOSNL |
Set OSNL (Oct3_4, Sox2, Nanog and Lin28) LentiViral Particles Set ( average 10^8TU_ml) |
100ul each |
1136-Eur |
Allele |
Viral System |
LVP-stems-m-N |
Full set (6 mouse stem factors with Neomycin marker), premade lentiviral particles |
200ul x 6 |
1130-Eur |
GenTarget |
|
ABP-SC-LEIOSKMP |
Set OSKMP (Oct3_1, Sox2, Klf4, c_Myc and p53 shRNA) Lentiviral Particles Set (average 10^8TU_ml ) |
100ul each |
1384-Eur |
Allele |
rna |
SC018-Neo |
Color Switch, CRE report cell line: HEK293-loxP-GFP-RFP Neo) , premade lentiviral particles |
2x10E6 cell/ml x1ml |
3336-Eur |
GenTarget |
|
ABP-SC-LVIOSKMP |
Set OSKMP (Oct3_4, Sox2, Klf4, c_Myc and p53 shRNA) Lentiviral Particles Set (average 10^8TU_ml ) |
100ul each |
1384-Eur |
Allele |
rna |
ABP-SC-LVIOSNLP |
Set OSNLP (Oct3_4, Sox2, Nanog, Lin28 and p53 shRNA) LentiViral Particles Set ( average 10^8TU_ml) |
100ul each |
1384-Eur |
Allele |
rna |
LV201B-1 |
Lentiviral Technology pSIF1-H1-siLuc-copGFP Positive Transduction Control (pre-packaged virus) |
>1 x 10^6 IFUs |
678-Eur |
SBI |
|
SC018-Bsd |
Color Switch, CRE report cell line: HEK293-loxP-GFP-RFP (Bsd) , premade lentiviral particles |
2x10E6 cell/ml x1ml |
3336-Eur |
GenTarget |
|
ABP-SC-LEIOSNLP |
Set OSNLP (Oct3_4, Sox2, Nanog, Lin28 and p53 shRNA) LentiViral Particles Set ( average 10^8TU_ml) |
100ul each |
1384-Eur |
Allele |
rna |
ABP-SC-LEIOSNLPT |
Set OSNLPH (Oct3_4, Sox2, Nanog, Lin28, Tert and p53 shRNA) LentiViral Particles Set ( average 10^8TU_ml) |
100ul each |
1666-Eur |
Allele |
rna |
QMSH812A-1 |
Lentiviral Technology PB-Cuo-shMCS-IRES-GFP-EF1-CymR-Puro Inducible shRNA Cloning and Expression Vector |
10 ug |
1033-Eur |
SBI |
|
ABP-SC-LEVIOSKMPT |
Set OSKMPH (Oct3_1, Sox2, Klf4, c_Myc, Tert and p53 shRNA) Lentiviral Particles Set (average 10^8TU_ml ) |
100ul each |
1666-Eur |
Allele |
rna |
ABP-SC-LVIOSKMPT |
Set OSKMPH (Oct3_4, Sox2, Klf4, c_Myc, Tert and p53 shRNA) Lentiviral Particles Set (average 10^8TU_ml ) |
100ul each |
1666-Eur |
Allele |
rna |
ABP-SC-LVIOSNLPT |
Set OSNLPH (Oct3_4, Sox2, Nanog, Lin28, Tert and p53 shRNA) LentiViral Particles Set ( average 10^8TU_ml) |
100ul each |
1666-Eur |
Allele |
rna |
LV401A-1 |
Lentiviral Technology HIV & FIV Positive Transduction Control Virus Sampler Kit [pSIF1- and pSIH-H1-siLuc-copGFP lentiviruses] |
>1 x 10^6 IFUs of each |
678-Eur |
SBI |
|
CD511VB-UHT |
Lentiviral Technology pCDH-CMV-MCS-EF1-copGFP cDNA Clon_Exp Vector [pre-packaged Ultra-High Titer virus] |
>1x10^9 IFUs |
1004-Eur |
SBI |
|
LVP013 |
CRE-2A-RFP (Bsd), CMV lentivirus: Pre-made lentiviral particles bicistronically express individual nuclear permeable CRE recombinase and the RFP marker under the same suCMV promoter. A Blasticidin mar |
1x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP336 |
CRE (Bsd), CMV lentivirus: Pre-made lentiviral particles expressing nuclear permeable CRE recombinase with Blasticidin marker, provided in DMEM medium with 10 percent FBS. |
1x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP297 |
CRE (Neo), CMV lentivirus: Pre-made lentiviral particles expressing nuclear permeable CRE recombinase with Neomycin marker, provided in DMEM medium with 10 percent FBS. |
1x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP337 |
CRE-2A-GFP (Bsd), CMV lentivirus: Pre-made lentiviral particles bicistronically express individual nuclear permeable CRE recombinase and the GFP marker under the same suCMV promoter. A Blasticidin mar |
1x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
ABP-SC-ESRKIT5 |
Allele Validated Pluripotency Promoter Reporter Lentiviral Particles Panel (Nanog, Oct_4, Rex1, typically ~1x10^8TU_ml) |
5x(1x10^7 TU) |
1924-Eur |
Allele |
Viral System |
ABP-SC-ESRKIT1 |
Allele Validated Pluripotency Promoter Reporter Lentiviral Particles Panel (Nanog, Oct_4, Rex1, typically ~1x10^8TU_ml) |
1x10^7 TU each |
683-Eur |
Allele |
Viral System |
LVP339 |
CRE (Puro), CMV lentivirus: Pre-made lentiviral particles expressing nuclear permeable CRE recombinase with Puromycin marker, provided in DMEM medium with 10 percent FBS. |
1x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
BLIV510PA-1 |
Lentiviral Dual Promoter, Dual Reporter: CMV-Luciferase-EF1-Puro Plasmid (10 ug) |
10 ug |
751-Eur |
SBI |
|
LVP557-Puro |
SV40 large T-antigen (Puro), EF1a lentiviral particles |
1x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
H1(shRNA-Ctr)-Puro |
shRNA-H1 (Neg)-(Puromycin) lentivirus, premade lentiviral particles |
1 x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
QM530A-2 |
Lentiviral Technology pCDH-CuO-MCS-IRES-GFP co-inducible IRES lentivector |
10 ug |
644-Eur |
SBI |
|
QM530A-1 |
Lentiviral Technology pCDH-CuO-MCS-IRES-GFP co-inducible IRES lentivector |
10 ug |
869-Eur |
SBI |
|
QM531A-2 |
Lentiviral Technology pCDH-CuO-MCS-IRES-RFP co-inducible IRES lentivector |
10 ug |
644-Eur |
SBI |
|
LVP359-Puro |
Chained mouse iPS (MKOS) (RFP-Puro) lentiviral particles |
1x106 IFU/ml x 0.5 ml |
1130-Eur |
GenTarget |
|
LVP358-Puro |
Chained human iPS (MKOS) (RFP-Puro) lentiviral particles |
1x106 IFU/ml x 0.5 ml |
1130-Eur |
GenTarget |
|
LV961A-UCR1 |
Lentiviral Technology Forward and Reverse UCR1 Primer Mix 5 μM |
50 ul |
166-Eur |
SBI |
|
LVP016-Puro |
SV40 large T-antigen (Puro), CMV lentiviral particles |
1x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP460-Puro |
LoxP GFP_RFP ColorSwitch (Puro) lentivirus, premade lentiviral particles |
1x107 IFU/ml x 200ul |
770-Eur |
GenTarget |
|
QM812B-1 |
Lentiviral Technology pCDH-CuO-MCS-IRES-GFP-EF1-CymR-T2A-Puro All-in-one inducible IRES lentivector |
10 ug |
1230-Eur |
SBI |
|
QM513B-1 |
Lentiviral Technology pCDH-CuO-MCS-EF1-GFP+Puro dual promoter and dual marker lentivector |
10 ug |
644-Eur |
SBI |
|
QM516B-2 |
Lentiviral Technology pCDH-CuO-MCS-EF1-RFP+Puro dual promoter and dual marker lentivector |
10 ug |
644-Eur |
SBI |
|
TR010VA-N |
Lentiviral Technology pGreenFire1-mCMV Virus (pTRH1 mCMV dscGFP T2A Fluc) + EF1-Neo |
>2 x 10^6 IFUs |
759-Eur |
SBI |
|
HT-pack |
Lentivirus packaging plasmids: Lentiviral packaging plasmid mixture for expresion of gag⁄pol, rev and VSVG. |
600ng/ul x 100ul |
600-Eur |
GenTarget |
|
TR010VA-1 |
Lentiviral Technology pGreenFire1-mCMV Virus (pTRH1 mCMV dscGFP T2A Fluc) |
>2 x 10^6 IFUs |
759-Eur |
SBI |
|
QM810A-1 |
Lentiviral Technology pCDH-CuO-MCS-IRES-GFP-EF1-CymR-T2A-Puro All-in-one inducible IRES lentivector |
10 ug |
1702-Eur |
SBI |
|
QM812A-1 |
Lentiviral Technology pCDH-CuO-MCS-IRES-GFP-EF1-CymR-T2A-Puro All-in-one inducible IRES lentivector |
10 ug |
1675-Eur |
SBI |
|
TR010VA-P |
Lentiviral Technology pGreenFire1-mCMV Virus (pTRH1 mCMV dscGFP T2A Fluc) + EF1-Puro |
>2 x 10^6 IFUs |
759-Eur |
SBI |
|
LVP460-Puro-PBS |
LoxP GFP_RFP ColorSwitch (Puro) lentivirus (concentrated), premade lentiviral particles |
5x107 IFU/ml x 200ul |
933-Eur |
GenTarget |
|
BLIV510PA-1 |
Bioluminescent Imaging Lentiviral Dual Promoter, Dual Reporter CMV-Luciferase-EF1-Puro Plasmid (10 ug) |
10 ug |
759-Eur |
SBI |
|
LVP316 |
h KLF4 (Neo) inducible particles, premade lentiviral particles |
1x10e7 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP459-PBS-RFP-Puro |
EF1a-TetR (RFP-Puro) Lentiviral particles |
5x107 IFU/ml x 200ul |
552-Eur |
GenTarget |
|
LVP312m |
m Sox2 (Neo) inducible particles ; premade lentiviral particles |
1x108 IFU/ml x 200ul |
400-Eur |
GenTarget |
|
LVP311m |
m OCT4 (Neo) inducible particles ; premade lentiviral particles |
1x108 IFU/ml x 200ul |
400-Eur |
GenTarget |
|
LVP316 |
h KLF4 (Neo) inducible particles; premade lentiviral particles |
1x108 IFU/ml x 200ul |
400-Eur |
GenTarget |
|
LVP459-Puro |
EF1a-TetR (Puro) Lentiviral particles |
1x107 IFU/ml x 200ul |
441-Eur |
GenTarget |
|
LVP003 |
h OCT4 (RFP-Bsd) inducible particles; premade lentiviral particles |
1x108 IFU/ml x 200ul |
400-Eur |
GenTarget |
|
LVP003m |
m OCT4 (RFP-Bsd) inducible particles ; premade lentiviral particles |
1x108 IFU/ml x 200ul |
400-Eur |
GenTarget |
|
LVP313 |
h NANOG (Neo) inducible particles, premade lentiviral particles |
1x10e7 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP004m |
m Sox2 (RFP-Bsd) inducible particles ; premade lentiviral particles |
1x108 IFU/ml x 200ul |
400-Eur |
GenTarget |
|
LVP459-Puro-PBS |
EF1a-TetR (Puro) Lentiviral particles |
5x107 IFU/ml x 200ul |
552-Eur |
GenTarget |
|
EF1a-Null-RP-PBS |
EF1a Control lentiviral particles (RFP-Puro) in PBS |
1 x108 IFU/ml x 200ul |
770-Eur |
GenTarget |
|
LVP459-PBS-Puro |
EF1a-TetR (Puro) Lentiviral particles |
5x107 IFU/ml x 200ul |
552-Eur |
GenTarget |
|
LVP008 |
h KLF4 (RFP-Bsd) inducible particles; premade lentiviral particles |
1x108 IFU/ml x 200ul |
400-Eur |
GenTarget |
|
LVP316m |
m KLF4 (Neo) inducible particles; premade lentiviral particles |
1x108 IFU/ml x 200ul |
400-Eur |
GenTarget |
|
LVP314m |
m LIN28 (Neo) inducible particles ; premade lentiviral particles |
1x108 IFU/ml x 200ul |
400-Eur |
GenTarget |
|
LVP311 |
h OCT4 (Neo) inducible particles, premade lentiviral particles |
1x10e7 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP312 |
h SOX2 (Neo) inducible particles, premade lentiviral particles |
1x10e7 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP314 |
h LIN28 (Neo) inducible particles, premade lentiviral particles |
1x10e7 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
H1(shRNA-Ctr)-RP |
shRNA-H1(Neg)-( RFP-Puro) lentivirus, premade lentiviral particles |
1 x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP311m |
m OCT4 (Neo) inducible particles , premade lentiviral particles |
1x10e7 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP312m |
m Sox2 (Neo) inducible particles , premade lentiviral particles |
1x10e7 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP313m |
m NANOG (Neo) inducible particles , premade lentiviral particles |
1x10e7 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP314m |
m LIN28 (Neo) inducible particles , premade lentiviral particles |
1x10e7 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP004 |
h SOX2 (RFP-Bsd) inducible particles; premade lentiviral particles |
1x108 IFU/ml x 200ul |
400-Eur |
GenTarget |
|
LVP316m |
m KLF4 (Neo) inducible particles, premade lentiviral particles |
1x10e7 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
EF1a-Null-GP-PBS |
EF1a Control lentiviral particles (GFP-Puro) in PBS |
1 x108 IFU/ml x 200ul |
770-Eur |
GenTarget |
|
LVP008m |
m Klf4 (RFP-Bsd) inducible particles , premade lentiviral particles |
1x10e7 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP005m |
m NANOG (RFP-Bsd) inducible particles , premade lentiviral particles |
1x10e7 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP005 |
h NANOG (RFP-Bsd) inducible particles, premade lentiviral particles |
1x10e7 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP008m |
m Klf4 (RFP-Bsd) inducible particles ; premade lentiviral particles |
1x108 IFU/ml x 200ul |
400-Eur |
GenTarget |
|
LVP004 |
h SOX2 (RFP-Bsd) inducible particles, premade lentiviral particles |
1x10e7 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP005m |
m NANOG (RFP-Bsd) inducible particles ; premade lentiviral particles |
1x108 IFU/ml x 200ul |
400-Eur |
GenTarget |
|
LVP006 |
h LIN28 (RFP-Bsd) inducible particles; premade lentiviral particles |
1x108 IFU/ml x 200ul |
400-Eur |
GenTarget |
|
LVP313m |
m NANOG (Neo) inducible particles ; premade lentiviral particles |
1x108 IFU/ml x 200ul |
400-Eur |
GenTarget |
|
LVP006m |
m LIN28 (RFP-Bsd) inducible particles ; premade lentiviral particles |
1x108 IFU/ml x 200ul |
400-Eur |
GenTarget |
|
LVP003m |
m OCT4 (RFP-Bsd) inducible particles , premade lentiviral particles |
1x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP003 |
h OCT4 (RFP-Bsd) inducible particles, premade lentiviral particles |
1x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
H1(shRNA-Ctr)-Bsd |
shRNA-H1 (Neg)-(blasticidin) lentivirus, premade lentiviral particles |
1 x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
H1(shRNA-Ctr)-GP |
shRNA-H1 (Neg)-( GFP-Puro) lentivirus, premade lentiviral particles |
1 x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP459-RFP-Puro |
EF1a-TetR (RFP-Puro) Lentiviral particles |
1x107 IFU/ml x 200ul |
441-Eur |
GenTarget |
|
LVP007 |
h cMyc (RFP-Bsd) inducible particles; premade lentiviral particles |
1x108 IFU/ml x 200ul |
400-Eur |
GenTarget |
|
EF1a-Null-GP |
EF1a Control lentiviral particles (GFP-Puro) |
1 x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP006 |
h LIN28 (RFP-Bsd) inducible particles, premade lentiviral particles |
1x10e7 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
EF1a-Null-RP |
EF1a Control lentiviral particles (RFP-Puro) |
1 x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP007 |
h cMyc (RFP-Bsd) inducible particles, premade lentiviral particles |
1x10e7 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP314 |
h LIN28 (Neo) inducible particles; premade lentiviral particles |
1x108 IFU/ml x 200ul |
400-Eur |
GenTarget |
|
LVP004m |
m Sox2 (RFP-Bsd) inducible particles , premade lentiviral particles |
1x10e7 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP313 |
h NANOG (Neo) inducible particles; premade lentiviral particles |
1x108 IFU/ml x 200ul |
400-Eur |
GenTarget |
|
LVP312 |
h SOX2 (Neo) inducible particles; premade lentiviral particles |
1x108 IFU/ml x 200ul |
400-Eur |
GenTarget |
|
LVP006m |
m LIN28 (RFP-Bsd) inducible particles , premade lentiviral particles |
1x10e7 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP008 |
h KLF4 (RFP-Bsd) inducible particles, premade lentiviral particles |
1x10e7 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP311 |
h OCT4 (Neo) inducible particles; premade lentiviral particles |
1x108 IFU/ml x 200ul |
400-Eur |
GenTarget |
|
LVP005 |
h NANOG (RFP-Bsd) inducible particles; premade lentiviral particles |
1x108 IFU/ml x 200ul |
400-Eur |
GenTarget |
|
LVP338 |
CRE-2A-RFP (Puro), CMV lentivirus: Pre-made lentiviral particles bicistronically express individual nuclear permeable CRE recombinase and the RFP marker under the same suCMV promoter. A Puromycin mark |
1x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP407 |
CRE-2A-GFP (Puro), CMV lentivirus: Pre-made lentiviral particles bicistronically express individual nuclear permeable CRE recombinase and the GFP marker under the same suCMV promoter. A Puromycin mark |
1x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
TR010PA-1 |
Lentiviral Technology pGreenFire1-mCMV Plasmid (pTRH1 mCMV dscGFP T2A Fluc, negative control) |
10 ug |
618-Eur |
SBI |
|
TR010PA-N |
Lentiviral Technology pGreenFire1-mCMV Plasmid (pTRH1 mCMV dscGFP T2A Fluc, negative control)+ EF1-Neo |
10 ug |
618-Eur |
SBI |
|
LVP-stems-h-EF1a |
Full set (6 human stem factors expressed under EF1a promoter); premade lentiviral particles |
200ul x 6 |
1186-Eur |
GenTarget |
|
TR010PA-P |
Lentiviral Technology pGreenFire1-mCMV Plasmid (pTRH1 mCMV dscGFP T2A Fluc, negative control)+ EF1-Puro |
10 ug |
618-Eur |
SBI |
|
SC018-Puro |
Color Switch, CRE report cell line: HEK293-loxP-GFP-RFP (Puro) , premade lentiviral particles |
2x10E6 cell/ml x1ml |
3336-Eur |
GenTarget |
|
LVP017-Puro-PBS |
CMV-TetR (Puro) Lentiviral particles |
5x107 IFU/ml x 200ul |
552-Eur |
GenTarget |
|
LVP017-Hygro-PBS |
CMV-TetR (Hygro) Lentiviral particles |
5x107 IFU/ml x 200ul |
552-Eur |
GenTarget |
|
LVP400-Puro |
rtTA (Puro) , Lentiviral particles |
1x107 IFU/ml x 200ul |
441-Eur |
GenTarget |
|
LVP007m |
m Myc (RFP-Bsd) inducible particles , premade lentiviral particles |
1x10e7 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP400-Puro-PBS |
rtTA (Puro) in PBS, Lentiviral particles |
5x107 IFU/ml x 200ul |
552-Eur |
GenTarget |
|
LVP315 |
h Myc (Neo) inducible particles, premade lentiviral particles |
1x10e7 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
EF1a-Null-Neo-PBS |
EF1a Control lentiviral particles (Neo) in PBS |
1 x108 IFU/ml x 200ul |
770-Eur |
GenTarget |
|
EF1a-Null-GB-PBS |
EF1a Control lentiviral particles (GFP-Bsd) in PBS |
1 x108 IFU/ml x 200ul |
770-Eur |
GenTarget |
|
CMV-Null-Puro |
CMV Control lentiviral particles (Puro) |
1 x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
H1(shRNA-Ctr)-GB |
shRNA-H1 (Neg)-( GFP-Bsd) lentivirus, premade lentiviral particles |
1 x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
EF1a-Null-RB-PBS |
EF1a Control lentiviral particles (RFP-Bsd) in PBS |
1 x108 IFU/ml x 200ul |
770-Eur |
GenTarget |
|
LVP315m |
m Myc (Neo) inducible particles , premade lentiviral particles |
1x10e7 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
H1(shRNA-Ctr)-RB |
shRNA-H1 (Neg)-( RFP-Bsd) lentivirus, premade lentiviral particles |
1 x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP007m |
m Myc (RFP-Bsd) inducible particles ; premade lentiviral particles |
1x108 IFU/ml x 200ul |
400-Eur |
GenTarget |
|
LVP017-Puro |
CMV-TetR (Puro) Lentiviral particles |
1x107 IFU/ml x 200ul |
441-Eur |
GenTarget |
|
LVP315m |
m Myc (Neo) inducible particles ; premade lentiviral particles |
1x108 IFU/ml x 200ul |
400-Eur |
GenTarget |
|
LVP335-Puro |
β-Lactamase (Puro) lentiviral particles |
1x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
EF1a-Null-Neo |
EF1a Control lentiviral particles (Neo) |
1 x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP017-Hygro |
CMV-TetR (Hygro) Lentiviral particles |
1x107 IFU/ml x 200ul |
441-Eur |
GenTarget |
|
EF1a-Null-GB |
EF1a Control lentiviral particles (GFP-Bsd) |
1 x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
EF1a-Null-Bsd |
EF1a Control lentiviral particles (Bsd) |
1 x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
EF1a-Null-RB |
EF1a Control lentiviral particles (RFP-Bsd) |
1 x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP315 |
h Myc (Neo) inducible particles; premade lentiviral particles |
1x108 IFU/ml x 200ul |
400-Eur |
GenTarget |
|
CMV-Null-Puro-PBS |
CMV Control lentiviral particles (Puro) in PBS |
1 x108 IFU/ml x 200ul |
770-Eur |
GenTarget |
|
EF1a-Null-Bsd-PBS |
EF1a Control lentiviral particles (Bsd) in PBS |
1 x108 IFU/ml x 200ul |
770-Eur |
GenTarget |
|
LVP-stems-h-EF1a-RP |
Full set (6 human stem factors expressed under EF1a promoter with RFP-puromycin marker), premade lentiviral particles |
200ul x 6 |
1130-Eur |
GenTarget |
|
LVP-stems-h-EF1a-puro |
Full set (6 human stem factors expressed under EF1a promoter with puromycin marker), premade lentiviral particles |
200ul x 6 |
1130-Eur |
GenTarget |
|
LVP392 |
h EDNRB: Pre-made inducible lentiviral particles for expressing human EDNRB with ORF sequence 100 percent matching to CDS region in NCBI ID: NM_000115.3. |
1 x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP027 |
CRE-2A-RFP (Neo), CMV lentivirus: Pre-made lentiviral particles bicistronically express individual nuclear permeable CRE recombinase and the RFP marker under the same suCMV promoter. A Neomycin marker |
1x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP408 |
CRE-2A-GFP (Neo), CMV lentivirus: Pre-made lentiviral particles bicistronically express individual nuclear permeable CRE recombinase and the GFP marker under the same suCMV promoter. A Neomycin marker |
1x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
28-182 |
PSIP1 encodes a multidomain adaptor protein that interacts with the nuclear import apparatus, lentiviral IN proteins and chromatin by means of an NLS, an IBD and additional chromatin-interacting domai |
0.1 mg |
595-Eur |
Prosci |
rat |
28-153 |
PSIP1 encodes a multidomain adaptor protein that interacts with the nuclear import apparatus, lentiviral IN proteins and chromatin by means of an NLS, an IBD and additional chromatin-interacting domai |
0.05 mg |
759-Eur |
Prosci |
rat |
LVP393 |
h CTNNB1: Pre-made inducible lentiviral particles for expressing human CTNNB1 with ORF sequence 100 percent matching to CDS region in NCBI ID: NM_001904.3. It also contains a RFP-Blasticidin fusion d |
1 x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP400 |
h MSH3: Pre-made inducible lentiviral particles for expressing human target: h MSH3 (alternative name: DUP; MRP1), with ORF sequence 100 percent matching to CDS region in NCBI ID: NM_002439.3. |
1 x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP519 |
CRE (Bsd), EF1a lentivirus: Pre-made lentiviral particles expressing nuclear permeable CRE recombinase under EF1a promoter with Blasticidin marker, provided in DMEM medium with 10 percent FBS. |
1x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP521 |
CRE (Neo), EF1a lentivirus: Pre-made lentiviral particles expressing nuclear permeable CRE recombinase under EF1a promoter with Neomycin marker, provided in DMEM medium with 10 percent FBS. |
1x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
H1(shRNA-Ctr)-GB |
shRNA-H1 (Neg)-( GFP-Bsd) lentivirus: Pre-made optional inducible lentiviral shRNA expression particles containing a hairpin insert that should not knockdown any known human or mouse gene. This non-ta |
1 x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
H1(shRNA-Ctr)-RB |
shRNA-H1 (Neg)-( RFP-Bsd) lentivirus: Pre-made optional inducible lentiviral shRNA expression particles containing a hairpin insert that should not knockdown any known human or mouse gene. This non-ta |
1 x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP520 |
CRE (Puro), EF1a lentivirus: Pre-made lentiviral particles expressing nuclear permeable CRE recombinase under EF1a promoter with Puromycin marker, provided in DMEM medium with 10 percent FBS. |
1x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP401 |
h ROR2: Pre-made inducible lentiviral particles for expressing human target: h ROR2 (alternative name: BDB; BDB1; NTRKR2), with ORF sequence 100 percent matching to CDS region in NCBI ID: NM_004560.3 |
1 x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP529 |
SLC2A10: Pre-made optional inducible lentiviral particles for expressing human target: SLC2A10 (alternative name: ATS, GLUT10). The sub-cloned codon sequence is identical (100 percent match) to CDS r |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
H1(shRNA-Ctr)-GP |
shRNA-H1 (Neg)-( GFP-Puro) lentivirus: Pre-made optional inducible lentiviral shRNA expression particles containing a hairpin insert that should not knockdown any known human or mouse gene. This non-t |
1 x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
H1(shRNA-Ctr)-Bsd |
shRNA-H1 (Neg)-(blasticidin) lentivirus: Pre-made optional inducible lentiviral shRNA expression particles containing a hairpin insert that should not knockdown any known human or mouse gene. This non |
1 x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
H1(shRNA-Ctr)-RP |
shRNA-H1(Neg)-( RFP-Puro) lentivirus: Pre-made optional inducible lentiviral shRNA expression particles containing a hairpin insert that should not knockdown any known human or mouse gene. This non-ta |
1 x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP530 |
m Gulo: Pre-made optional inducible lentiviral particles for expressing mouse target: m Gulo (alternative name: 5730581M22, AU018375, BC028822, sfx, unh, unhip). The sub-cloned codon sequence is iden |
1x107 IFU/ml x 200ul |
490-Eur |
GenTarget |
|
LVP359 |
Chained mouse iPS (OKSM) inducible lentiviral particles: prmade lentivirus from single vector for iPS cell generation, expressing four mouse iPS factor, c-Myc, Klf4, Oct4 and Sox2 under a Tetracycline |
1x106 IFU/ml x 1.0 ml |
1130-Eur |
GenTarget |
|
LVP358 |
Chained human iPS (OKSM) inducible lentiviral particles: prmade lentivirus from single vector for iPS cell generation, expressing four human iPS factor, c-Myc, Klf4, Oct4 and Sox2 under a Tetracycline |
1x106 IFU/ml x 1.0 ml |
1130-Eur |
GenTarget |
|
H1(shRNA-Ctr)-Puro |
shRNA-H1 (Neg)-(Puromycin) lentivirus: Pre-made optional inducible lentiviral shRNA expression particles containing a hairpin insert that should not knockdown any known human or mouse gene. This non-t |
1 x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
TR000PA-1 |
Lentiviral Technology pGreenFire Control Pack- pGreenFire negative and positive control plasmids, only available with purchase of other pGF reporters |
10 ug each |
421-Eur |
SBI |
|
CD510VB-1 |
Lentiviral Technology pCDH-CMV-MCS-EF1-Puro cDNA Vector cDNA Clon_Exp Vector [pre-packaged virus] |
>1 x 10^6 IFUs |
759-Eur |
SBI |
|
LVP315 |
h Myc (Neo) inducible particles: Pre-made tet-inducible, serum-free lentiviral particles expressing human MYC gene. A Neomycin marker was expressed under RSV promoter. |
1x10e7 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP461-PBS |
Luciferase (firefly)-
2A-GFP (RFP-Bsd), in vivo ready: Pre-made lentiviral particles bicistronically expressing firefly luciferase and GFP under optinal inducible CMV promoter. And a RFP-Blasticidin |
5x107 IFU/ml x 200ul |
770-Eur |
GenTarget |
|
LVP524 |
CRE-2A-RFP (Neo), EF1a lentivirus: Pre-made lentiviral particles bicistronically express (under EF1a promoter) nuclear permeable CRE recombinase and the RFP marker under the same suEF1a promoter. A N |
1x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP461 |
Luciferase (firefly)-
2A-GFP (RFP-Bsd)
: Pre-made lentiviral particles bicistronically expressing firefly luciferase and GFP under optinal inducible CMV promoter. And a RFP-Blasticidin fusion dual mar |
1x107 IFU/ml x 200ul |
552-Eur |
GenTarget |
|
LVP527 |
CRE-2A-GFP (Neo), EF1a lentivirus: Pre-made lentiviral particles bicistronically express (under EF1a promoter) nuclear permeable CRE recombinase and the GFP marker under the same suEF1a promoter. A N |
1x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP323-PBS |
Luciferase (firefly)-2A-GFP (Bsd), in vivo ready: Pre-made lentiviral particles expressing firefly luciferase with GFP and Blasticidin dual marker, provided in PBS solution. |
5x107 IFU/ml x 200ul |
770-Eur |
GenTarget |
|
LVP525 |
CRE-2A-GFP (Bsd), EF1a lentivirus: Pre-made lentiviral particles bicistronically express (under EF1a promoter) nuclear permeable CRE recombinase and the GFP marker under the same suEF1a promoter. A B |
1x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP315m |
m Myc (Neo) inducible particles : Pre-made tet-inducible, serum-free lentiviral particles expressing mouse MYC gene. A Neomycin marker was expressed under RSV promoter. |
1x10e7 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP522 |
CRE-2A-RFP (Bsd), EF1a lentivirus: Pre-made lentiviral particles bicistronically express (under EF1a promoter) nuclear permeable CRE recombinase and the RFP marker under the same suEF1a promoter. A Bl |
1x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP462-PBS |
Luciferase (firefly)-
2A-GFP (RFP-Puro), in vivo ready: Pre-made lentiviral particles bicistronically expressing firefly luciferase and GFP under optinal inducible CMV promoter. And a RFP-Puromycin f |
5x107 IFU/ml x 200ul |
770-Eur |
GenTarget |
|
LVP463 |
EF1a-Luc (firefly)-
2A-GFP (RFP-Bsd)
: Pre-made lentiviral particles bicistronically expressing firefly luciferase and GFP under an enhanced EF1a promoter. And a RFP-Blasticidin fusion dual marker is |
1x107 IFU/ml x 200ul |
552-Eur |
GenTarget |
|
LVP463-PBS |
EF1a-Luc (firefly)-
2A-GFP (RFP-Bsd), in vivo ready: Pre-made lentiviral particles bicistronically expressing firefly luciferase and GFP under an enhanced EF1a promoter. And a RFP-Blasticidin fusion d |
5x107 IFU/ml x 200ul |
770-Eur |
GenTarget |
|
LVP523 |
CRE-2A-RFP (Puro), EF1a lentivirus: Pre-made lentiviral particles bicistronically express (under EF1a promoter) nuclear permeable CRE recombinase and the RFP marker under the same suEF1a promoter. A |
1x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP526 |
CRE-2A-GFP (Puro), EF1a lentivirus: Pre-made lentiviral particles bicistronically express (under EF1a promoter) nuclear permeable CRE recombinase and the GFP marker under the same suEF1a promoter. A |
1x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LTSH-Bsd |
pEco-Lenti-H1-shRNA-(Bsd) cloning kit: shRNA cloning kit for generate optional inducible lentiviral RNAi expression clones with Blasticidin selection marker |
kit |
770-Eur |
GenTarget |
|
LVP324-PBS |
Luciferase (firefly)-2A-RFP (Puro), in vivo ready: Pre-made lentiviral particles expressing firefly luciferase with RFP and puromycin dual marker, provided in PBS solution. |
5x107 IFU/ml x 200ul |
770-Eur |
GenTarget |
|
LVP374 |
Luciferase (Cypridina), (GFP-Bsd): Pre-made lucifierase (Cypridina) lentiviral particles. Luciferase was expressed under a tetrcycline inducible suCMV promoter. A GFP-Blasticidin fusion dual marker w |
1 x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP368-PBS |
Luciferase (Renilla), (GFP-Bsd), in vivo ready: Pre-made lucifierase (Renilla) lentiviral particles. Luciferase was expressed under a tetrcycline inducible suCMV promoter. A GFP-Blasticidin fusion du |
5 x107 IFU/ml x 200ul |
770-Eur |
GenTarget |
|
LVP403 |
Luciferase (firefly)-2A-GFP (Neo)
: Pre-made lentiviral particles expressing firefly luciferase with GFP and Neomycin dual marker, provided in DMEM medium with 10 percent FBS and 60ug_ml of polybrene |
1x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP378-PBS |
Luciferase (Cypridina), (Bsd), in vivo ready : Pre-made lucifierase (Cypridina) lentiviral particles. Luciferase was expressed under a tetrcycline inducible suCMV promoter. A blasticidin marker was ex |
5 x107 IFU/ml x 200ul |
770-Eur |
GenTarget |
|
LVP373 |
Luciferase (Cypridina)
(RFP-Bsd)
: Pre-made lucifierase (Cypridina) lentiviral particles. Luciferase was expressed under a tetrcycline inducible suCMV promoter. A RFP-Blasticidin fusion dual marker |
1 x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP402 |
Luciferase (firefly)-2A-RFP (Neo)
: Pre-made lentiviral particles expressing firefly luciferase with RFP and Neomycin dual marker, provided in DMEM medium with 10 percent FBS and 60ug_ml of polybrene |
1x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP311m |
m OCT4 (Neo) inducible particles : Pre-made tet-inducible, serum-free lentiviral particles expressing mouse Oct3_4 gene. A Neomycin marker was expressed under RSV promoter. |
1x10e7 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP374-PBS |
Luciferase (Cypridina), (GFP-Bsd), in vivo ready: Pre-made lucifierase (Cypridina) lentiviral particles. Luciferase was expressed under a tetrcycline inducible suCMV promoter. A GFP-Blasticidin fusio |
5 x107 IFU/ml x 200ul |
770-Eur |
GenTarget |
|
LVP373-PBS |
Luciferase (Cypridina), (RFP-Bsd), in vivo ready: Pre-made lucifierase (Cypridina) lentiviral particles. Luciferase was expressed under a tetrcycline inducible suCMV promoter. A A RFP-Blasticidin fusi |
5 x107 IFU/ml x 200ul |
770-Eur |
GenTarget |
|
LVP368 |
Luciferase (Renilla), (GFP-Bsd): Pre-made lucifierase (Renilla) lentiviral particles. Luciferase was expressed under a tetrcycline inducible suCMV promoter. A GFP-Blasticidin fusion dual marker was e |
1 x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP323 |
Luciferase (firefly)-2A-GFP (Bsd): Pre-made lentiviral particles expressing firefly luciferase with GFP and Blasticidin dual marker, provided in DMEM medium with 10 percent FBS and 60ug_ml of polybre |
1x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP362 |
Luciferase (Gaussia), (GFP-Bsd): Pre-made lucifierase (Gaussia) lentiviral particles. Luciferase was expressed under a tetrcycline inducible suCMV promoter. A GFP-Blasticidin fusion dual marker was e |
1 x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP362-PBS |
Luciferase (Gaussia), (GFP-Bsd), in vivo ready: Pre-made lucifierase (Gaussia) lentiviral particles. Luciferase was expressed under a tetrcycline inducible suCMV promoter. A GFP-Blasticidin fusion du |
5 x107 IFU/ml x 200ul |
770-Eur |
GenTarget |
|
LVP361-PBS |
Luciferase (Gaussia), (RFP-Bsd), in vivo ready: Pre-made lucifierase (Gaussia) lentiviral particles. Luciferase was expressed under a tetrcycline inducible suCMV promoter. A A RFP-Blasticidin fusion d |
5 x107 IFU/ml x 200ul |
770-Eur |
GenTarget |
|
LVP311 |
h OCT4 (Neo) inducible particles: Pre-made tet-inducible, serum-free lentiviral particles expressing human Oct3_4 gene. A Neomycin marker was expressed under RSV promoter. |
1x10e7 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP009 |
Luciferase (firefly)-2A-RFP (Bsd)
: Pre-made lentiviral particles expressing firefly luciferase with RFP and Blasticidin dual marker, provided in DMEM medium with 10 percent FBS and 60ug_ml of polyb |
1x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP464-PBS |
EF1a-Luc (firefly)-
2A-GFP (RFP-Puro), in vivo ready: Pre-made lentiviral particles bicistronically expressing firefly luciferase and GFP under an enhanced EF1a promoter. And a RFP-Puromycin fusion du |
5x107 IFU/ml x 200ul |
770-Eur |
GenTarget |
|
LVP462 |
Luciferase (firefly)-
2A-GFP (RFP-Puro)
: Pre-made lentiviral particles bicistronically expressing firefly luciferase and GFP under optinal inducible CMV promoter. And a RFP-Puromycin fusion dual mark |
1x107 IFU/ml x 200ul |
552-Eur |
GenTarget |
|
LVP464 |
EF1a-Luc (firefly)-
2A-GFP (RFP-Puro)
: Pre-made lentiviral particles bicistronically expressing firefly luciferase and GFP under an enhanced EF1a promoter. And a RFP-Puromycin fusion dual marker is e |
1x107 IFU/ml x 200ul |
552-Eur |
GenTarget |
|
LVP361 |
Luciferase (Gaussia)
(RFP-Bsd)
: Pre-made lucifierase (Gaussia) lentiviral particles. Luciferase was expressed under a tetrcycline inducible suCMV promoter. A RFP-Blasticidin fusion dual marker was |
1 x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP367 |
Luciferase (Renilla)
(RFP-Bsd)
: Pre-made lucifierase (Renilla) lentiviral particles. Luciferase was expressed under a tetrcycline inducible suCMV promoter. A RFP-Blasticidin fusion dual marker was |
1 x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP367-PBS |
Luciferase (Renilla), (RFP-Bsd), in vivo ready: Pre-made lucifierase (Renilla) lentiviral particles. Luciferase was expressed under a tetrcycline inducible suCMV promoter. A A RFP-Blasticidin fusion d |
5 x107 IFU/ml x 200ul |
770-Eur |
GenTarget |
|
LVP375-PBS |
Luciferase (Cypridina), (RFP-Puro), in vivo ready: Pre-made lucifierase (Cypridina) lentiviral particles. Luciferase was expressed under a tetrcycline inducible suCMV promoter. A RFP-puromycin fusion |
5 x107 IFU/ml x 200ul |
770-Eur |
GenTarget |
|
LVP376-PBS |
Luciferase (Cypridina), (Neo), in vivo ready: Pre-made lucifierase (Cypridina) lentiviral particles. Luciferase was expressed under a tetrcycline inducible suCMV promoter. A Neomycin marker was expres |
5 x107 IFU/ml x 200ul |
770-Eur |
GenTarget |
|
LVP366-PBS |
Luciferase (Gaussia), (Bsd), in vivo ready : Pre-made lucifierase (Gaussia) lentiviral particles. Luciferase was expressed under a tetrcycline inducible suCMV promoter. A blasticidin marker was expres |
5 x107 IFU/ml x 200ul |
770-Eur |
GenTarget |
|
LVP363 |
Luciferase (Gaussia), (RFP-Puro): Pre-made lucifierase (Gaussia) lentiviral particles. Luciferase was expressed under a tetrcycline inducible suCMV promoter. A RFP-puromycin fusion dual marker was exp |
1 x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP375 |
Luciferase (Cypridina), (RFP-Puro): Pre-made lucifierase (Cypridina) lentiviral particles. Luciferase was expressed under a tetrcycline inducible suCMV promoter. A RFP-puromycin fusion dual marker was |
1 x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP020 |
Luciferase (firefly)-2A-GFP (Puro)
: Pre-made lentiviral particles expressing firefly luciferase with GFP and Puromycin dual marker, provided in DMEM medium with 10 percent FBS and 60ug_ml of polybr |
1x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP003 |
h OCT4 (RFP-Bsd) inducible particles: Pre-made tet-inducible, serum-free lentiviral particles expressing human Oct3_4 gene. A Blasticidin-RFP fusion marker was expressed under RSV promoter. |
1x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP369 |
Luciferase (Renilla), (RFP-Puro): Pre-made lucifierase (Renilla) lentiviral particles. Luciferase was expressed under a tetrcycline inducible suCMV promoter. A RFP-puromycin fusion dual marker was exp |
1 x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP372-PBS |
Luciferase (Renilla), (Bsd), in vivo ready : Pre-made lucifierase (Renilla) lentiviral particles. Luciferase was expressed under a tetrcycline inducible suCMV promoter. A blasticidin marker was expres |
5 x107 IFU/ml x 200ul |
770-Eur |
GenTarget |
|
LVP377-PBS |
Luciferase (Cypridina), (Puro), in vivo ready: Pre-made lucifierase (Cypridina) lentiviral particles. Luciferase was expressed under a tetrcycline inducible suCMV promoter. A puromycin marker was expr |
5 x107 IFU/ml x 200ul |
770-Eur |
GenTarget |
|
LVP365-PBS |
Luciferase (Gaussia), (Puro), in vivo ready: Pre-made lucifierase (Gaussia) lentiviral particles. Luciferase was expressed under a tetrcycline inducible suCMV promoter. A puromycin marker was expresse |
5 x107 IFU/ml x 200ul |
770-Eur |
GenTarget |
|
LVP371-PBS |
Luciferase (Renilla), (Puro), in vivo ready: Pre-made lucifierase (Renilla) lentiviral particles. Luciferase was expressed under a tetrcycline inducible suCMV promoter. A puromycin marker was expresse |
5 x107 IFU/ml x 200ul |
770-Eur |
GenTarget |
|
LVP369-PBS |
Luciferase (Renilla), (RFP-Puro), in vivo ready: Pre-made lucifierase (Renilla) lentiviral particles. Luciferase was expressed under a tetrcycline inducible suCMV promoter. A RFP-puromycin fusion dual |
5 x107 IFU/ml x 200ul |
770-Eur |
GenTarget |
|
LVP363-PBS |
Luciferase (Gaussia), (RFP-Puro), in vivo ready: Pre-made lucifierase (Gaussia) lentiviral particles. Luciferase was expressed under a tetrcycline inducible suCMV promoter. A RFP-puromycin fusion dual |
5 x107 IFU/ml x 200ul |
770-Eur |
GenTarget |
|
QM600A-1 |
Lentiviral Technology Cumate Starter Pack Your choice of inducible vector below, + CymR-T2A-Puro (packaged virus, QM200VA-1) and Cumate solution (1000x, QM100A-1). Indicate your inducible lentivecto |
1 kit |
1153-Eur |
SBI |
|
EF1a-Null-Puro |
EF1a Control lentiviral particles (Puro) |
1 x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
EF1a-Null-Puro-PBS |
EF1a Control lentiviral particles (Puro) in PBS |
1 x108 IFU/ml x 200ul |
770-Eur |
GenTarget |
|
LVP460-Bsd-PBS |
LoxP GFP_RFP ColorSwitch (Bsd) lentivirus (concentrated): Pre-made lentiviral particles expressing "LoxP-GFP-stop-LoxP-RFP-Stop" cassette under suCMV promoter. It also contains a Blasticidin antibioti |
5x107 IFU/ml x 200ul |
933-Eur |
GenTarget |
|
LVP460-Neo-PBS |
LoxP GFP_RFP ColorSwitch (Neo) lentivirus (concentrated): Pre-made lentiviral particles expressing "LoxP-GFP-stop-LoxP-RFP-Stop" cassette under suCMV promoter. It also contains a Neomycin antibiotic s |
5x107 IFU/ml x 200ul |
933-Eur |
GenTarget |
|
LVP460-Bsd |
LoxP GFP_RFP ColorSwitch (Bsd) lentivirus: Pre-made lentiviral particles expressing "LoxP-GFP-stop-LoxP-RFP-Stop" cassette under suCMV promoter. It also contains a Blasticidin antibiotic selection mar |
1x107 IFU/ml x 200ul |
770-Eur |
GenTarget |
|
LVP460-Neo |
LoxP GFP_RFP ColorSwitch (Neo) lentivirus: Pre-made lentiviral particles expressing "LoxP-GFP-stop-LoxP-RFP-Stop" cassette under suCMV promoter. It also contains a Neomycin antibiotic selection marker |
1x107 IFU/ml x 200ul |
770-Eur |
GenTarget |
|
LVP372 |
Luciferase (Renilla), (Bsd) : Pre-made lucifierase (Renilla) lentiviral particles. Luciferase was expressed under a tetrcycline inducible suCMV promoter. A Blasticidin marker was expressed under RSV p |
1 x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP366 |
Luciferase (Gaussia), (Bsd) : Pre-made lucifierase (Gaussia) lentiviral particles. Luciferase was expressed under a tetrcycline inducible suCMV promoter. A Blasticidin marker was expressed under RSV p |
1 x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LTSH-GB |
pEco-Lenti-H1-shRNA-(GFP-Bsd) cloning kit: shRNA cloning kit for generate inducible inducible lentiviral RNAi expression clones with GFP-Blasticidin selection marker |
kit |
770-Eur |
GenTarget |
|
LTSH-RB |
pEco-Lenti-H1-shRNA-(RFP-Bsd) cloning kit: shRNA cloning kit for generate inducible inducible lentiviral RNAi expression clones with RFP-Blasticidin selection marker |
kit |
770-Eur |
GenTarget |
|
LVP376 |
Luciferase (Cypridina), (Neo) : Pre-made lucifierase (Cypridina) lentiviral particles. Luciferase was expressed under a tetrcycline inducible suCMV promoter. A Neomycin marker was expressed under RSV |
1 x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP378 |
Luciferase (Cypridina), (Bsd) : Pre-made lucifierase (Cypridina) lentiviral particles. Luciferase was expressed under a tetrcycline inducible suCMV promoter. A Blasticidin marker was expressed under R |
1 x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP326 |
Luciferase (firefly) (Bsd): Pre-made lucifierase (firefly) lentiviral particles. Luciferase was expressed under a tetrcycline inducible suCMV promoter. A Blasticidin marker was expressed under RSV pro |
1 x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP439 |
EF1a-Luciferase (firefly)-2A-RFP (Bsd) : Pre-made lentiviral particles bicistronically expressing firefly luciferase and RFP fluorescent protein under EF1a promoter, with Neomycin selection marker un |
1x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP438 |
EF1a-Luciferase (firefly)-2A-GFP (Neo): Pre-made lentiviral particles bicistronically expressing firefly luciferase and GFP fluorescent protein under EF1a promoter, with Neomycin selection marker und |
1x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP441 |
EF1a-Luciferase (firefly)-2A-RFP (Neo): Pre-made lentiviral particles bicistronically expressing firefly luciferase and RFP fluorescent protein under EF1a promoter, with Neomycin selection marker und |
1x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP436 |
EF1a-Luciferase (firefly)-2A-GFP (Bsd): Pre-made lentiviral particles bicistronically expressing firefly luciferase and GFP fluorescent protein under EF1a promoter, with Neomycin selection marker und |
1x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LTSH-GP |
pEco-Lenti-H1-shRNA-(GFP-Puro) cloning kit: shRNA cloning kit for generate inducible inducible lentiviral RNAi expression clones with GFP-Puromycin selection marker |
kit |
770-Eur |
GenTarget |
|
LVP314 |
h LIN28 (Neo) inducible particles: Pre-made tet-inducible, serum-free lentiviral particles expressing human LIN28 gene. A Neomycin marker was expressed under RSV promoter. |
1x10e7 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP316 |
h KLF4 (Neo) inducible particles: Pre-made tet-inducible, serum-free lentiviral particles expressing human KLF4 gene. A Neomycin marker was expressed under RSV promoter. |
1x10e7 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP313m |
m NANOG (Neo) inducible particles : Pre-made tet-inducible, serum-free lentiviral particles expressing mouse NANOG gene. A Neomycin marker was expressed under RSV promoter. |
1x10e7 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP314m |
m LIN28 (Neo) inducible particles : Pre-made tet-inducible, serum-free lentiviral particles expressing mouse LIN28 gene. A Neomycin marker was expressed under RSV promoter. |
1x10e7 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP370 |
Luciferase (Renilla), (Neo) : Pre-made lucifierase (Renilla) lentiviral particles. Luciferase was expressed under a tetrcycline inducible suCMV promoter. A Neomycin marker was expressed under RSV prom |
1 x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP365 |
Luciferase (Gaussia), (Puro): Pre-made lucifierase (Gaussia) lentiviral particles. Luciferase was expressed under a tetrcycline inducible suCMV promoter. A puromycin marker was expressed under RSV pro |
1 x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP316m |
m KLF4 (Neo) inducible particles: Pre-made tet-inducible, serum-free lentiviral particles expressing mouse KLF4 gene. A Neomycin marker was expressed under RSV promoter. |
1x10e7 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP364 |
Luciferase (Gaussia), (Neo) : Pre-made lucifierase (Gaussia) lentiviral particles. Luciferase was expressed under a tetrcycline inducible suCMV promoter. A Neomycin marker was expressed under RSV prom |
1 x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP312 |
h SOX2 (Neo) inducible particles: Pre-made tet-inducible, serum-free lentiviral particles expressing human SOX2 gene. A Neomycin marker was expressed under RSV promoter. |
1x10e7 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP312m |
m Sox2 (Neo) inducible particles : Pre-made tet-inducible, serum-free lentiviral particles expressing mouse SOX2 gene. A Neomycin marker was expressed under RSV promoter. |
1x10e7 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP324 |
Luciferase (firefly)-2A-RFP (Puromycin): Pre-made lentiviral particles expressing firefly luciferase with RFP and Puromycin dual marker, provided in DMEM medium with 10 percent FBS and 60ug_ml of pol |
1x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP371 |
Luciferase (Renilla), (Puro): Pre-made lucifierase (Renilla) lentiviral particles. Luciferase was expressed under a tetrcycline inducible suCMV promoter. A puromycin marker was expressed under RSV pro |
1 x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP283 |
Luciferase (firefly), (Neo): Pre-made lucifierase (firefly) lentiviral particles. Luciferase was expressed under a tetrcycline inducible suCMV promoter. A Neomycin marker was expressed under RSV promo |
5 x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LTSH-RP |
pEco-Lenti-H1-shRNA-(RFP-Puro) cloning kit: shRNA cloning kit for generate inducible inducible lentiviral RNAi expression clones with RFP-puromycin selection marker |
kit |
770-Eur |
GenTarget |
|
LVP313 |
h NANOG (Neo) inducible particles: Pre-made tet-inducible, serum-free lentiviral particles expressing human NANOG gene. A Neomycin marker was expressed under RSV promoter. |
1x10e7 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP377 |
Luciferase (Cypridina), (Puro): Pre-made lucifierase (Cypridina) lentiviral particles. Luciferase was expressed under a tetrcycline inducible suCMV promoter. A puromycin marker was expressed under RSV |
1 x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP440 |
EF1a-Luciferase (firefly)-2A-RFP (Puro): Pre-made lentiviral particles bicistronically expressing firefly luciferase and RFP fluorescent protein under EF1a promoter, with Puromycin selection marker u |
1x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP283-PBS |
Luciferase (firefly), (Neo), in vivo ready: Pre-made lucifierase (firefly) lentiviral particles. Luciferase was expressed under a tetrcycline inducible suCMV promoter. A Neomycin marker was expressed |
5 x107 IFU/ml x 200ul |
770-Eur |
GenTarget |
|
LVP439-PBS |
EF1a-Luciferase (firefly)-2A-RFP (Bsd), in vivo ready: Pre-made lentiviral particles bicistronically expressing firefly luciferase and RFP fluorescent protein under EF1a promoter, with Neomycin selec |
5x10e7 IFU/ml x 200ul |
770-Eur |
GenTarget |
|
LVP438-PBS |
EF1a-Luciferase (firefly)-2A-GFP (Neo), in vivo ready: Pre-made lentiviral particles bicistronically expressing firefly luciferase and GFP fluorescent protein under EF1a promoter, with Neomycin selec |
5x10e7 IFU/ml x 200ul |
770-Eur |
GenTarget |
|
LVP004 |
h SOX2 (RFP-Bsd) inducible particles: Pre-made tet-inducible, serum-free lentiviral particles expressing human SOX2 gene. A Blasticidin-RFP fusion marker was expressed under RSV promoter. |
1x10e7 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP440-PBS |
EF1a-Luciferase (firefly)-2A-RFP (Puro), in vivo ready: Pre-made lentiviral particles bicistronically expressing firefly luciferase and RFP fluorescent protein under EF1a promoter, with Puromycin sel |
5x10e7 IFU/ml x 200ul |
770-Eur |
GenTarget |
|
LVP441-PBS |
EF1a-Luciferase (firefly)-2A-RFP (Neo), in vivo ready: Pre-made lentiviral particles bicistronically expressing firefly luciferase and RFP fluorescent protein under EF1a promoter, with Neomycin selec |
5x10e7 IFU/ml x 200ul |
770-Eur |
GenTarget |
|
LVP005 |
h NANOG (RFP-Bsd) inducible particles: Pre-made tet-inducible, serum-free lentiviral particles expressing human NANOG gene. A Blasticidin-RFP fusion marker was expressed under RSV promoter. |
1x10e7 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP007 |
h cMyc (RFP-Bsd) inducible particles: Pre-made tet-inducible, serum-free lentiviral particles expressing human cMyc gene. A Blasticidin-RFP fusion marker was expressed under RSV promoter. |
1x10e7 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP008 |
h KLF4 (RFP-Bsd) inducible particles: Pre-made tet-inducible, serum-free lentiviral particles expressing human Klf4 gene. A Blasticidin-RFP fusion marker was expressed under RSV promoter. |
1x10e7 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LTSH-Puro |
pEco-Lenti-H1-shRNA-(Puro) cloning kit: shRNA cloning kit for generate optional inducible lentiviral RNAi expression clones with Puromycin selection marker |
kit |
770-Eur |
GenTarget |
|
LVP325 |
Luciferase (firefly)
(Puro): Pre-made lucifierase (firefly) lentiviral particles. Luciferase was expressed under a tetrcycline inducible suCMV promoter. A puromycin marker was expressed under RSV prom |
1 x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP437-PBS |
EF1a-Luciferase (firefly)-2A-GFP (Puro), in vivo ready: Pre-made lentiviral particles bicistronically expressing firefly luciferase and GFP fluorescent protein under EF1a promoter, with Puromycin sel |
5x10e7 IFU/ml x 200ul |
770-Eur |
GenTarget |
|
LVP437 |
EF1a-Luciferase (firefly)-2A-GFP (Puro): Pre-made lentiviral particles bicistronically expressing firefly luciferase and GFP fluorescent protein under EF1a promoter, with Puromycin selection marker u |
1x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP006 |
h LIN28 (RFP-Bsd) inducible particles: Pre-made tet-inducible, serum-free lentiviral particles expressing human LIN28 gene. A Blasticidin-RFP fusion marker was expressed under RSV promoter. |
1x10e7 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP370-PBS |
Luciferase (Renilla), (Neo), in vivo ready: Pre-made lucifierase (Renilla) lentiviral particles. Luciferase was expressed under a tetrcycline inducible suCMV promoter. A Neomycin marker was expressed |
5 x107 IFU/ml x 200ul |
770-Eur |
GenTarget |
|
LVP364-PBS |
Luciferase (Gaussia), (Neo), in vivo ready: Pre-made lucifierase (Gaussia) lentiviral particles. Luciferase was expressed under a tetrcycline inducible suCMV promoter. A Neomycin marker was expressed |
5 x107 IFU/ml x 200ul |
770-Eur |
GenTarget |
|
LVP433 |
EF1a-Luciferase (firefly) (Bsd): Pre-made lentiviral particles expressing firefly luciferase under EF1a promoter with Blastidicin selection marker, provided in DMEM medium with 10 percent FBS and 60u |
1x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP433-PBS |
EF1a-Luciferase (firefly), (Bsd), in vivo ready: Pre-made lentiviral particles expressing firefly luciferase under EF1a promoter with Blastidicin selection marker, provided in PBS solution. |
5x10e7 IFU/ml x 200ul |
770-Eur |
GenTarget |
|
LVP435-PBS |
EF1a-Luciferase (firefly), (Neo), in vivo ready: Pre-made lentiviral particles expressing firefly luciferase under EF1a promoter with Neomycin selection marker, provided in PBS solution. |
5x10e7 IFU/ml x 200ul |
770-Eur |
GenTarget |
|
LVP436-PBS |
EF1a-Luciferase (firefly)-2A-GFP (Bsd), in vivo ready: Pre-made lentiviral particles bicistronically expressing firefly luciferase and GFP fluorescent protein under EF1a promoter, with Neomycin selec |
5x10e7 IFU/ml x 200ul |
770-Eur |
GenTarget |
|
LVP434-PBS |
EF1a-Luciferase (firefly), (Puro), in vivo ready: Pre-made lentiviral particles expressing firefly luciferase under EF1a promoter with Puromycin selection marker, provided in PBS solution. |
5x10e7 IFU/ml x 200ul |
770-Eur |
GenTarget |
|
LVP435 |
EF1a-Luciferase (firefly) (Neo): Pre-made lentiviral particles expressing firefly luciferase under EF1a promoter with Neomycin selection marker, provided in DMEM medium with 10 percent FBS and 60ug_m |
1x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP434 |
EF1a-Luciferase (firefly) (Puro): Pre-made lentiviral particles expressing firefly luciferase under EF1a promoter with Puromycin selection marker, provided in DMEM medium with 10 percent FBS and 60ug |
1x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP-stems-m-RB |
Full set (6 mouse stem factors with RFP-Bsd marker): Pre-made tet-inducible, serum-free lentiviral particles for Six mouse stem cell factors: Oct4, NANOG, SOX2, cMyc, LIN28 and Klf4. A RFP-Bsd fusion |
200ul x 6 |
1130-Eur |
GenTarget |
|
LVP-stems-h-RB |
Full set (6 human stem factors-with RFP-Bsd marker): Pre-made tet-inducible, serum-free lentiviral particles for Six human stem cell factors: Oct4, NANOG, SOX2, cMyc, LIN28 and Klf4. A RFP-BSD dual fu |
200ul x 6 |
1130-Eur |
GenTarget |
|
CMV-Null-RP |
CMV Control lentiviral particles (RFP-Puro): Negative control lentivirus contains a null spacer insert under CMV promoter, serves as the negative control of lentivurs treatment for the specificity of |
1 x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
CMV-Null-GP |
CMV Control lentiviral particles (GFP-Puro): Negative control lentivirus contains a null spacer insert under CMV promoter, serves as the negative control of lentivurs treatment for the specificity of |
1 x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
CMV-Null-RB |
CMV Control lentiviral particles (RFP-Bsd): Negative control lentivirus contains a null spacer insert under CMV promoter, serves as the negative control of lentivurs treatment for the specificity of |
1 x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
CMV-Null-Bsd |
CMV Control lentiviral particles (Bsd): Negative control lentivirus contains a null spacer insert under CMV promoter, serves as the negative control of lentivurs treatment for the specificity of any |
1 x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
CMV-Null-Neo |
CMV Control lentiviral particles (Neo): Negative control lentivirus contains a null spacer insert under CMV promoter, serves as the negative control of lentivurs treatment for the specificity of any |
1 x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
CMV-Null-GB |
CMV Control lentiviral particles (GFP-Bsd): Negative control lentivirus contains a null spacer insert under CMV promoter, serves as the negative control of lentivurs treatment for the specificity of |
1 x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP460-Puro-PBS |
LoxP GFP_RFP ColorSwitch (Puro) lentivirus (concentrated): Pre-made lentiviral particles expressing "LoxP-GFP-stop-LoxP-RFP-Stop" cassette under suCMV promoter. It also contains a puromycin antibiotic |
5x107 IFU/ml x 200ul |
933-Eur |
GenTarget |
|
LVP460-Puro |
LoxP GFP_RFP ColorSwitch (Puro) lentivirus: Pre-made lentiviral particles expressing "LoxP-GFP-stop-LoxP-RFP-Stop" cassette under suCMV promoter. It also contains a puromycin antibiotic selection mark |
1x107 IFU/ml x 200ul |
770-Eur |
GenTarget |
|
LVP007m |
m Myc (RFP-Bsd) inducible particles : Pre-made tet-inducible lentiviral particles expressing a mouse gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed mouse gene, Myc, is fully |
1x10e7 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP-stems-m-N |
Full set (6 mouse stem factors with Neomycin marker): Pre-made tet-inducible, serum-free lentiviral particles for Six mouse stem cell factors: Oct4, NANOG, SOX2, cMyc, LIN28 and Klf4. A Neomycin marke |
200ul x 6 |
1130-Eur |
GenTarget |
|
LVP-stems-h-N |
Full set (6 human stem factors-with Neomycin marker): Pre-made tet-inducible, serum-free lentiviral particles for Six human stem cell factors: Oct4, NANOG, SOX2, cMyc, LIN28 and Klf4. A Neomycin marke |
200ul x 6 |
1130-Eur |
GenTarget |
|
LVP-stems-h-EF1a |
Full set (6 human stem factors expressed under EF1a promoter): Pre-made, serum-free lentiviral particles for Six human stem cell factors: Oct4, NANOG, SOX2, cMyc, LIN28 and Klf4. Each factor was expre |
200ul x 6 |
1130-Eur |
GenTarget |
|
CMV-Null-Puro |
CMV Control lentiviral particles (Puro): Negative control lentivirus contains a null spacer insert under CMV promoter, serves as the negative control of lentivurs treatment for the specificity of any |
1 x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP008m |
m Klf4 (RFP-Bsd) inducible particles : Pre-made tet-inducible lentiviral particles expressing a mouse gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed mouse gene, Klf4, is ful |
1x10e7 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP006m |
m LIN28 (RFP-Bsd) inducible particles : Pre-made tet-inducible lentiviral particles expressing a mouse gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed mouse gene,LIN28, is fu |
1x10e7 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP005m |
m NANOG (RFP-Bsd) inducible particles : Pre-made tet-inducible lentiviral particles expressing a mouse gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed mouse gene, NANOG, is f |
1x10e7 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP003m |
m OCT4 (RFP-Bsd) inducible particles : Pre-made tet-inducible lentiviral particles expressing a mouse gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed mouse gene, OCT4, is ful |
1x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
LVP004m |
m Sox2 (RFP-Bsd) inducible particles : Pre-made tet-inducible lentiviral particles expressing a mouse gene with a Blasticidin-RFP fusion marker (Dual selection). The expressed mouse gene, Sox2, is ful |
1x10e7 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
EF1a-Null-RP |
EF1a Control lentiviral particles (RFP-Puro): Negative control lentivirus contains a null spacer insert under EF1a promoter, serves as the negative control of lentivurs treatment for the specificity |
1 x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
EF1a-Null-GP |
EF1a Control lentiviral particles (GFP-Puro): Negative control lentivirus contains a null spacer insert under EF1a promoter, serves as the negative control of lentivurs treatment for the specificity |
1 x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
EF1a-Null-RB |
EF1a Control lentiviral particles (RFP-Bsd): Negative control lentivirus contains a null spacer insert under EF1a promoter, serves as the negative control of lentivurs treatment for the specificity o |
1 x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
EF1a-Null-GB |
EF1a Control lentiviral particles (GFP-Bsd): Negative control lentivirus contains a null spacer insert under EF1a promoter, serves as the negative control of lentivurs treatment for the specificity o |
1 x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
EF1a-Null-Neo |
EF1a Control lentiviral particles (Neo): Negative control lentivirus contains a null spacer insert under EF1a promoter, serves as the negative control of lentivurs treatment for the specificity of an |
1 x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
EF1a-Null-Bsd |
EF1a Control lentiviral particles (Bsd): Negative control lentivirus contains a null spacer insert under EF1a promoter, serves as the negative control of lentivurs treatment for the specificity of an |
1 x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|
EF1a-Null-Puro |
EF1a Control lentiviral particles (Puro): Negative control lentivirus contains a null spacer insert under EF1a promoter, serves as the negative control of lentivurs treatment for the specificity of a |
1 x107 IFU/ml x 200ul |
381-Eur |
GenTarget |
|